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Abstract of Thesis 
Over the last decade or more, chronic illness research has consistently found that 
the assumed linear relationship between knowledge and behaviour or between 
behaviour change and improved health outcomes does not exist. Furthermore, the 
link between behaviour and health status is not as strong as the link between 
illness-specific efficacy belief and health status. Strategies to increase confidence 
in illness-specific behaviours have gradually assumed more importance in 
improving health outcomes.  
 
Strategies to improve behaviour-specific efficacy belief can assist individuals to 
change their behaviour by influencing behavioural choices, effort and persistence 
with task demands. Concomitantly, it has been suggested that there is a positive 
relationship between efficacy belief and psychosocial functioning. It is unclear as 
to whether this empirical evidence also applies to chronic illness conditions with a 
complex self-care regimen. The degree to which a more general level of 
confidence, or efficacy belief, can also contribute to psychosocial functioning is 
unknown. The focus of this study was to examine the relative impact of general and 
illness-specific efficacy expectations on psychosocial adaptation to illness over 
nine months. The study measured illness-specific efficacy beliefs when it was 
expected that they were still developing. The illness-specific beliefs were 
compared to the purportedly more stable general efficacy belief.  
 
This longitudinal study employed an exploratory predictive design to measure 
efficacy beliefs in the natural setting. Data were collected at entry to the study, at 
three and nine months. Participants included adults from three chronic illness 
groups: Arthritis (n = 135), diabetes type 1 (n = 104) and type 2 (n = 122). The 
self-report questionnaires used to collect the data were three illness-specific 
efficacy belief measures, general self-efficacy and the Psychosocial Adjustment to 





Multiple regression analysis provided evidence of between-group differences in the 
positive contribution of general and illness-specific efficacy beliefs to psychosocial 
adaptation for chronic illness groups with different regimen attributes. The 
variables best able to predict psychosocial adaptation to illness over time, after 
being adjusted for perceived level of stress and general self-efficacy (belief in 
abilities in general), were illness-specific efficacy beliefs. A general efficacy belief 
contributed to the illness adaptation process initially but its influence reduced as 
the influence of illness-specific beliefs increased. Repeated measures MANOVA 
confirmed the stability of general efficacy belief.  
 
The contribution of this study to current knowledge of self-efficacy theory is its 
application to self-management programs for chronic illness groups. The findings 
suggest that the more stable general efficacy belief has a role in psychosocial 
adaptation to chronic illness during the period when illness-specific efficacy 
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EXPLANATION OF TERMS 
For the purposes of this study, the following terms are explained. 
a) Efficacy beliefs 
Judgements about ability or personal efficacy beliefs play an important role 
in effective therapeutic interventions (Maddux, 1995a). Efficacy beliefs, 
also referred to as efficacy expectations, were operationalised as a general 
construct (Sherer et al., 1982) and as multidimensional illness-specific 
measures relevant to individuals with diabetes (Hurley, 1990) or arthritis 
(Lorig, Chastain, Ung, Shoor, & Holman, 1989a). All efficacy expectation 
or belief measures were reported to be based on Bandura’s work (1977).  
General efficacy belief refers to “… a general set of expectations that the 
individual carries into new situations. These generalized expectancies 
should influence the individual’s expectations of mastery in the new 
situation” (Sherer et al., 1982, p. 664). 
Illness-specific efficacy belief refers to people’s “beliefs in their 
capabilities to mobilize the motivation, cognitive resources, and courses of 
action needed to exercise control over task demands” (Bandura, 1990, p. 
316). In this study, the term illness-specific efficacy beliefs will be used to 
refer to the individual’s belief in ability to carry out specific self-care 
behaviours.  
b) Lifestyle 
Lifestyle refers to “Patterns of behavioural choices made from alternatives 
that are available to people according to their socio-economic 
circumstances and to the ease with which they are able to choose certain 
ones over others” (Milio, 1981, p.176). 
c) Mastery experiences 
Performance mastery experience is a composite of prior experiences 
associated with carrying out the behaviour (McAuley, Lox & Duncan 
1993). It is the cognitive process associated with preconceptions about 
ability, perceived difficulty of task, effort needed and circumstances that 
will influence a change in efficacy belief (Bandura, 1997). Enactive 
 
 xvi
experience that leads to success is the most powerful source of efficacy 
information (Maddux & Lewis, 1995).  
d) Outcome expectations 
While personal efficacy expectation is a judgement about ability in relation 
to a particular behaviour or task, outcome expectation is a judgement about 
the result of enacting the behaviour (task) in question - a judgement as to 
whether the recommended behaviour will have the desired effect. Outcome 
expectation has been classified as a positive or negative expectation of a 
physical, social or self-evaluative nature (Bandura, 1989). 
 
e) Psychosocial adaptation to illness 
Psychosocial refers to more than just intrapsychic processes. Psychosocial 
includes “… interactions between the individual and other individuals and 
the institutions representing his or her sociocultural environment” 
(Derogatis & Derogatis, 1990 p. 1). More specifically, how the illness 
affects the person’s interpersonal relationships with principal cohabitants, 
interpersonal relationships with extended family and friends, social support 
expectations of others and the degree of perceived psychological distress. 
Taken together, they become judgements about the person’s psychosocial 
adjustment. 
 
In this study, the term adaptation will be used in general discussion to 
differentiate between the process and the study’s end-point measure, 
Psychosocial Adjustment to Illness Scale - Self Report version (PAIS) 
(Derogatis & Derogatis, 1990). Psychosocial adjustment refers to the 
theoretical endpoint of the adaptation process (Livneh & Antonak, 1997). 
The PAIS has seven primary domains that collectively predict psychosocial 
adjustment. The domains are health care orientation, vocational 
environment, domestic environment, sexual relationships, extended family, 




Although not measured in this study, self-care behaviour or illness-specific 
behaviour refers to a regimen of multiple tasks that people carry out in the 
management of their condition. Self-care behaviours or self-management 
tasks are described as a set of skilled behaviours engaged in by individuals 
to manage their illness (Goodall & Halford, 1991). The regimen may 
involve learning new behaviours, avoiding risk behaviours or both. 
Specifically, the treatment of chronic illnesses like diabetes and rheumatoid 
arthritis relies on the individual being able to carry out complex self-care 
tasks designed to control symptoms and avoid acute as well as chronic 
complications. At best, the regimen becomes a guide to possible 
behavioural choices.  
g) Self-management courses referred to in this study 
Two of the three groups in this study attended a six-week self-management 
course designed to assist individuals to master the relevant self-care 
regimen requirements. Each course consisted of two-hour, weekly lectures 
relevant to arthritis (Arthritis Self-Management Course – ASMC) or 




CHAPTER 1: INTRODUCTION 
1.1 INTRODUCTION 
It has been recognised for at least a decade that the treatment of disease and illness 
in industrialised countries has changed from reliance solely on medical 
interventions to also include the development of personal skills to adapt to the 
illness process (Connelly, 1987). Personal skills that enable individuals to exercise 
more control over lifestyle choices and environmental determinants of health 
(World Health Organization, 1986). It has been recommended that researchers look 
beyond behaviour change as the mediator of health status and accept that people’s 
perceptions, not objective reality, largely determine behaviour (Anderson & 
Funnell, 2000; Bandura, 1991).  
 
In particular, people’s perceptions of their ability to undertake certain tasks will 
determine their choice of behaviour, the effort that is made and the degree of 
persistence with the behaviour when problems arise (Bandura, 1997). In relation to 
a chronic illness self-care regimen, the behavioural perceptions may relate to more 
than one behaviour type. For example, the need to adopt a new behaviour 
(exercise), the need to cease at-risk behaviour (smoking) or to modify an existing 
behaviour (food choice). Each of the behaviour types can be perceived as a 
challenge for the person, influencing the amount of effort undertaken and or 
persistence under duress. 
 
The degree to which individuals meet the challenge and adjust to the demands of 
an illness experience while continuing prescribed and ascribed roles in their daily 
lives impacts on the course of the illness (Connell, Gallant, & Davis, 1995; 
Griffith, Field, & Lustman, 1990; Pollock, Christian, & Sands, 1990; White, 
Richter, & Fry, 1992). It is believed that successful management of challenging 
situations leads to adaptive or positive adjustment (Barry, 1996; Pollock, 1993; 
Pollock et al., 1990). Livneh and Antonak (1997) also suggest that one of the 
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characteristics of successful adaptation, along with positive self-esteem, personal 
mastery and adaptive coping, is self-efficacy.  
 
Self-efficacy is a cognitive resource or capacity of the individual to adapt and cope 
with chronic illness as much as life events in general (Bandura, 1997). Efficacious 
individuals are able to cope under diverse conditions and are willing to meet new 
challenges (Bandura, 1997). For the newly diagnosed individual faced with a 
complex regimen of care, belief about their ability to change and to cease or initiate 
new behaviours is generally believed to be important in determining successful 
adaptation to chronic illness (Cox & Gonder-Frederick, 1992). What is not clear, 
however, is the degree to which a general efficacy belief can also contribute to 
psychosocial functioning. The focus of the current study was to examine the 
relative impact of general and illness-specific efficacy beliefs on psychosocial 
adaptation to illness over time.  
 
In the current study, psychosocial adaptation to illness was chosen as the dependent 
variable because the perceived burden and intrusiveness of chronic illness has been 
acknowledged by a number of authors as having a direct impact on psychosocial 
adjustment (Connell et al., 1995; Landis, 1991; Pollock, 1993; White et al., 1992; 
Willoughby, Kee, Demi, & Parker, 2000). Two further points about psychosocial 
adjustment were of relevance. First, that several studies have determined that 
psychosocial adaptation is independent of a specific illness (Cassileth et al., 1984; 
Felton, Revenson, & Hinrichsen, 1984; Pollock, 1993; Pollock et al., 1990). 
Secondly, that a universal process of adaptation to chronic illness does not appear 
to exist. Variations in the adaptation process are linked to the nature of the illness 
as well as to the person’s developmental phase or stage of life when the chronic 
illness occurs (Livneh & Antonak, 1997; Rolland, 1984).  
 
The current study sought to target individuals in what Rolland (1984) refers to as 
the ‘initial adjustment’ period before the chronic ‘long haul’ phase of an illness that 
requires a rest-of-life commitment to self-care. The early period of adjustment, 
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which may take months to years, is defined by awareness that behaviour change is 
necessary, including the questioning of effective strategies and personal abilities 
(Maddux & Lewis, 1995). The ‘long haul’ or the maintenance phase of behaviour 
change, where the challenge is sustaining long-term behaviour change, occurs six 
months after behaviour change has been initiated (Ruggiero & Prochaska, 1993). 
The intention was to measure the individual’s efficacy beliefs, both general and 
specific, at a time when, according to Maddux and Lewis, behaviour-specific 
efficacy beliefs were more likely to be still developing. Also, the relative impact of 
general and specific efficacy beliefs on the individual’s psychosocial adaptation to 
illness was of interest. Self-efficacy theory proposes that any increase in the 
individual’s sense of efficacy belief – in specific situations and across a range of 
situations – facilitates adaptation (Maddux & Lewis, 1995, p. 47). The degree to 
which this is true both in the early stages of a chronic illness and also true of 
psychosocial adaptation has not been tested. Variations in the adaptation process 
because of the nature of the illness (Livneh & Antonak, 1997; Roland, 1984) may 
well be influenced by condition-specific efficacy beliefs. 
1.2 BACKGROUND TO THE PROBLEM 
Although the relevant indicators suggest that Australia is one of the healthiest 
countries in the world, Australians persist with unhealthy risk behaviours such as 
smoking (25%) and are overweight (45.7% for females; 66.3% for men) 
(Australian Institute Health and Welfare, 1998). Many chronic illnesses are caused 
by, or exacerbated by, lifestyle behaviours such as smoking, lack of exercise and 
poor dietary choices (Zimmet, 1992). For example, Australia has an increasingly 
overweight population in which the percentage of people who reported 
participation in physical exercise declined with increasing age (Australian Institute 
Health and Welfare, 1998).  
 
Evidence of the need to influence lifestyle choices to counter the increase in 
associated chronic illnesses was highlighted with the addition of diabetes mellitus 
to the National Health Priority Areas (NHPA) in 1996. McCarty, Zimmet, Dalton, 
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Segal and Welborn (1996) estimated that the minimum “… total cost of diabetes in 
Australia aggregates to around $1 billion annually or at least $2,774 per year for 
each Australian with diagnosed diabetes”. McCarty et al. also indicated the cost 
estimate to be conservative because of the lack of data at the time and because they 
did not include the psychosocial costs of premature death or loss of quality of life.  
 
There is a need for both cost-effective and health-effective strategies to reduce the 
incidence of potentially preventable diseases such as diabetes type 2. However, the 
increasing incidence of diabetes type 2, an age-related condition in which lifestyle 
has a role, is exacerbated in at least two ways. First, diabetes type 2 is largely 
undiagnosed until secondary diabetes complications are evident (McCarty et al., 
1996). Secondly, there is ample research to demonstrate that non-compliance with 
health-related behaviour changes that effect lifestyle is the norm (Blackwell, 1992; 
Dunn, 1986; Leventhal & Cameron, 1987). Changes in one’s lifestyle are difficult 
at any time and no less so for illness prevention in at-risk populations (Wing, 
Venditti, Jakicic, Polley, & Lang, 1998) as they are for health promotion in general 
(Antonovsky, 1996; Robertson & Minkler, 1994; Sluijs & Knibbe, 1991).  
 
The Ottawa Charter (World Health Organization, 1986) suggested that strategies to 
enable people to make healthy lifestyle choices should be used. Self-efficacy 
theory provides the scientific rationale for strategies that have the potential to 
increase people’s belief in their ability to undertake behaviour change. Healthy 
choices have the prospect of being able to reduce the incidence of lifestyle diseases 
and, therefore, health costs.  
1.3 PURPOSE AND RATIONALE FOR THE STUDY 
The purpose of the study was to measure the relative impact of general and illness-
specific efficacy beliefs on psychosocial adaptation to illness over time for selected 
chronic illness groups. A secondary purpose was to measure changes in illness-
specific beliefs over the nine months of the study and to make comparisons with 
the purportedly more stable general efficacy belief. Whilst there is support for the 
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notion that a more general efficacy belief is stable in adults, it has not been tested 
with individuals who are still in the early stages of adapting to the lifestyle changes 
required in the self-management of a chronic illness.  
1.3.1 Hypotheses 
Five hypotheses were tested. 
1. General efficacy belief will be stable over time.  
2. Illness-specific efficacy belief will increase over time. 
3. The strength of the relationship between general and illness-specific 
efficacy beliefs will increase over time. 
4. A general efficacy belief (trait) is a better predictor of future adaptation 
to illness than illness-specific efficacy belief. 
5. The influences of illness-specific efficacy beliefs, relative to general 
efficacy belief, are better concurrent predictors of adaptation to 
illness. 
1.3.2 Significance of the study 
Therapeutic self-care is viewed as a primary health resource in a health care system 
in which individuals are responsible for their health and, as such, individuals are 
expected to avoid risk factors and adopt positive health behaviours (Kickbusch, 
1989). For the health care professional and the notion of the individual being 
responsible for their own care, the challenge is to avoid the victim blaming rhetoric 
often associated with research that focuses on the behaviour of the individual as if 
behaviour alone determines health outcomes (Dean, 1996). To meet this challenge, 
the discourse in the health care literature is about the facilitation of empowerment 
for the individual to make informed choices and the development of cognitive 
resources to manage health status (Robertson & Minkler, 1994). Concomitantly, 
the health literature also recognises that an individual’s objectives and values about 
health are not necessarily congruent with those of the health care professional’s 
(Leeder, 1992).  
 
For example, the recommendations for diabetes self-management courses are about 
client empowerment and focus on strategies to facilitate lifestyle changes to 
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achieve effective therapeutic self-care (Ahroni, 1996; Ruggiero & Prochaska, 
1993) and less on adherence to a regimen (Anderson & Funnell, 2000; Dunning, 
1999). The cognitive dissonance for health care professionals directly involved is 
that, while they are aware of the impending outcomes when the self-management 
program is not followed, they are also aware of the person’s right to choose not to 
comply. The juxtaposition of these two ideas is at the heart of the issue. The health 
professional’s need to act to encourage regimen compliance whilst concurrently 
acknowledging individual responsibility for actions. That is, situations in which 
there is evidence of infrequent and variable testing of blood-glucose that will 
ultimately lead to diabetic complications (Estacio et al., 1998; Faas, Schellevis, & 
van Eijk, 1997; Heinemann, Overmann, & Muhlhauser, 1998; Wysocki, 1989). It 
is, therefore, little wonder that the person living with the chronic illness encounters 
the conflicting message of “... take charge but comply” (Hernandez, 1995). The 
person is expected to be in charge of their own self-care, to make decisions based 
upon blood glucose results, but is also expected to comply with a regimen 
determined by others rather than follow a regimen the person sees as being based 
on individual needs. 
 
Through facilitating personal efficacy belief in the client’s ability to manage 
therapeutic self-care in relation to a chronic illness, rather than focusing on 
behaviour itself, health care professionals can at least avoid the paternalism of 
compliance. Thus it is argued that, in order for individuals to take an active role in 
their own health, they need more than knowledge about their condition and how the 
regimen will help. Intervention strategies must also include building personal 
beliefs in their ability to manage the self-care regimen and the development of 
positive expectations about the health outcomes (Bradley, 1989).  
 
From the client’s perspective, studies have demonstrated that chronic illness self-
care behaviour is influenced more by competing lifestyle and family demands than 
recommendations from health care professions (Haug, 1988; Hunt, Arar, & Larme, 
1998; Kickbusch, 1989). Health compromising behaviours found to compete more 
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with lifestyle preferences include changes to diet and the need to increase activity 
levels (Glasgow, Ruggiero, Eakin, Dryfoos, & Chobanian, 1997; Grembowski et 
al., 1993; Wing et al., 1998). Clients may attempt to make decisions based on their 
knowledge about the medical condition but this will be influenced by choices for 
their way of life (Keeling, Williams Utz, Shuster, & Boyle, 1993; Thorne, 1990). 
For example, in a recent Australian study, 76% of the 714 heart attack survivors 
who were surveyed indicated that it was more important to continue their chosen 
lifestyle, regardless of the effect on the length of life (Glasziou, Bronwid, & Simes, 
1994).  
1.4 EXPLANATORY HEALTH BEHAVIOUR THEORIES 
The systematic study of health-related behaviour began in the early 1970s 
(Blackwell, 1989; Haynes, 1987). Since then models to explain and modify health-
related behaviour in response to expert advice have largely centred on the cognitive 
and social learning theories. There were, however, at least two issues to be 
resolved. First, that the iterative nature of science in relation to concepts and 
measures in this area has not resulted in adequate psychometric development. 
Failure to identify consistent determinants of outcomes across studies was 
attributed partly to the complexity of behavioural measures but also to the earlier 
poorly designed and non-theoretical attempts to understand the link between 
behaviour and health outcomes (Blackwell, 1989).  
 
Secondly, the extent of the research focus for therapeutic self-care was for a long 
time the individual (the patient) seeking assistance from the health care system. 
Researchers have not convincingly demonstrated that changes in health-related 
behaviours resulted in improvements in health status (Lorig & Laurin, 1985; Haug, 
1988; Glasgow, McCaull & Schafer, 1987) or even an improved health-related 
quality of life (Freeman, Blalock, Holman, Liang, & Meenan, 1996; Thorne, 1990). 
The proposition that health status is influenced by health behaviour has an 
appealing logic, but considering the complexity of health behaviour determinants 
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in chronic illness, it has only modest support (Freeman et al., 1996; Shillitoe, 1995; 
Wallston, 1991).  
 
Ideally, in the case of research involving chronic illnesses that have a complex 
regimen of self-care behaviours, the theory used to guide research needs to be 
comprehensive enough to explain the adoption of new behaviours and avoidance of 
risky behaviours. The chosen theory would also need to be able to explain habitual 
behaviour change and maintenance of desired behaviours, with or without periods 
of relapse. Kirscht (1988) considered that for stopping or starting a repetitive 
behaviour and where health considerations were clearly linked to action, cognitive 
models were more appropriate. More specifically, Fishbein (1993), commenting on 
his general theory of intention, felt that for a class of behaviours (to exercise as 
opposed to exercise 20 minutes each day) and behaviours not under volitional 
control (losing weight as intention to reach a goal), intention was a poor predictor. 
He suggested that “Bandura’s (1989) construct of self-efficacy may be an 
important determinant of intention and/or behaviour” (p. xxii).  
 
Theories that had been used to explain health behaviours in chronic illness studies 
and explored at the time of setting up the current study in 1994 included the health 
belief model (Rosenstock, 1990), self-efficacy theory (Bandura, 1977), learned 
helplessness (Seligman, 1975), and health locus of control (Wallston, 1991).  
 
The health belief model (HBM) assumed people would make the right decision 
(Stone, 1979) and that once the facts were given, behaviour change would occur. 
The assumption that most people valued health highly or were motivated for health 
reasons to change is unfounded (Robertson & Minkler, 1994). Theoretically, the 
HBM is not able to explain intention to perform the behaviour in question 
(Schwarzer, 1992), nor how to change habitual behaviour patterns or spontaneous 
behaviours (Salazar, 1991). Conceptually, when confidence in ability is low, 
efficacy expectation (belief) has been equated with the HBM component 
‘perceived barriers to preventive action’. Both ‘perceived barriers ‘ and low 
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efficacy beliefs have been associated with a decrease in the adoption of behaviour 
(Rosenstock, 1985; Rosenstock, Strecher, & Becker, 1988).  
 
Alternatively, learned helplessness and outcome-based futility of self-efficacy 
theory are thought to have some similarity (Gonzalez, Goeppinger, & Lorig, 1990), 
except that learned helplessness does not consider the person’s perception of their 
ability (Buckelew & Parker, 1989). This difference is important since efficacy 
belief about ability is more important than outcome expectations when health 
outcomes are not entirely controlled by behavioural input (Bandura, 1986; 
Schwarzer, 1992). Furthermore, in contrast to self-efficacy theory, there are no 
direct theory derived interventions from the learned helplessness model (Buckelew 
& Parker, 1989; Gonzalez et al., 1990).  
 
In relation to health status and chronic illness, Health Locus of Control (HLC) 
scales were found to be either a weak predictor or non-predictive (Lorig, Lubeck, 
Kraines, Seleznick, & Holman, 1985; O'Connor, Crabtree, & Abourizk, 1992; 
Shillinger, 1983; Wallston, 1992) and independent of health behaviours (Sallis, 
Pinski, Grossman, Patterson, & Nader, 1988). In fact, Weitzel (1989) found that 
Sherer’s general efficacy scale was a better predictor of health-promoting 
behaviours than health locus of control.  
 
The first health locus of control (HLC) scale (Wallston, Wallston, Kaplan, & 
Maides, 1976) was developed to increase the predictability of Rotter’s (1966) 
generalised expectancy locus of control (LOC) construct in health-related 
situations. Health Locus of Control belief was found to be specific to the health 
domain but not to any particular health behaviour, and may not be stable (Wallston, 
1991). Locus of control has been conceptualised as an internal-external duality of 
personal orientation to life’s challenges. Internal orientation referred to the 
individual’s belief that health status was determined by one’s own behaviour. 
Alternatively, an external locus of control referred to individuals who believed that 
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health status was determined by powerful-others, by fate or by chance (Wallston, 
1989).  
 
Whether HLC was used alone to predict behaviour or in combination with a health 
value measure, when health was not valued or status was not contingent upon 
behaviour, a weak correlation was likely (Wallston, 1992). Wallston (1991) 
reiterated an earlier call for inclusion of other constructs to explain health 
behaviour, as HLC was not the most important determinant. For example, efficacy 
beliefs about health-related diet and exercise behaviours were found to mediate 
health behaviours, while health locus of control did not (Sallis et al., 1988).  
 
Self-efficacy theory was purported to be a better predictor of behaviour than locus 
of control because self-efficacy related to the behaviour and context in question 
(Bandura, 1997; Sallis et al., 1988; Wallston, 1991). The consequences of greater 
belief in one’s ability were thought to be psychological and physiological well-
being. Specifically, self-efficacy mediated the relationship between behavioural 
competence and psychological well-being (Bandura, 1977; Bandura, 1986; 
McAuley, Lox, & Duncan, 1993; Stuifbergen, Seraphine, & Roberts, 2000). 
 
The preponderance of evidence to determine relative usefulness, logical adequacy 
and generalisability of theory to chronic illness supports the use of self-efficacy 
theory for the current study.  
1.4.1 Introduction to self-efficacy theory 
The following discussion is a prelude to the detail provided in Chapter 3 – Self-
Efficacy Theory and Psychosocial Literature. The details of self-efficacy theory 
include an explanation of efficacy belief development, generality of efficacy belief 
and health outcomes associated with self-efficacy theory. Self-efficacy theory is 
viewed as an important behavioural hermeneutic in many domains, including 
health (Bandura, 1997; O'Leary, 1985; Schunk & Carbonari, 1984; Velicer, 
DiClemente, Rossi, & Prochaska, 1990). Self-efficacy theory has two cognitive 
components. The first is perceived efficacy belief (efficacy expectation) and refers 
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to a person’s confidence in being able to maintain a particular behaviour when 
situational challenges exist (Bandura, 1982; O'Leary, 1985). Such beliefs vary for 
different behaviours according to the degree of successful experiences with 
enactment of the behaviour. The second cognitive component of self-efficacy 
theory is outcome expectancy. Outcome expectancy refers to a belief that a 
particular behaviour will produce a particular outcome (Bandura, 1977). Both 
efficacy belief and outcome expectancy are important determinants of behaviour 
and their differential influence is explained further in Chapter 3.  
 
In relation to health behaviours, self-efficacy theory supported intervention 
strategies to effect current and prospective behaviour change related to new 
behaviour or stopping risk behaviour. For example, the positive influence of 
behaviour-specific efficacy beliefs on smoking cessation (Mothersill, McDowell, & 
Rosser, 1988; Schwarzer & Fuchs, 1995), exercise for illness prevention (Conn, 
1998; McAuley et al., 1993; Schwarzer & Fuchs, 1995; Velicer, Rossi, Prochaska, 
& DiClemente, 1996), or weight management (Shannon, Bagby, Wang, & Trenker, 
1990) has been demonstrated. The strengthening of efficacy belief, therefore, was 
seen as a way of increasing health-related behaviour and pursuant to that, improved 
health status (Glasgow & McCaul, 1982; Grembowski et al., 1993; Lorig & 
Holman, 1998; Taal, Rasker, Seydel, & Wiegman, 1993a).  
 
Efficacy beliefs were also found to provide a linking mechanism between 
psychosocial factors and health-related outcomes in stressful life transitions 
(Jerusalem & Mittag, 1995), in acute (Holroyd et al., 1984) and chronic illnesses 
(Holman & Lorig, 1992). Self-efficacy theory has also been useful as an 
intervention strategy to explain multiple, concurrent, self-care behaviour changes 
in diabetes (Glasgow et al., 1992; Hurley & Shea, 1992) and arthritis research 
(Lorig et al., 1989a; Rejeski, Ettinger, Martin, & Morgan, 1998; Taal et al., 1993b). 
The reality of clinical practice for diabetes and arthritis management requires 
interventions that improve people’s belief in their ability to initiate healthy 




The cognitive appraisal mechanisms of self-efficacy increase the predictive power 
of behaviour through behavioural choices, effort and persistence (Bandura, Adams, 
Hardy, & Howells, 1980). According to Bandura (1997), behaviour itself can only 
be a predictor of future health status if the behaviour remains stable and other 
factors that impact on the health outcome also remain the same. When health status 
is not routinely contingent upon behaviour, efficacy beliefs account for more of the 
variation in behaviour than outcome expectancies (Bandura, 1997); an important 
consideration in the initial period after diagnosis when behaviour would be most 
variable. This is particularly relevant for metabolic control and arthritis pain – both 
health outcomes are influenced by more than illness-specific behaviour (Glasgow 
et al., 1989; Lorig et al., 1989b; O'Leary, Shoor, Lorig, & Holman, 1988; Rubin, 
Peyrot, & Saudek, 1989).  
 
Much of the health-related research on self-efficacy involving chronic illness 
groups has either not targeted recently diagnosed individuals or excluded them. 
Since self-efficacy belief specific to a particular task or behaviour develops over 
time (Bandura, 1989; Stretcher, De Villis, Becker, & Rosenstock, 1986), its initial 
usefulness as an explanatory variable for the person who has recently been 
diagnosed with a chronic illness needs to be tested over time.  
 
The influences of self-efficacy judgements, both general and specific, are 
especially relevant when substantial changes are occurring in the early stages of 
chronic illness management (Ruggiero & Prochaska, 1993). The purported stability 
of general efficacy belief in adults is suggested as the focus for clinical 
investigation during the early post-diagnosis period when the strength of the 
illness-specific efficacy beliefs are still developing. A positive belief in abilities in 
general would not only increase the likelihood that the individual would make the 
lifestyle changes but the changes would also persist under duress. The development 
of confidence related to the illness-specific behaviour can only occur if the 
behaviour change persists. Alternatively, when perceived barriers exist the person 
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with lower efficacy belief about ability in general may initially need more help 
than the person with higher efficacy belief. This nexus between behaviour and the 
development of efficacy beliefs is important when a rest-of-life behaviour change 
is required.  
 
The popular mantra behind the need for this research can be expressed in the 
following way. If you think you can - you might. If you think you can’t – you’re 
right (Lawrance & McLeroy, 1986). 
1.5 SUMMARY 
This study holds that psychological resources shape individual behaviour. To adapt 
to the life-style changes generated by the demands of chronic illness and a complex 
self-care regimen, the person needs to develop the capacity to sustain the desired 
behaviour. The influence of self-referent thought is an essential part of behaviour 
change and ensuing adaptive functioning (Bandura, 1997). For the person 
attempting the many illness-related behaviour changes associated with a complex 
self-care regimen, neither the relationship between efficacy beliefs (general and 
specific), nor their individual contribution to psychosocial adaptation to chronic 
illness is clear.  
 
The current study will compare general and illness-specific efficacy beliefs and 
their relative impact on psychosocial adaptation in selected chronic illness samples. 
Correlational data and applied statistical techniques will be used to determine if the 
theoretical predictions fit the data. Multiple regression analyses will determine the 
percentage of variance in psychosocial adaptation to illness (PAIS) accounted for 
by general and specific efficacy beliefs.  
1.6 OVERVIEW OF THESIS 
This thesis is presented in six chapters. The first chapter has introduced the purpose 
and rationale for the study, hypotheses, background to the problem and its 
significance for health outcomes. Chapter two discusses the rationale for the choice 
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of chronic illnesses used to test the study’s hypotheses, the prevalence of each 
illness, and its impact on lifestyle. Self-efficacy theory and psychosocial adaptation 
to chronic illness are discussed in Chapter three, along with the literature review of 
studies that have applied the variables of interest to the selected chronic illnesses. 
Chapter four describes the study design, data collection and method of analysis. 
Chapter five presents the findings of the study. In addition to discussing the 
findings in the context of the extant literature, Chapter six discusses the 
implications of the findings, the limitations of the study and makes some 
recommendations for clinical practice and research.  
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CHAPTER 2: MEDICAL CONDITIONS 
 
Chapter 2 reviews the criteria used to select the three chronic illnesses studied, the 
prevalence of each illness, the self-care regimen and the literature related to the 
impact of these illnesses on lifestyle. The review moves from a general discussion 
of the rationale for the selected chronic illness conditions to the more specific 
aspects of each illness.  
2.1 RATIONALE FOR THE SELECTED ILLNESS CONDITIONS 
The selection of three chronic illness groups was determined initially by the 
potential to access participants, sufficient incidence of new cases within the local 
population and differences in typology of illnesses. After selecting conditions that 
met the first two criteria, the typology put forward by Rolland (1984) was used. In 
this typology, chronic illnesses differ in their onset, course, outcome and degree of 
incapacitation of illness. Onset can be acute or chronic, course can be progressive, 
constant or relapsing, outcome can be fatal, shortened life span or non-fatal and 
incapacitation can be determined by the presence or absence of any significant 
impairment to one of the five faculties or to movement. Using this typology, three 
illnesses were identified as progressive with a gradual onset that suited the study 
design. Furthermore, diabetes types 1 and 2 were classified as ‘not incapacitating’ 
but may have a shortened life span due to diabetic complications. Type 1 diabetes 
was categorised as possibly fatal and type 2 diabetes as non-fatal (Rolland, 1984).  
 
A further consideration in the selection of illness conditions was the degree of 
complexity of the therapeutic self-care regimen. The selected illness conditions 
needed to involve life-style behaviour changes rather than simply remembering to 
take medication. It is reasonable to assume that the more complex the regimen the 
more likely it will be that efficacy beliefs about ability will change. According to 
self-efficacy theory successful enactment of the required behaviour change 
reinforces and increases the behaviour-specific efficacy belief (Bandura, 1997).  
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The arthritic diseases and diabetes mellitus were considered to require significant 
lifestyle behaviour changes as part of a complex self-care regimen. The inclusion 
of rheumatoid arthritis (RA), osteo-arthritis (OA) and fibromyalgia syndrome 
(FMS) in one group was based on reported similarity in the focus of self-
management requirements (Lorig & Fries, 1990). For example, the non-medicinal 
component useful for this group includes regulated exercise, joint protection, 
weight control and relaxation techniques.  
 
By way of confirming the complexity of the self-care regimen and its impact on 
quality of life, results from the Short Form 36 questions (SF-36, a global measure 
of the impact of disease on health-related quality of life) were considered. The SF-
36 health survey included in the 1995 National Health Survey (Australian Institute 
Health & Welfare, 1998) confirmed that the life-style changes associated with 
conditions such as diabetes and arthritis had a considerable effect on people’s 
perception of health and well-being. The SF-36 has eight dimensions of health: 
physical functioning, role limitations due to physical problems, role limitations due 
to emotional problems, bodily pain, general health perceptions, vitality, social 
functioning and mental health (Ware & Sherbourne, 1992). An earlier study 
(Stewart et al., 1989) found that, compared to patients without a chronic illness, 
individuals with diabetes scored far worse than did arthritis patients on perceptions 
of health. Stewart et al. also found that arthritis patients reported lower quality-of-
life scores (physical, role, and mental health domains) than did diabetes patients. 
 
Another measure of illness impact, the Diabetes Care Profile (Anderson, 
Fitzgerald, Wisdom, Davis, & Hiss, 1997; Fitzgerald, Connell, Hess, Funnell, & 
Hiss, 1996) indicated a greater negative impact on quality of life for people with 
diabetes who were using insulin compared with those who were not using insulin 
to manage their diabetes. Similarly, others have also reported that the need to use 
insulin had a greater impact on quality of life for individuals with type 2 diabetes 
compared with those on oral medication or diet alone (Glasgow et al., 1997; 
Jacobson & de Groot, 1994).  
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It is argued that the cognitive self-regulatory factors that influence motivation and 
efficacy belief (Bandura, 1989; Zimmerman, 1989) are particularly relevant to the 
therapeutic self-care regimens of diabetes mellitus and the arthritic diseases. Given 
the impact of the self-care regimens of diabetes mellitus and the arthritic diseases 
this view is consistent with findings from a review of health promotion research. 
That personal attributes such as a general confidence in abilities and a belief in 
ability to undertake new challenges, become the resources that influence lifestyle 
changes (Dean, 1996). Newly diagnosed individuals with a chronic illness have the 
burden not only of the illness and the impact of its intrusiveness to deal with, but 
also the everyday normative stressors and lifestyle hassles shared by those without 
a chronic illness. In the early period after diagnosis, the illness is perceived as 
overwhelming and beyond one’s control (Eberhardt, Larrson, & Nived, 1993; 
Emery, 1997; Samuelsson, Ahlmen, & Sullivan, 1993; White et al., 1992). Self-
efficacy theory suggests a measure of perceived control.  
2.2 DIABETES MELLITUS  
“Diabetes mellitus is a chronic condition resulting from either a deficiency in the 
production and release of insulin into the blood stream, or an inability to use the 
insulin produced” (Australian Bureau of Statistics, 1997 p. 5). The 
pathophysiological reasons for the inability to maintain blood glucose levels within 
the normal range vary, and form the basis for the two main diagnostic types: 
insulin dependent diabetes mellitus, or type 1; and non-insulin-dependent diabetes 
mellitus or type 2 (American Diabetes Association, 1998d).  
 
The Expert Committee on the Diagnosis & Classification of Diabetes Mellitus 
(American Diabetes Association, 1998e) recommended the use of the terms type 1 
and type 2 instead of the previous nomenclature of IDDM, NIDDM respectively.  
• Type 1 diabetes – autoimmune and idiopathic disease leading to beta cell 
destruction resulting in absolute insulin deficiency. Exogenous insulin is 
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needed for survival and the person is at risk of keto-acidosis. The onset is often 
acute and severe (McCarty et al., 1996).  
• Type 2 diabetes – insulin resistance as a result of relative or absolute insulin 
deficiency (DeFronzo, Bonadonna, & Ferrannini, 1992). It can be 
asymptomatic for years. People with type 2 diabetes are not dependent on 
insulin, are not ketosis prone and are often obese with the obesity itself 
contributing to insulin resistance. Weight reduction may reduce the insulin 
resistance but will not result in a cure (McCarty et al., 1996).  
• Insulin requiring diabetes refers to the person who meets the type 2 diagnostic 
criteria but for whom the underlying pathology has changed to the extent that 
insulin is required at least once a day to maintain normal blood glucose levels 
(DeFronzo et al., 1992; Kuzuya & Matsuda, 1997). Diagnostically, these 
individuals remain type 2 as the metabolic defect has not changed.  
 
In the study, the two diabetic groups either need insulin to manage the diabetes 
(IU) or do not (N-IU). Diabetes type 2 individuals who are insulin-requiring have 
been included in the IU group as their need to use insulin impacts on lifestyle 
(Kuzuya & Matsuda, 1997).  
 
2.2.1 Prevalence 
The 1995 National Health Survey (NHS) found that 2.4% of Australians reported 
that they had been diagnosed with some form of diabetes mellitus, however, the 
AIHW (1998) indicated that there was no reliable estimate of the prevalence and 
no national information on its incidence. It has been suggested by McCarty et al. 
(1996) and Welborn, Knuiman, Bartholomew and Whittall (1995), that the true 
prevalence of diabetes in Australia is much higher than self-reports revealed and 
could be as high as 3.8%. This was also reflected in statistics for other 
industrialised countries (American Diabetes Association, 1998c) including England 
and New Zealand (McCarty et al., 1996). The reported prevalence of type 2 
diabetes among Aboriginal populations in Australia ranged from 5% to 19% 
(Dobson, Penman, & eighty two others, 1994) and other ethnic groups in Australia 
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are also at greater risk of type 2 diabetes than Australian Caucasians (McCarty et 
al., 1996). 
 
The prevalence for diabetes rises with age and was 8.9% for people over 75 years 
of age (Australian Bureau of Statistics, 1997). Most of this increase is due to type 2 
diabetes which occurs more commonly after 40 years of age (Australian Institute 
Health and Welfare, 1998) and represents approximately 42% of those who 
reported that they had diabetes (Australian Bureau of Statistics, 1997). 
Furthermore, the research literature indicated that the prevalence of undiagnosed, 
type 2 diabetes was approximately the same as diagnosed diabetics in populations 
of both the United States of America (Harris, 1993) and Australia (Australian 
Bureau of Statistics, 1997). Of concern is the finding that type 2 diabetes develops 
slowly over 6 to12 years before the clinical diagnosis occurs (Carter, Dunn, & 
Turtle, 1993). In fact, Welborn (1995) described diabetes as an epidemic of worse 
proportions than HIV infection. He calls for this “… silent and continuing 
epidemic …” (p. 445) to be notifiable.  
 
The early symptoms of type 2 diabetes are easily confused with the signs of aging 
and considered by the individual as not worth bothering about. A national 
campaign, Defuse Diabetes, hopes to raise community awareness of this 
increasingly prevalent condition to enable diagnosis before diabetic complications 
occur (P. Williams, Campaign Coordinator, Defuse Diabetes, Diabetes Australia 
(WA), personal communication August 24th, 2000). The risk factors for type 2 
diabetes include being over 50 years, overweight and with high blood pressure 
regardless of a family history of diabetes. Although screening for type 2 diabetes in 
general is important, more specific strategies are needed to prevent its occurrence 
in susceptible individuals (Harris, 1993) and high risk groups (Zimmet, 1992). For 
example, it has been found that fat consumption predicted type 2 risk in individuals 
with impaired glucose tolerance after controlling for obesity and markers of 
glucose metabolism (Marshall, Hoag, Shetterly, & Hamman, 1994). The AIHW 
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(1998) indicated that the proportion of overweight or obese individuals has 
increased from 26.7% in 1980 to 45.7% in 1995. 
2.2.2 Impact on way of life 
The dysfunctional nature of the homeostatic mechanisms controlling carbohydrate, 
protein and fat metabolism in people with diabetes necessitates major adjustment to 
their way of life aimed at normalising blood glucose levels. This means active 
involvement by the individual, several times a day, every day, in an effort to 
regulate the blood glucose within a narrow range. Active involvement means 
making choices in relation to diet, exercise and or insulin as to how much or when, 
while considering the ‘what if’ situation. Choices that may, depending on the 
person’s attitude to their condition and competence, increase daily stress levels.  
 
The effect of life stress in the course and management of diabetes has been 
recognised for nearly 50 years (Hinkle & Wolf, 1952; Hunt et al., 1998). 
Furthermore, stress has been found to have a bi-directional impact in that 
psychological stress affects blood glucose levels and the diabetes can affect stress 
levels (Aikens & Mayes, 1997; Cox & Gonder-Frederick, 1992). In the case of the 
non-diabetic, normal homeostatic mechanisms ensure a normal blood glucose level 
despite infection, headache, family argument or overtime at work. The impact of 
these same events for the person with diabetes requires recognition of the potential 
impact on blood glucose levels, action to ascertain the extent of change in blood 
glucose, followed by a decision as to if and what remedial action to take. Even 
when there are no unforeseen events and the prescribed regimen is followed, 
metabolic responses may result in recurrent episodes of hyperglycaemia or 
hypoglycaemia (Armstrong, 1987). This in itself can cause stress and a sense of 
helplessness for the person unable to understand the effects of stress on diabetes 
management (Aikens & Mayes, 1997; Gonder-Frederick, Cox, Bobbitt, & 
Pennebaker, 1989; Griffith et al., 1990).  
 
Problem-solving associated with the various regimen self-care requirements was 
found to be an important factor in achieving metabolic control (Peyrot & Rubin, 
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1988) and there was an interdependent relationship between problem solving, 
behaviour and blood glucose (Glasgow et al., 1992; Toobert & Glasgow, 1991). 
For example, research has demonstrated that learning and memory improved with 
glycaemic control for older type 2 subjects (Gradman, Laws, Thompson, & 
Reaven, 1993). Hypoglycaemia reduces the amount of blood glucose available to 
the brain and results in temporary cognitive-motor impairment (Gonder-Frederick, 
Cox, Kovatchev, Schlundt, & Clarke, 1997; Holmes, Koepke, & Thompson, 1986) 
and more permanent damage in the case of frequent hypoglycaemic episodes 
(Wredling, Levander, Adamson, & Lins, 1990). An earlier study, however, found 
that type 1 and type 2 adults (N = 98) who adjusted their own insulin dosage or 
dietary intake, rather than follow a pre-set regimen, had better metabolic control 
(Peyrot & Rubin, 1988).   
 
Diabetes is one of the most physiologically and behaviourally demanding chronic 
illnesses (Hunt et al., 1998; Padgett, Nord, Heins, & Arfken, 1996), and 
psychosocial factors are relevant to nearly every aspect of diabetes and its 
treatment (Fisher, Delamater, Bertelson, & Kirkley, 1982). The onset and 
chronicity of diabetes have been associated with, among other things, insecurity 
and fear of an uncertain future (Carey et al., 1991; White et al., 1992). The 1995 
National Health Survey (Australian Bureau of Statistics, 1997) found that 49% of 
diabetics rated their health as fair or poor compared to 16% of the non-diabetics. 
The standardised mean scores for the eight dimensions of the SF-36 questionnaire 
indicated that the diabetic group scores were significantly lower (negative) on all 
dimensions than the non-diabetic group. The dimensions with the largest 
differences were general health and role limitations due to physical health 
problems.  
2.2.3 Diabetes self-care regimen 
The goal in management of diabetes is to normalise the blood glucose (BG) level 
as there is a direct relationship between long-term hyperglycaemia and the risk of 
future diabetic complications (American Diabetes Association, 1998d). People with 
diabetes and health care workers commonly acknowledge that diabetes mellitus 
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will inevitably result in one or more complications because of the difficulty 
individuals have in maintaining euglycaemia all day every day.  
 
The need to change diet behaviours was found to be common after diagnosis 
(Snetselaar, 1995), however, diet change was also economically difficult (Hunt et 
al., 1998). Furthermore, people with diabetes are expected to have more than a tacit 
understanding of the carbohydrate content of foods. This level of knowledge and 
interest for a non-diabetic individual could be taken to indicate an eating pathology 
(Shillitoe, 1995).  
 
Persons with type 2 diabetes (not requiring insulin) maintain normal blood glucose 
levels with dietary restrictions alone, dietary restrictions and oral medication and or 
exercise. Exercise is important as it lowers blood glucose levels and can also 
improve cardiovascular fitness, as well as assist with weight reduction. Cox and 
Gonder-Frederick found a direct relationship between weight loss and improved 
metabolic control for individuals with type 2 diabetes. Hence, for the person with 
type 2 diabetes without complications, exercise in conjunction with diet, is often 
recommended to improve blood glucose levels (American Diabetes Association, 
1998a; Bloomgarden, 1997; Horton, 1988).  
 
The life-style changes associated with diet and exercise to reduce weight were 
found to be the most difficult aspect of a diabetic regimen (Armstrong, 1987; 
Rubin, Peyrot, & Saudek, 1991). Likewise, the Nurses Health Study (Shimakawa et 
al., 1993) found that nurses with type 2 diabetes were not able to sustain the early 
post-diagnosis weight loss. Furthermore, that compared to their age-matched 
controls, there were no consistent differences for complex carbohydrate intake. 
Adults with diabetes are least likely to follow lifestyle recommendations involving 
changes to diet and or increasing physical activity (Ary, Toobert, Wilson, & 
Glasgow, 1986; Glasgow, McCaul, & Schafer, 1987; Wing et al., 1998). 
Recommendations associated with the taking of medications were more likely to be 
followed as they have a lesser impact on lifestyle (Ruggiero et al., 1997).  
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If the blood glucose levels cannot be reduced to within a near normal range, 
eventually insulin injections will be required. Although the decision to include 
insulin is just another tool in the medical regimen, its inclusion can also be 
perceived negatively by the person (Hunt, Valenuela, & Pugh, 1997). 
 
Persons with type 1 diabetes and insulin-requiring type 2 diabetes need to give 
themselves insulin injections each day, but for most people, the regimen involves 
multiple injections per day, including blood glucose testing. Fear of injecting and 
or self-testing is not uncommon (Hunt et al., 1997; Snoek, Mollema, Heine, Bouter, 
& van der Ploeg, 1997). 
 
Maintenance of blood glucose at recommended levels requires knowledge of the 
disease process, a systematic problem-solving process to use this knowledge and 
psychomotor competency to implement the regimen behaviours. To manage 
diabetes on a daily basis the person needs knowledge as to why blood glucose self-
management (BGSM) should be done routinely, and circumstances that would 
necessitate greater frequency of BGSM (Wysocki, 1989). The Diabetes Control 
and Complications Trial (DCCT) found that the better the blood glucose control is 
maintained, the more likely the onset of microvascular complications will be 
delayed and their progression slowed. This ten year study included 1440 type 1 
subjects who were followed for an average of seven years (American Diabetes 
Association, 1998d). Since the results of the DCCT study were made public, there 
has been a more aggressive approach to developing strategies to help the person 
manage and maintain BG levels within the accepted normal range (Cox & Gonder-
Frederick, 1992; Hunt et al., 1998). In particular, the DCCT study demonstrated a 
need to change the thinking in diabetic clinics. Rather than accept a higher, more 
liberal blood glucose target range, health care professions working with diabetics 
were advised to encourage clients to achieve a lower, narrower non-diabetic blood 
glucose range (Michael & Sabo, 1996). What has been demonstrated as a 
significant clinical goal, however, may not translate with equal force to the 
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individual’s view of reality. To some individuals, BGSM is an essential self-care 
strategy – to others it is a continual reminder of their disease (Fox et al., 1984; 
Hunt et al., 1998). Without knowledge and a belief in ability, behaviour change is 
less likely to occur. 
 
Processes that are physiologically automatic and invisible for the non-diabetic 
become, for the diabetic, purposive behaviours controlled by constant cognitive 
mechanisms: a process of behavioural self-regulation (Gonder-Frederick & Cox, 
1991; Wing et al., 1998). The effort required by the person with type 1 diabetes to 
maintain BG within the narrow recommended range may involve three or more 
daily injections, with BG testing on each occasion and perhaps more often. This in 
itself is a considerable commitment, particularly when success also means an 
increased risk of hypoglycaemic episodes (Marsh & Stanton, 1996). To avoid 
hypoglycaemia, even more frequent BG testing is necessary. Other measures to 
control BG include adjusting meal frequency and/or content, changing activity 
patterns and/or adjusting insulin dosage. While these examples illustrate to some 
extent the self-regulation required, they also explain why the vast majority of 
individuals are not able or willing to try and achieve the ‘tight’ non-diabetic blood 
glucose range (Cox, Miller, & Mull, 1987a; Cox, Irvine, Gonder-Frederick, 
Nowacek, & Butterfield, 1987b; Gonder-Frederick et al., 1997; Marsh & Stanton, 
1996).  
2.2.4 Lifestyle risk factors for diabetes 
The 1995 National Health Survey (Australian Bureau of Statistics, 1997) revealed 
that, compared to the non-diabetic person, people with diabetes were more likely to 
have major health problems including hypertension, high cholesterol, heart disease, 
kidney disease, cataracts, blindness, glaucoma, limb amputations or stroke. For 
individuals with diabetes who provided height and weight data for Body Mass 
Index calculations (BMI), 37% were overweight and a further 21% were obese. 
This compared negatively with the non-diabetic group in which 25% were found to 
be overweight and a further 8% were obese. Comparing the two main diabetic 
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groups, 67% of the type 2 group were overweight or obese compared to 49% of the 
type 1 group.  
 
Body Mass Index (BMI) is calculated from the equation Weight (kg) / Height (m2) 
and is suitable for use with men and women from the age of 18 years (National 
Health and Medical Research Council, 1985). The four BMI categories include 
underweight, less than 20kg/m2; acceptable weight, 20-25kg/m2; overweight, 25-
30kg/m2; obese, more than 30kg/m2. 
 
Weight reduction to meet the normal BMI score of 20 to 25kg/m2 is an essential 
part of ongoing diabetes control and prevention of further deterioration in health 
for the person with type 2 diabetes. Being overweight is a risk factor not only for 
diabetes, but when associated with other risk factors such as smoking or 
hypertension, the likelihood of further diabetic complications is compounded 
(American Diabetes Association, 1998b). For example, whether diagnosed or not, 
the person with type 2 diabetes is at increased risk for macro-vascular damage and 
diseases such as coronary heart disease, stroke and peripheral vascular disease, 
visual disorders, increased risk of infections, nephropathy and neuropathies 
(McCarty et al., 1996). A United Kingdom survey of 5102 newly diagnosed type 2 
individuals found a significant change in prevalence over six years (from age at 
diagnosis) of macro and micro-vascular diabetic complications (Davis, Stratton, 
Fox, Holman, & Turner, 1997). It was also found that retinopathy begins to 
develop four to seven years before clinical diagnosis of type 2 diabetes (Carter et 
al., 1993; Harris, 1993).  
 
The behavioural and cognitive demands generated by diabetes mellitus are 
considerable (Cox & Gonder-Frederick, 1992; Hamberg & Inoff, 1983; Hunt et al., 
1998). Hamberg and Inoff referred to ‘the predictable crises of diabetes’ that cause 
distress after diagnosis. These include uncertainty of future health, feelings of 
incompetence in relation to self-care responsibilities, helplessness, loss of valued 
life goals together with lifestyle changes due to diabetes. Other potential causes of 
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distress include the adverse effects of a hypoglycaemic episode (possibly in 
public), the potential to perceive blood glucose results which are too high or low as 
a failure, and the unwanted weight gain associated with insulin use (Hunt et al., 
1997; Shillitoe, 1995). A strong sense of personal confidence in the ability to cope 
with any one or all of these contingencies is necessary.  
 
For example, the person with diabetes may have had little understanding of how 
insulin works, never had to give an injection, never had to worry about diet or 
exercise – let alone the inter-relationships of each. In such situations, an initial 
generalised efficacy expectation could be more important to the person’s illness 
response (psychosocial adaptation) than the level and strength of the still 
developing task-specific efficacy beliefs associated with the different aspects of the 
regimen (Tipton & Worthington, 1984).  
 
Collectively, effective problem-solving skills are required to incorporate the 
therapeutic self-care regimen into a daily routine that still leaves room for a 
lifestyle not too different from that of family and friends. Diabetes is a problem-
based condition (Armstrong, 1987 p. 567) which necessitates that people become 
experts in their own care and know how to learn from past experiences with hypo- 
and hyperglycaemic episodes. Hernandez, (1995) refers to this as “ the science of 
one, a personalised science of living with diabetes.“ (p. 35). 
2.3 RHEUMATIC DISEASE 
The term rheumatic disease includes more than 100 chronic conditions involving 
the joints and or connective tissue. Among the most prevalent of the rheumatic 
diseases are rheumatoid arthritis, osteo-arthritis, and fibromyalgia (Taal, Seydel, 
Rasker, & Weigman, 1993c). Rheumatoid arthritis (RA) is a chronic systemic 
disease that starts between 20 and 40 years of age and affects more women than 
men. However, it does have a juvenile form which can start as young as six months 
of age. Onset is gradual and for some people, the episodes of acute symptoms may 
be separated by lengthy remissions. Inflammation of the synovial lining of the 
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affected joint ultimately results in cartilage and bone destruction that leads to joint 
deformity and reduced joint function (Rasker & Cosh, 1987). 
 
Osteo-arthritis (OA) involves degeneration of the articular cartilage with 
hypertrophy (regeneration) of bone at the margins of the joint (spurs) (Taal et al., 
1993c). It affects males and females equally, and occurs as part of the normal aging 
process affecting joints that are used more often or is related to poor management 
of joint injury at any age. The amount of damage to one or more joints determines 
the degree of pain and stiffness, but it is generally less crippling than RA (Lorig & 
Fries, 1990).  
 
Fibromyalgia syndrome (FMS) is a non-articular disease characterised by a 
syndrome of sleep disturbance, diffuse musculo-skeletal pain, tiredness and 
morning stiffness (Block, 1999). It is a chronic pain syndrome of unknown 
aetiology and unpredictable course (Buckelew, Murray, Hewett, Johnson, & 
Huyser, 1995; Hallberg & Carlsson, 2000; Taal et al., 1993c) that appears to be 
made worse by cold, noise, stress, changing weather and tiredness (Hanrahan, 
1997). Fibromyalgia syndrome occurs more often in women (80 – 90%) 
(Hanrahan, 1997; Taal et al., 1993c; Wolfe, 1997).  
2.3.1 Prevalence 
The 1995 National Health Survey conducted by the Australian Bureau of Statistics 
(ABS), found the self-reported prevalence estimate of arthritis (rheumatoid and 
osteo) to be 15%. Prevalence differences for age groups exist. In general, the 
prevalence increases with age for both genders with a higher percentage for 
females in any age group and highest in the 65 to 74 year group (56%). The profile 
for Western Australians aged 50 years and over indicates arthritis to be the second 
most prevalent condition, with 13% more females than males reporting it (Milligan 
& Daly, 1996). More recently, in America, arthritis has been described as a 
‘looming epidemic’ (Meenan, Callahan, & Helmick, 1999 p. 79).  
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Since the status of FMS as a discrete disorder is still being debated (Wolfe, 1997) 
the prevalence statistics are not readily available, although Hanrahan (1997) cites a 
USA study which found about 2% of the population reported fibromyalgia; 80% of 
whom were women. Fibromyalgia in the Australian population has not been 
reported in published literature.  
2.3.2 Impact on way of life 
Life-style sources of stress associated with the rheumatic diseases, including FMS, 
comprise loss of vocational or social roles as a consequence of decreased mobility 
or other physical disabilities, decreased functional capacity (strength), fatigue and 
chronic pain (Devins, Edworthy, Guthrie, & Martin, 1992; Katz, 1995; Taal et al., 
1993c). In addition, living with uncertainty and the feelings of guilt associated with 
enforced change in roles can reduce the person’s quality of life (Devins et al., 
1992; Freeman et al., 1996; Samuelsson et al., 1993). Arthritis affects not only 
physical functioning but also psychological and social aspects (Anderson, Bradley, 
Young, Lisa, & Wise, 1985; DeVellis McEvoy, 1995; Eberhardt et al., 1993; Taal 
et al., 1993a). Considerable personal effort is required to follow the typical regimen 
recommendations even on a good day when pain and or fatigue are marginally less 
than at other times (Hallberg & Carlsson, 2000; Shaul, 1995).  
 
Katz (1995) found that the ratings of the impact of seven stressors was significantly 
negatively correlated with perceived coping efficacy for adult males and females 
(N = 446; mean age 60.6 yrs). The correlations ranged from r = -.62 (p < .01) for 
medication side effects to r = -.15 (p < .01) for burden of taking care of rheumatoid 
arthritis. The other stressors included pain (r = -.48), unpredictability of symptoms 
(r = -.48), functional impairment (r = -.47), change in joint appearances (r = -.47) 
and fatigue (r = -.44). 
 
Pain was often the main reason for seeking medical help (Buckelew & Parker, 
1989). Pain caused by the disease process, further limited not only activity, but also 
contributed to loss of quality of life and psychological distress, problems of 
depression and anxiety (Jacobs, van der Heide, Rasker, & Bijlsma, 1993; Taal et 
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al., 1993c). In this way, arthritis pain perception is a complex phenomenon that is 
greater than the tissue damage alone (Buckelew & Parker, 1989). Dissatisfaction 
with illness-related abilities exacerbated psychological distress both concurrently 
and long term (18 months) in a recently diagnosed group of rheumatoid arthritis 
participants (Blalock, Orlando, Mutran, DeVellis, & DeVellis, 1998). Furthermore, 
women with rheumatoid arthritis were found to experience greater distress and 
perceived more role limitations than men (Reisine & Fifield, 1995). 
 
In a review of the literature dealing with arthritis pain, its impact and treatment, 
Buckelew and Parker (1989) found support for the notion that cognitive-
behavioural interventions reduced pain behaviours and self-reported pain levels. 
The strongest support came from studies using self-efficacy to modulate the effects 
of cognitive-behavioural interventions. In particular, cognitive restructuring or 
reinterpretation of arthritis symptoms was important (Gonzalez et al., 1990). 
Learned helplessness was also recognised as a critical factor in pain management 
that could be addressed through cognitive-behavioural interventions (Smarr et al., 
1997; Smith & Wallston, 1992; Smith, Peck, & Ward, 1990). In particular, 
Buckelew and Parker suggested that the complexity of the pain phenomenon be 
recognised and more attention given to the client’s psychological state. Pain 
interventions need to focus as much on the affective and cognitive components as 
on the sensory component of pain (Blalock et al., 1998).  
 
Reported symptoms of anxiety and depression were not uncommon among patients 
with rheumatoid diseases (Devins et al., 1992). Evidence from a variety of sources, 
including longitudinal studies, however, indicated that the prevalence of depressive 
symptoms “… is probably no greater than that found in other serious chronic 
diseases” (DeVellis McEvoy, 1995 p. 284). And yet, FMS patients reported higher 
pain and psychological stress levels than a group of RA patients (Hawley & Wolfe, 
1991). Hawley and Wolfe assessed 1522 patients with various rheumatic disorders 
using a pain visual analogue scale (VAS), the Stamford Health Assessment 
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questionnaire and obtained a score for anxiety and depression from the Arthritis 
Impact Measurement Scale.  
 
Much of the literature indicates that symptoms of psychological distress (anxiety or 
depression) are not related to disease severity (Eberhardt et al., 1993; Lambert, 
Lambert, Klipple, & Mewshaw, 1989) or a particular chronic illness diagnosis 
(Cassileth et al., 1984; Devins et al., 1992). Development of depressive symptoms 
was related to the degree to which the illness interfered with previously established 
life-style patterns including recreational activities (Buckelew et al., 1995; Devins et 
al., 1992). This pattern was also observed by Katz and Yelin (1995) in that loss of 
10% or more of the women’s valued activities was a significant predictor of the 
later onset of depressive symptoms (Odds ratio = 6.77, 95%CI 2.35-19.55, p < .01).  
 
Whether rheumatic diseases develop insidiously or as an acute episode of pain and 
stiffness, the unpredictability and functional impairment meant changed work and 
family routines (Devins et al., 1992). This in turn diminished the person’s sense of 
identity, independence, self-confidence and ability to plan for the future with any 
degree of confidence (Anderson et al., 1985; Parker et al., 1988).  
2.3.3 Arthritis self-care regimen 
The goals of treatment and management of RA, OA and FMS are palliative not 
curative. The focus is on relief of pain, prevention of fatigue, and prevention of 
further joint destruction / stiffness. Even though treatment is a combination of rest, 
controlled exercise and medication with constant adjustment according to disease 
activity (Lorig & Fries, 1990), the symptoms are unpredictable and variable 
(Hirano, Laurent, & Lorig, 1994; McEvoy, Blalock, Hahn, DeVillis, & Hochbaum, 
1988). More recently, early treatment clinics (two weeks from initial GP visit) have 
been increasingly adopted as a model in the United Kingdom (Emery, 1997). The 
clinic aims to make an early diagnosis, treat the inflammatory arthritis and reduce 
pain that together reduces functional disability. The longer the inflammatory stage, 
the greater the damage by way of bony erosion or secondary osteoporosis. 
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Although arthritic conditions do not respond to a particular diet, weight loss may 
be necessary to reduce the weight-bearing load on lower joints. Weight loss can 
help reduce pain, leading to an improvement in mobility and quality of life. 
Inactivity is not an option. Inactivity will not only increase the likelihood of weight 
gain, but also joint flexibility is lost. The person with arthritis needs to balance rest 
requirements with appropriate exercises, within pain limits, to maintain joint 
flexibility and muscle strength. Joint protection principally relies on the strength of 
the joint muscles. (Lorig & Fries, 1990)  
 
Fear that exercise might exacerbate the disease is common, not only to people with 
an arthritis condition, but also to health professionals who are reluctant to 
recommend vigorous exercise (Gecht, Connell, Sinacore, & Prohaska, 1996). 
Further compounding the issue of recommendations and perceptions of harm, the 
literature on exercise participation in adult surveys indicates exercise activity to be 
least likely for women and older persons (Australian Institute Health & Welfare, 
1998; (Bauman, Owen, & Rushworth, 1990). Since arthritis is largely a chronic 
illness associated with women and older persons, strategies used in an arthritis self-
management program need to consider this finding.  
 
Arthritis self-management requires the development of personal resources such as 
coping, self-efficacy and problem-solving skills to make the daily adjustments to 
the recommended regimen (Lorig et al., 1989b; O'Leary et al., 1988). The change 
in focus for intervention studies also reflects this notion (Freeman et al., 1996). 
Similarly, a review of studies between 1987 and 1991 found a continuing reduction 
in the use of ‘knowledge’ as the only dependent variable (Hirano et al., 1994). For 
example, Hirano et al. found that the more recent arthritis education studies that 
included an intervention also measured psychosocial and health status outcome 
variables.  
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2.4 CHAPTER SUMMARY 
The rationale for the selected chronic illnesses chosen as the substantive platform 
to test the study’s hypotheses was based on several criteria. The criteria included 
access to participants, sufficient incidence of new cases for a longitudinal study 
within the time constraints of a higher degree award, a self-care regimen that 
involved more than one behaviour change and the typology put forward by Rolland 
(1984). Rolland’s typology was used to guide the selection of three chronic 
illnesses that differ as to onset, course, outcome and degree of incapacitation of 
illness (See section 2.1), yet had a common requirement for significant long-term 
behaviour changes. This chapter has discussed the prevalence of each illness, the 
impact of each on lifestyle and the therapeutic regimen for each. In addition, the 
lifestyle risk factors for diabetes mellitus were discussed. This discussion builds on 
the background information found in Chapter 1 and provides a link to the review in 
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CHAPTER 3: SELF-EFFICACY THEORY AND PSYCHOSOCIAL 
ADAPTATION LITERATURE 
 
This chapter presents an overview of self-efficacy theory, psychosocial adaptation to 
illness and the related health-outcome research findings from the diabetic and arthritis 
literature. Self-efficacy theory, as described by Bandura (1977-1997) will be discussed 
first. The discussion includes the influence of two expectancies, efficacy beliefs or 
expectations and outcome expectations. Strategies to enhance self-efficacy and the 
effect of these strategies on behaviour change are also discussed.  
 
The chapter also addresses the methodological issues involved in self-efficacy research 
findings related to the selected chronic illnesses. This chapter is not intended to be a 
comprehensive review of studies that have considered self-efficacy in its various 
guises. But rather, it is to illustrate the requirements and difficulties in respect of four 
areas that need to be addressed in undertaking the current study. First, there are only a 
few studies that have explored the changes in illness-specific efficacy beliefs. Second, 
the clinical applicability to chronic illness of studies that only measure a single 
behaviour belief versus multiple behaviour beliefs will be discussed. Third, scales that 
use a composite self-efficacy score to analyse a multi-dimensional construct add to the 
variability of results. Lastly, differences in the level of the self-efficacy measures in 
relation to the chronic illness findings will be discussed. That is, the self-efficacy 
measure can be behaviour and context specific, only context specific (domain 
measure) or not specific to behaviour or context.  
 
The chapter concludes with studies that have applied self-efficacy theory to the 
selected chronic illnesses and a discussion of psychosocial adaptation to illness. 
Psychosocial adaptation to illness will be discussed in general and in relation to 
research findings from the diabetic and generic arthritis literature. Although studies 
could not be found that used the instrument Psychosocial Adjustment to Illness 
(Derogatis & Derogatis, 1990) with an illness-specific efficacy scale, the link between 
self-efficacy and psychosocial adaptation to illness will be presented.  
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3.1 SELF-EFFICACY THEORY 
Self-efficacy theory has demonstrated the potential to explain the adoption of new 
health-related behaviours (McAuley et al., 1993; Schwarzer & Fuchs, 1995; Stretcher 
et al., 1986; Taylor, Bandura, Ewart, Miller, & DeBusk, 1985) and the avoidance of 
risky lifestyle behaviours, including habitual behaviours (DiClemente et al., 1991; 
Lawrance & McLeroy, 1986; Shannon et al., 1990). Furthermore, self-efficacy theory 
has proven its place in maintenance of behaviours associated with chronic illness in 
general (Lorig, 1996; Ruggiero & Prochaska, 1993).  
 
Self-efficacy theory is one of the social cognitive theories, and differs by virtue of its 
specificity and its recognition of the dual cognitive mechanisms that influence 
behaviour - outcome expectations and personal efficacy belief in ability to carry out 
the task (Bandura, 1986). Although outcome expectations and efficacy belief are 
viewed as different mechanisms, their influence on behaviour change is synergistic. 
Bandura (1977; Bandura, 1982; Bandura, 1986) saw a distinction between the person's 
perception of the expected outcome of behaviour (outcome expectation) and the 
person's perception of their ability (efficacy belief) to complete the behaviour 
successfully. Both outcome expectations (belief that the behaviour will have the 
desired effect) and efficacy belief (confidence in ability) are required for any given 
outcome. The latter belief controls the thought processes and emotional reactions, 
thereby affecting the person's choice of behaviour, degree of effort and persistence 
(Bandura, 1989). The greater the efficacy belief the more likely the person will choose 
to make an effort to change behaviour and or persist with the behaviour when 
problems are encountered. 
 
Enhancement of situational confidence in starting and maintaining behaviour change is 
included as one of the intervention strategies for three of the five reported stages of 
behaviour change (Prochaska, DiClemente, & Norcross, 1993; Ruggiero & Prochaska, 
1993). Self-efficacy strategies are suggested for the first two stages of behaviour 
change: precontemplation (not thinking about behaviour change in the foreseeable 
future) and contemplation (considering change in the foreseeable future). The 
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characteristics of the precontemplation stage that indicate the person is not thinking 
about behaviour change include an under estimation of the benefits and an over 
estimation of the constraints. The person is considered to be contemplating behaviour 
change when the benefits and barriers are viewed more equally but doubt may still 
exists. Enhancement of self-efficacy was also seen as an important strategy in the last 
of these iterative stages - relapse prevention or maintenance of behaviour change 
(Prochaska et al., 1993; Ruggiero & Prochaska, 1993).  
3.1.1 Efficacy belief / expectation 
Judgement about the particular task is built on past experiences and will vary 
according to the level (or magnitude) of efficacy belief, strength of the belief and 
generality of the belief (Bandura, 1977; Bandura, 1986). There is empirical evidence 
to support the assertion that efficacy beliefs about ability are independent of actual 
ability (Liebert & Spiegler, 1994).  
 
Initial performance of a new skill is affected by immediately preceding relevant 
experiences (sources of information) that contribute to efficacy beliefs about ability to 
carry out a specific behaviour. As one of the more important sources of information, 
past accomplishments may be the main influence on strength and level of efficacy 
beliefs for a new task. When a new task has not yet been mastered, perceptions of 
performance may be a personally biased interpretation based upon the person’s 
physical, social, or self-evaluative outcome expectations for similar events. 
Specifically, the efficacy belief derived from a similar prior challenge and experience 
influences the individual’s level of efficacy expectation. Similar prior challenge and 
experience also influence the generalisation of the earlier belief to the new but similar 
task. In this way, the person determines if the task is to be attempted (worth the effort) 
and the extent of persistence in the face of difficulties or an unresponsive environment 
(Bandura, 1982; Shannon et al., 1990).  
 
Belief in one’s ability to undertake behaviour is an important link between knowing 
what to do and actually doing it (Bandura, 1982; Grembowski et al., 1993). It reflects 
the confidence and motivation that help in making decisions about a course of action. 
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In particular, lifestyle behavioural changes are likely to be reliant on efficacy belief to 
overcome perceived barriers to adopting the new behaviour (Rosenstock et al., 1988; 
Schultz & Shultz, 1998; Shannon et al., 1990). Efficacy expectation influences the 
three categories of action or personal change: the adoption of new behaviours, 
generalised use under different conditions, and maintenance of the behaviour over time 
(Bandura, 1986; Schwarzer & Fuchs, 1995).  
 
High efficacy belief does not imply that the behaviour will be performed without 
anxiety (Feist, 1994). Bandura (1991) referred to several studies that confirmed 
efficacy belief was able to mediate the relationship between stress or anxiety and a 
sense of the controllability of an adverse situation. Life in general is replete with 
adversities, setbacks and failures both large and small. When perceived coping ability 
does not match an unresponsive environment, a perception of threat exists. To 
counteract the threat, an optimistic sense of personal efficacy was needed (Bandura, 
1986). Setbacks and difficulties served to strengthen efficacy belief if the person 
persevered and succeeded. In the face of difficulty, individuals with strong efficacy 
belief have fewer self-doubts and will recover quickly. Individuals with stronger 
efficacy belief may feel anxious but are more likely to attend to what was familiar in a 
new task or situation, than focus on the unknown (Bandura, 1997; Jerusalem & Mittag, 
1995). In relation to health, individuals with a stronger efficacy belief were not as 
likely to perceive themselves as sick and less likely to be depressed compared to 
people with a low efficacy belief (Bandura, 1997; Gecas, 1989).  
 
Additionally, individuals with a low efficacy belief are more likely to worry about 
negative events in the past and be unable to cope with uncertainty. In this situation, 
individuals may believe that a potential threat is beyond their control, may visualise 
failure and become distressed with the resultant impaired level of performance. The 
interactions of poor performance, low efficacy belief and stress symptoms become 
iterative. The less resilient person will stop trying to reach the goal (Bandura, 1986; 
Jerusalem & Mittag, 1995).  
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3.1.2 Outcome expectations 
While personal efficacy expectation is a judgement about ability in relation to a 
particular behaviour or task, outcome expectation is a judgement about the result of 
enacting the behaviour (task) in question - a judgement as to whether the 
recommended behaviour will have the desired effect. Outcome expectation has been 
classified as a positive or negative expectation of a physical, social or self-evaluative 
nature (Bandura, 1989). 
 
Outcome expectation was found to be important at the intention stage of behaviour 
change and less so for the maintenance of the behaviour change (Schwarzer & Fuchs, 
1995). In particular, without prior experience of a behaviour, “outcome expectations 
may have a stronger direct influence” (Schwarzer, 1992 p. 234). For example, 
Maddux, Sherer and Rogers (1982) used 95 introductory psychology students to test 
the theory that efficacy and outcome expectancies were independent. The study had 
three levels (high, low, and no information) for both cognitive expectancies. 
Information in brochures about a simple interpersonal skill of minimal risk was varied 
to reflect three levels of both difficulty in using the technique (efficacy expectancy) 
and effectiveness of the technique (outcome expectancy). Maddux et al. found 
outcome expectancy to be independent of efficacy belief in relation to intention to 
perform the behaviour change. Specifically, intention to perform a behaviour was 
significantly associated with higher levels of outcome expectancy (F{2, 87} = 12.32, p 
<.01), whereas intention was not significantly associated with efficacy belief.  
 
Outcome expectations were not measured in many studies, and mixed results were 
found for those that did (Shannon et al., 1990). Outcome expectation and efficacy 
belief were found to be good predictors of intention to undertake breast self-
examination behaviour (Seydel, Taal, & Weigman, 1990). Conversely, in relation to a 
less serious health outcome, outcome expectation was not predictive of intention to 
floss teeth (Beck & Lund, 1981), lose weight (Shannon et al., 1990) or use pain coping 
strategies (Jensen, Turner, & Romano, 1991) when efficacy beliefs were controlled in 
respective regression analyses. It may be that, “the greater the risk of aversive 
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consequences, the greater the salience of self-efficacy expectation” (Maddux et al., 
1982 p. 211). Alternatively, Maddux et al. suggested that, when the health threat was 
perceived to be more serious, the inconsistencies related to both outcome expectations 
and efficacy beliefs might be accounted for by the moderating influence of an 
additional but untested variable.  
3.1.3 Behaviour  
Behaviour is as important to the aetiology of many chronic conditions as it is to the 
self-care regimen. Although the interaction of efficacy belief and action-outcome 
expectation generally determine behaviour, optimal performance usually requires both 
efficacy and outcome expectation to be high (Gecas, 1989; Lent, Lopez, & Bieschke, 
1991; Stretcher et al., 1986). The likelihood that recommended behaviour will be 
adopted depends on three aspects of people’s understanding. Their perception of the 
degree of risk followed by an expectation that the behaviour will reduce the risk and 
their expectation that they are capable of making the behaviour change. Together, the 
three perceptions influence behaviour intention (Bandura, 1997). Good intentions 
alone are not sufficient for people to adopt health practices, cease risky behaviours or 
change the habits of a lifetime (Grembowski et al., 1993).  
 
In low risk situations, outcome expectation was found to be more important to the 
formation of intention to change or adopt behaviour (Maddux et al., 1982). Efficacy 
expectation about ability, however, influenced behaviour from initiation through to 
long-term maintenance (Bandura, 1986; Schwarzer & Fuchs, 1995).  
 
Optimal performance requires a reasonable degree of association between action and 
outcome. Without it, individuals develop a sense of hopelessness or learned 
helplessness (Buckelew & Parker, 1989; Sullivan, 1993). In particular, when the match 
between efficacy belief and the particular behaviour cannot predict outcome in a 
reliable way, the efficacy belief becomes more important in explaining behaviour 
change (Bandura, 1982). Bandura suggested that people give up trying because they 
either doubted their level of performance (efficacy-based futility) or they believed that 
they could not influence the outcome regardless of their ability (outcome-based 
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futility). This lack of coherence between action and outcome is particularly relevant to 
some health-related behaviours (Blackwell, 1992; Lorig et al., 1989b; Wallston, 1991). 
The unpredictable course and the varying disease activity of rheumatoid arthritis (RA) 
caused patients to view their disease as uncontrollable (Long & Sangster, 1993), 
leading to lower efficacy beliefs in relation to self-care behaviours (Bradley et al., 
1984; Taal et al., 1993a). Similarly, the uncertainty and ambiguity associated with 
future diabetic complications (Carey et al., 1991), regardless of how well ‘controlled’ 
the diabetes may have been in the past, increase fear and guilt (Armstrong, 1987; Hunt 
et al., 1998).  
3.1.4 Development of self-efficacy 
Antecedents in the development of efficacy belief (level / magnitude, strength, and 
generality of the belief) for a particular task are the four sources of information 
provided by direct and indirect experiences. The four sources include performance 
mastery experiences, vicarious experience, verbal persuasion and cues associated with 
physiological status (Bandura, 1982). The individual uses this information to make 
judgements about personal efficacy. Hence, each source has the potential to enhance or 
decrease efficacy belief. Bandura recommended that strategies to build self-efficacy 
use all four sources of information. Strategies or treatment to increase efficacy belief 
operate differently not only for each of the sources (Bandura, 1977), but the sources of 
efficacy information impact differently for each type of behaviour (Ewart, Taylor, 
Reese, & DeBusk, 1983; Taylor et al., 1985).  
 
Regardless of the source of the mastery information, attribution of successful and 
unsuccessful performances to personal ability and effort is an important determinant of 
the magnitude of an individual’s efficacy expectation. 
The cognitive processing of efficacy information concerns the types of cues 
people have learned to use as indicators of personal efficacy and the inference 
rules they apply for integrating efficacy information from different sources 
(Bandura, 1982, p. 127).  
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3.1.4.1 Performance mastery experience  
Performance mastery experience is a composite of prior experiences associated with 
carrying out the behaviour (McAuley et al., 1993). It is the cognitive process 
associated with preconceptions about ability, perceived difficulty of task, effort needed 
and circumstances that will influence a change in efficacy belief (Bandura, 1997). 
 
Successful achievements over time will strengthen efficacy expectation about ability to 
perform specific tasks and generalise to similar tasks, but will also increase the 
person’s ability to withstand the occasional failure. Overcoming the occasional failure 
through determined effort and persistence can help to strengthen efficacy belief 
further. The effect of failure, however, depends on the stage at which it occurred. A 
failure in the early stages of performance mastery will be harder to recover from than 
failure at a later stage (Bandura, 1997).  
 
Enactment of the behaviour has consistently explained a greater percentage of efficacy 
belief than other sources (Bandura, 1986; Gecas, 1989; Rosenstock et al., 1988). The 
greater the perceived difficulty of the task, the greater its contribution to efficacy 
expectation when the behaviour is successful. Successfully enacting the behaviour 
results in higher, more generalised, and stronger efficacy belief than vicarious 
experience or other behaviour feedback sources (Bandura, 1982). The term ‘more 
generalised’ refers to the transfer of efficacy beliefs to similar situations and tasks in 
which the person has self-doubts (Ewart, Stewart, Gillilan, & Kelemen, 1986; Kaplan, 
Atkins, & Reinsch, 1984). Efficacy cognition is dynamic and changes as new 
experiences influence one’s perception about abilities. Personal mastery experiences 
contribute to efficacy belief that generalise to actions other than the original target 
behaviour (Sherer et al., 1982).  
3.1.4.2 Vicarious experiences  
Rosenstock et al. (1988) found vicarious experience to be only second in importance to 
the experience of enacting the behaviour. Vicarious experiences enable judgement 
based on the observation of another’s performance. The greater the perceived 
similarity to oneself, the greater the impact of the modeled success or failure (Bandura, 
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1997). Vicarious experience, however, cannot be relied upon as the sole source of 
efficacy information, as the effect can be negated by perceived personal failure 
(Bandura, 1997; Schunk & Carbonari, 1984).  
 
The model in vicarious learning for young people with type 1 diabetes learning how to 
manage their blood glucose level needs to illustrate the competing commitments of the 
relevant age-group (Schunk & Carbonari, 1984). Good days and bad days are part of 
life, but overall, by relating one’s own experiences, the model should be able to 
convince the person that the challenge can be met. It is also important that clear 
outcomes are evident. Individuals are then able to persuade themselves that if others 
can do it, they can also (Liebert & Spiegler, 1994). 
3.1.4.3 Verbal persuasion 
Verbal persuasion has been found to increase efficacy belief and outcome expectation, 
and leads to change in behavioural intentions (Maddux et al., 1982). Verbal persuasion 
by others, even when realistic, is a weaker source of mastery expectation than the 
previous two (3.1.4.1 Performance mastery and 3.1.4.2 Vicarious experiences). While 
verbal persuasion is easy to provide and readily available, mastery expectation 
developed by this means is also easily lost by a subsequent less than ideal performance 
and may even discredit the persuader. Used in conjunction with other sources, rather 
than having an independent role, exhortation and suggestion by credible others can be 
effective (Bandura, 1977). Returning to the example of the young diabetic, verbal 
persuasion could include discussions about how to overcome perceived barriers to 
blood glucose management, how to safely enjoy ‘the party’ or prevent problems during 
holidays. Self-instruction packages are classified as verbal persuasion.  
3.1.4.4 Emotional arousal 
Emotional arousal, derived from physiologic cues such as heart beat and breathing 
pattern, is used by individuals to judge their degree of anxiety and readiness to act. 
Higher levels of anxiety serve as negative feedback that can erode self-confidence and 
performance, especially for complex tasks (Bandura, 1986). That is, in threatening 
situations, personal efficacy belief affect emotional reactions as well as behaviour. 
Perceived inefficacy in coping with unfavourable events has been shown to have a 
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negatively effect on heart rate, on blood pressure, and on serum levels of 
catecholamines (Bandura, 1982; O'Leary, 1985).  
 
Physiological cues are considered critical for the diabetic who needs to learn to 
recognise the differing symptoms associated with hypo- and hyperglycaemia in order 
to take remedial action. While symptoms are a useful indicator of blood glucose levels, 
they can also be interpreted by the person as a sign that they have failed to ‘control’ 
the condition or have done something ‘wrong’. For example, remedial action that had 
to be covert to avoid criticism from a judgmental family member (Daniels & Rapley, 
1997). Such distress scenarios arising from unsupportive family or social situations 
add to the stress felt by the person (Gonder-Frederick et al., 1989; Hamberg & Inoff, 
1983; MacLean & Lo, 1998), which further impedes cognitive abilities and increases 
the potential for inappropriate choices (Manne & Zautra, 1989). Indeed, regardless of 
health status, competent people can still be troubled by a sense of inefficacy and make 
inappropriate choices (O'Leary, 1985).  
 
Similarly, arthritis sufferers need to recognise that the presence of pain need not 
indicate further joint damage; that pain and fatigue may be the normal effect of 
exercise undertaken as part of the self-care routine (Holman & Lorig, 1992; Taal, 
Rasker, & Weigman, 1996). Individuals are more likely to be optimistic about their 
situation when they are not anxious or feeling tense, although, moderate levels of 
anxiety have been shown to improve efficacy belief and quality of behavioural effort 
(Feist, 1994). That is, moderate levels of anxiety assisted with the successful 
completion of simple tasks but interfered with complex tasks.  
 
Nevertheless, fear of failure can become a self-fulfilling prophecy. Modes of treatment 
that have been used to reduce the negative emotional arousal associated with pain and 
anxiety include relaxation techniques, biofeedback and symbolic exposure (Feist, 
1994). 
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3.1.5 The generality of self-efficacy 
The five processes through which mastery experiences produce generality of personal 
efficacy belief include co-development of competencies, similarity of task sub-skills, 
perception of commonality of behavioural demands, diverse coping skills and 
development of self-regulatory ability (Bandura, 1997; Ewart et al., 1986). First, the 
co-development of competencies refers to skills that are acquired by the person 
concurrently. For example, the aim of self-management classes associated with 
diabetes or arthritis is to improve the individual’s competency level for all regimen 
behaviours needed for managing the illness. This is not to say that the rate of 
competency development will be the same – only concurrent development in, for 
example, dietary choices, adoption of an exercise routine and or the testing of blood 
glucose at appropriate times each day. Secondly, efficacy belief is likely to generalise 
when the activities have a similarity in terms of required sub-skills. Thirdly, similar 
behavioural demands produce a generalised personal efficacy belief, in that, for 
example, the cognitive skills used to establish a blood-glucose testing routine also 
have application for an exercise routine. All require organisational skills, commitment 
to a daily routine and an understanding of the disease process. The fourth process 
relates to successful coping strategies for one type of threatening environment (the 
diabetic eating away from home for the first time) that can have a positive effect on 
efficacy expectation for other potential threats. The fifth process through which 
mastery experiences foster generality in efficacy belief is self-regulation. Self-
regulatory skills include: being able to determine the demands of the new task, setting 
goals to guide effort, having alternative courses of action ready, using personal 
rewards to reach proximal goals and continuing under duress while controlling 
intrusive doubts (Zimmerman, 1989). 
 
In summary, the degree to which the five processes assist with the generalisability of 
efficacy belief to learn or unlearn behaviour depends on its similarity to the attributes 
of previous successful attempts. Dissimilar task demands are less likely to facilitate 
transfer of efficacy belief. 
Chapter 3: Self-efficacy theory & psychosocial adaptation literature  
 44
3.1.6 Self-efficacy theory and health outcomes 
When Self-efficacy theory is applied to health it has been argued that: 
1) Perceived self-efficacy for behaviors that affect health status will predict 
future health status, given that subjects believe that the outcome of the 
behaviour will be improved health status and that they value improved health 
status, 2) Self-efficacy is not a static trait; it can be altered, and 3) Enhanced 
self-efficacy will be associated with improved health status in the areas 
affected by those specific behaviours (Lorig et al., 1989a, p. 38). 
 
The evidence for self-efficacy theory as an explanatory framework for health 
behaviours and outcomes is extensive. It includes application in anxiety disorders, 
depression, smoking avoidance, weight loss, pain management, cardiac rehabilitation 
and adherence to both simple and complex self-care regimens (Bandura, 1991; 
Schwarzer & Fuchs, 1995). Increased efficacy beliefs can predict future positive 
health-related behaviour change (Glasgow et al., 1989; Kavanagh, Gooley, & Wilson, 
1993; Stretcher et al., 1986), although, not consistently for all self-care behaviours 
(Kingery & Glasgow, 1989; Skelly, Marshall, Haughey, Davis, & Dunford, 1995).  
 
Self-efficacy theory has been used extensively in educational programs because of its 
role as a mediator between knowledge and health-related behaviour (Lawrance & 
McLeroy, 1986; Schwarzer, 1994), and between behaviour and health outcomes. For 
example, perceived efficacy to control pain may contribute as much as the person’s 
pain management skills to pain perception (Holroyd et al., 1984; Litt, 1988). Findings 
from the arthritis or diabetes related research that have not involved self-efficacy 
theory, however, indicate that the association between behaviour and a health status 
outcome variable is more variable (Lenker, Lorig, & Gallagher, 1984; Lorig et al., 
1989b; Padgett, 1991; Skelly et al., 1995).  
 
A 1981 evaluation of the Arthritis Self-Management Course (ASMC) revealed that it 
was able to improve health behaviours and improve health status (Lorig, Kraines, & 
Holman, 1981). However, subsequent analysis revealed a lack of association between 
the two variables (Lorig, Lubeck, & Holman, 1982). After an extensive review of the 
literature, Lorig and Laurin (1985) suggested that methodological factors such as a 
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response bias could have contributed to the finding indicating a lack of an association 
between behaviour and health outcome. Alternatively, another variable could have 
provided the explanation. Their conclusion referred to four possible variables 
including self-efficacy. Subsequent research by Lorig and colleagues identified the 
significant effect of self-efficacy on behavioural intention (Lorig et al., 1989a; Lorig & 
Gonzalez, 1992; Lorig et al., 1989b). 
 
Most of the chronic illness research that used self-efficacy theory to explain behaviour 
and health status outcomes was correlational (Ewart et al., 1983; Glasgow et al., 1992; 
O'Leary, 1985). There was, however, evidence for a causal link between self-efficacy 
and pain tolerance (Litt, 1988). Similarly, Lorig and associates established that the 
association between efficacy beliefs and arthritis health outcomes existed, that 
increases in the former resulted in improvements in health outcomes, both concurrent 
and over time (Lorig & Gonzalez, 1992). Of particular relevance to the issue of 
causality was their finding that the effect of the ASMC on health outcomes improved 
even more after strategies to enhance self-efficacy were added to the course.  
 
Strengthening of efficacy beliefs was also suggested as a treatment strategy to prevent 
depressive states associated with learned helplessness or a sense of inadequacy 
(Cunningham, Lockwood, & Cunningham, 1991; Padgett, 1991). Depressive 
symptoms were found to be associated with several chronic illnesses (DeVellis 
McEvoy, 1995; Feldman, 1974) including diabetes (Lustman, Griffith, & Clouse, 
1988; Padgett, 1991; Peyrot & Rubin, 1997) and rheumatoid arthritis (Buckelew & 
Parker, 1989; Katz, 1995; Revenson & Felton, 1989; Schiaffino, Revenson, & 
Gibofsky, 1991). This association is of clinical significance because its presence 
interferes with people’s functional abilities (Parker & Wright, 1995; Smith & 
Wallston, 1992).  
3.2 SELF-EFFICACY MEASUREMENT ISSUES 
There are four self-efficacy measurement issues relevant to the literature to be 
discussed. First, the difficulty associated with the relevance of findings from single-
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behaviour belief (self-care behaviour) research to the situation of multiple behaviour 
beliefs associated with a complex regimen. Secondly, the use of a composite score to 
represent diverse behaviours or beliefs, and thirdly, duration of illness has not been 
measured in relation to the change in efficacy belief. Hence, findings that are based on 
participants diagnosed for more than five years may not be relevant for newly 
diagnosed people. Lastly, the level of measurement to be used (general, domain or 
specific) has varied between studies.  
3.2.1 Single versus multiple behaviour change 
It can be argued that research based on a single health-related behaviour such as 
smoking or exercise can be generalised to other similar smoking or exercise 
populations but not across behaviour domains. For example, efficacy belief specific to 
a change in eating behaviours was found to be weakly related (r = .21) to efficacy 
belief for smoking cessation (DiClemente, 1986). Furthermore, efficacy belief related 
to dietary choices to control diabetes was rated lower than efficacy belief related to the 
taking of diabetic medication (Glasgow et al., 1989).  
 
From the chronic illness research, therapeutic regimen behaviours vary within the 
same chronic illness and the regimen of self-care involves at least two, but mostly 
more than two tasks. The extant literature suggests that rarely are the findings for all 
behaviours / tasks or health outcomes similar within any one study, with one or more 
achieving statistical significance and others not reaching significance (Anderson et al., 
1995; Glasgow et al., 1989; Lorig et al., 1989a; McCaul, Glasgow, & Schafer, 1987; 
O'Leary et al., 1988).  
 
The findings in the above studies should not be surprising because behaviours 
associated with a complex regimen may involve the concurrent challenges of initiating 
a new behaviour while trying to break habitual behaviours judged by others to be 
detrimental to health status. For example, the recently diagnosed diabetic may need to 
quit smoking while also learning how to manage blood glucose through diet and 
exercise. The difficulties associated with lifestyle change that were identified in single 
behaviour research related to diet, exercise or smoking, are then compounded when the 
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person has to follow a self-care regimen involving two or more lifestyle behaviours. 
The implications for the current study will be the within group comparisons of 
multiple illness-specific efficacy beliefs and the concurrent between group comparison 
of a more general efficacy belief. 
3.2.2 Use of a composite measure for data reduction. 
Many of the reviewed studies describe the use of a composite measure. The specificity 
of illness-specific efficacy scales suggests that scores for two or more scales cannot be 
treated as sub-scales and aggregated to one efficacy belief score for analysis as it does 
not represent a uni-dimensional construct. Hair, Anderson, Tatham and Black (1998) 
suggested that the creation of a composite or summated measure should be based on 
four criteria. The criteria were listed as follows: the scale conforms to its conceptual 
definition, items are uni-dimensional, it meets appropriate reliability levels, and the 
scale conforms to various forms of validity, including convergent and discriminant 
validity.  
 
Nevertheless, studies have used a total, un-weighted self-efficacy score, referred to as 
a composite score (Buckelew et al., 1996; Hurley & Shea, 1992; McCaul et al., 1987; 
Padgett, 1991; Simeoni, Bauman, Stenmark, & O'Brien, 1995), to substitute for two or 
more uni-dimensional scales in an effort to improve the predictor-to-subject ratio.  
 
The composite variable in some studies (Hurley & Shea, 1992; McCaul et al., 1987; 
Padgett, 1991; Skelly et al., 1995) appeared to represent diverse efficacy beliefs 
related to different regimen tasks. Using composite scales ignores the evidence that 
there are variations in strength of efficacy beliefs for different behaviours and contexts 
(DiClemente, 1986; Kingery & Glasgow, 1989). Smarr et al. (1997) recognised the 
problem in their paper but rationalised their summated score on the basis that “… the 
total self-efficacy measure is closely aligned with the general constructs of mastery, 
personal control, and non-helplessness” (p. 24).  
 
Composite variables also result in another problem for interpretation of data when 
used in this way. The composite variable is not able to show the differential 
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contribution of behaviour-specific efficacy and outcome expectations of different 
health outcomes or behaviours. Still, the prevalence of using a composite score 
suggests the strategy has been accepted as reasonable - despite its limitations. 
3.2.3 Target population: Newly diagnosed versus longer term 
The third self-efficacy measurement issue has implications for the clinical application 
of self-efficacy theory. Most of the self-efficacy theory research with respect to 
chronic illness involved using long-term illness groups. In fact, several studies 
excluded diabetic subjects diagnosed for less than one year (Glasgow et al., 1989; 
Kingery & Glasgow, 1989; McCaul et al., 1987; Padgett, 1991; Skelly et al., 1995). 
Inclusion criteria have not focused on the newly diagnosed.  
 
Furthermore, several of the diabetic studies had neither newly diagnosed participants 
nor an intervention (Kavanagh et al., 1993; Kingery & Glasgow, 1989; Skelly et al., 
1995). Behaviour-specific efficacy belief can be enhanced through intervention studies 
or through feedback from mastery experiences in non-intervention studies. The non-
intervention studies rely upon the person’s own resources, internal and external, and 
the passage of time - all of which may have had its maximum effect if the person had 
been diagnosed for several years.  
3.2.4 Instruments: Specific, domain and general. 
The most specific of the three levels of efficacy expectation refers to a designated task 
and the context for performance of the task. Alternatively, the intermediate or domain 
level refers to behaviours that share common properties. The most general level, 
however, sometimes referred to as being trait-like (Earley & Lituchy, 1991) or a 
collective entity (Bandura, 1986), does not specify behaviour or context.  
3.2.4.1 Specific level measure 
Since most of the self-efficacy research has involved the prediction of one or two 
behaviours, the testing of self-efficacy belief as highly task-specific has been 
appropriate (Wallston, 1991). For example, Kaplan et al. (1984), using a generalised 
health locus of control expectancy measure and a task-specific measure, was able to 
confirm the superiority of specific expectancy belief as a mediator of behaviour 
change (exercise compliance). The study sample was a group of older adults with 
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chronic obstructive pulmonary disease (N = 60). Similarly, Barrios (1985) was able to 
confirm the superiority of specific self-efficacy expectation as a mediator of pain 
tolerance in a group of college students (N = 80).  
 
In relation to multiple health-related behaviours, a descriptive, correlation study 
examined lifestyle behaviours of individuals on a disability mailing list (N = 117 
adults) covering 22 conditions of varying disability and duration of disability 
(Stuifbergen & Becker, 1994). Stuifbergen and Becker found that people who were 
more likely to engage in health promoting lifestyle behaviours were female with 
higher levels of specific self-efficacy, higher general efficacy and a wellness 
orientation to health.  
 
Although Stuifbergen and Becker (1994) found specific and general efficacy beliefs 
(total score for each scale) to be significantly correlated (r = .37, p < .01), the specific 
efficacy measure explained more (38% compared to 6%) of the health-promoting 
lifestyle behaviour scores than Sherer et al.’s (1982) general efficacy subscale. 
Stuifbergen and Becker’s results, however, cannot be generalised to a chronic illness 
group in which illness-specific beliefs are still developing. Certainly, people with 
acquired disabilities or chronic illness need to make lifestyle changes, but Stuifbergen 
and Becker’s study was not designed to take account of efficacy beliefs specific to 
target behaviours and illness context. Hence, there remains insufficient evidence about 
the relationship of general and illness-specific efficacy beliefs in recently diagnosed 
chronic illness groups who have a complex regimen of care involving lifestyle 
changes. 
3.2.4.2 Domain level measure. 
The Perceived Health Competence Scale (PHCS, 8 items) was developed as a domain 
specific measure (Smith, Wallston, & Smith, 1995). The PHCS purports to measure 
perceived competence (self-efficacy) at an intermediate level of specificity. All items 
refer to health in general – not specific to any condition and are worded to reflect 
ability or health outcome expectations. Psychometric testing of the PHCS was 
completed over five studies using undergraduate students (n = 186 and n = 54), long 
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term rheumatoid arthritis (RA) subjects (n = 238), West Point cadets (n = 528) and 
middle management adults starting a health promotion program (n = 100). Confirming 
an earlier finding by Wallston (1992), Smith et al. (1995) concluded that personal 
competence, which they had likened to generalised self-efficacy but at a domain level, 
and health locus of control were distinct constructs. 
3.2.4.3 Trait-like measure 
There has also been some agreement that a more generalised efficacy belief is a 
function of early life experiences and remains relatively stable, changing infrequently 
during adult life (Jerusalem & Mittag, 1995; Shelton, 1990; Sherer et al., 1982). Earley 
and Lituchy (1991) and Jerusalem and Mittag (1995) viewed self-efficacy as a trait-
like general sense of confidence that reflected a person’s perceived ability in different 
situational demands. Similarly, Shelton viewed general self-efficacy belief as a 
composite of past successes and failures that influenced a person’s attitude to new 
challenges.  
 
According to Schwarzer (1993), the 10-item General Self-Efficacy Scale (GSES) 
developed by them, when compared to other dispositional measures such as self-
esteem or trait anxiety, was able to confirm the principles of self-efficacy theory. In 
addition, it provided normative data derived from five community group studies 
conducted between 1985 and 1991 (N = 1660) in Germany. The GSES was further 
tested with three arthritis groups (N = 80, 79 & 66) in England (Barlow, Williams, & 
Wright, 1996) and found to be inversely correlated with depression across the three 
groups (rs = -.50 to -.29, p ≤ .018). People with arthritis who had higher generalised 
self-efficacy belief had more positive psychological well-being (rs = .52 to .34, p ≤ 
.006). However, there was no significant association between the GSES scores and 
health outcome measures of pain, functional impairment and fatigue. General efficacy 
belief was independent of specific health outcomes. 
 
A similar general efficacy scale developed by Sherer and associates (1982) purported 
to measure a “ general set of expectations that the individual carries into new 
situations” (p. 664). The level of generalised expectancies was influenced by prior 
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varied experiences. Sherer (1990) indicated that Bandura’s idea of personal efficacy 
beliefs reflected a continuum of ‘very specific’ to ‘quite general’ and that while 
Bandura and associates concentrated on the situation-specific end of the continuum, he 
had researched the other end.  
 
Sherer et al.’s (1983) 23-item Self-Efficacy Scale (SE) was designed to measure 
efficacy beliefs unrelated to specific situations or behaviours and it has rarely been 
applied to a chronic illness group. One study did find a significant negative correlation 
(r = -.31, p = .014) between the 17-item general subscale of SE and metabolic control 
for individuals with type 1 diabetes (n = 49) but no association for the type 2 group (n 
= 48). The better the metabolic control for the type 1 group (low GHb), the higher the 
self-efficacy score (Rapley, 1991). Other support for the 17-item subscale as a 
predictor of general health-related behaviour has been reported in health promotion 
among adults with disabilities (Becker, Stuifbergen, Ingalabe, & Sands, 1989), blue 
collar workers (Weitzel, 1989) and health-fair attendees (Waller, Crow, Sands, & 
Becker, 1988). 
 
Sherer et al.’s 17-item general self-efficacy subscale (GSE) has been used to establish 
the construct validity of a domain level health self-efficacy measure (Becker, 
Stuifbergen, Oh, & Hall, 1993). A moderate correlation (rs = .26 to .43) was found 
between the GSE and a total score for the Self-Rated Abilities for Health Practices 
Scale and its four subscales. This finding was confirmed in a further cross sectional 
study (Stuifbergen & Becker, 1994).  
 
In summary, it can be argued that there is limited support for a less specific measure of 
self-efficacy and these few studies cited demonstrate the potential usefulness of 
predicting chronic illness health-related outcomes from less specific measures. Not 
withstanding the tension between a standardised measure for use across domains and 
the need for specificity of behaviour and context (Abraham, 1994), it would be useful 
for clinicians to know the extent to which efficacy beliefs can be generalised from one 
chronic illness to another (Lawrance & McLeroy, 1986; Schwarzer, 1994). Initial 
Chapter 3: Self-efficacy theory & psychosocial adaptation literature  
 52
support provided to the newly diagnosed can be guided by the person’s general set of 
expectations of mastery. To this end, the current study attempted to ascertain the 
degree of association between general efficacy belief and illness-specific efficacy 
belief for selected illness groups.  
 
When considering the lifestyle changes generated by a complex, chronic illness self-
care regimen, the conceptual difference between the broader and more stable general 
efficacy belief and behaviour-specific efficacy belief may have important implications, 
particularly for the person when they are first diagnosed. Whether studies have used 
longitudinal, cross-sectional or point-in-time designs, the task-specific results obtained 
from long-term chronic illness groups cannot presume to be transferable to recently 
diagnosed populations.  
3.3 SELF-EFFICACY THEORY AND SELECTED CHRONIC ILLNESSES  
The study presented in this thesis adopts the view that research that has confirmed the 
relationship between a specific efficacy belief and a single behaviour intention cannot 
be generalised to situations in which individuals need to adopt a complex regimen of 
self-care. In order to manage the different aspects of the disease process, mitigate 
complications and generally adjust to the consequences of chronic illness, the 
development of multiple efficacy beliefs needs to be considered. The next part of the 
literature review will focus on diabetic and arthritis studies. Unless otherwise stated, 
the studies used task-specific measures of efficacy belief.  
 
As stated at the beginning of the chapter, the reporting of illness-specific efficacy 
mainly focused on its association with, or predictive ability for self-care behaviours 
over time. This was true in the diabetes (Glasgow et al., 1992; Hurley & Shea, 1992; 
Kingery & Glasgow, 1989; McCaul et al., 1987) and the arthritis literature (Parker et 
al., 1993; Schiaffino et al., 1991; Shoor & Holman, 1984; Smarr et al., 1997; Taal et 
al., 1993a). For example, the focus for the patient education review article by Taal et 
al. (1996) was on the predictive influence of self-efficacy theory on behaviour and 
health status. 
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Studies have also sought to test the stability of the self-efficacy instrument itself over 
time (Hurley, 1990; Kavanagh et al., 1993; Kingery & Glasgow, 1989; McCaul et al., 
1987; Sallis et al., 1988) rather than test for changes in efficacy belief over time. Other 
studies measured illness-specific efficacy beliefs at one point in time only (Glasgow et 
al., 1989; Hurley & Shea, 1992; Padgett, 1991). The problem that then emerges is the 
lack of evidence in the chronic illness literature as to the rate of increase within and 
between illness groups.  
 
Nevertheless, the testing of self-efficacy theory’s role in behaviour change and health 
outcomes relevant to chronic illness management has been considerable. Where 
studies did not have an intervention, they relied upon changes in behaviour and other 
sources of efficacy information to elicit future reciprocal increase in efficacy belief 
(Bandura, 1991; O'Leary, 1985). For example, if the behavioural task, once enacted, is 
perceived by the individual as a positive experience an increase in confidence will 
ensue and the greater the likelihood that the behavioural task will be repeated. In 
theory, the reciprocal effect between a positive behavioural experience and the 
building of efficacy belief continues to accrue as the behaviour persists. Each of the 
four sources of efficacy information, not just enactment of the behaviour, has the 
potential to increase the person’s sense of confidence in ability. The current study did 
not have an intervention and hence, changes in efficacy belief relied upon the four 
sources of efficacy information (See section 3.1.4) in the every-day lives of 
participants.  
3.3.1. Rheumatic diseases 
As early as 1984, Shoor and Holman (1984) reported on the possible contribution of 
psychological factors, rather than behaviour, to functional outcomes in chronic 
arthritis. The bases for their finding at that time were diagnostic criteria and clinical 
studies. Two of the diagnostic criteria for rheumatoid arthritis relied on people’s 
perception of their pain and health status. In relation to clinical studies, a “… weak 
correlation between function and biological markers of disease activity …” (p. 325) 
was found. Shoor and Holman (1984) cited findings from various clinical studies that 
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indicated a high incidence of psychological abnormalities such as depression, that 
when treated, were able to improve prognosis. 
 
Furthermore, a randomised-controlled study (Lorig et al., 1982) found that self-care 
behaviours and improvement in pain and disability were not correlated. Although 
significant improvement in self-care behaviours and health status had occurred as a 
result of the Arthritis Self-Management Course (ASMC), there was no correlation 
between the two variables. A subsequent modified grounded theory study (N = 54) to 
explore this apparent anomaly, concluded that “… control and affect may be important 
mediating factors for health-status outcomes of arthritis education” (Lenker et al., 
1984 p. 71). 
 
The earlier assertions of Shoor and Holman (1984) in relation to the lack of association 
between health behaviours and health status were also confirmed in other clinical 
studies (Johnson, 1992; Lorig & Laurin, 1985; O'Leary et al., 1988). Concomitantly, 
other studies were able to provide support for the effect of self-efficacy in arthritis-
related health outcomes (Buckelew & Parker, 1989; Lorig & Gonzalez, 1992; 
Stretcher et al., 1986; Taal et al., 1993a).  
 
Lorig et al. (1989a) found that efficacy beliefs correlated with present and future 
health status for a mixed arthritis group who took an ASMC (N = 95). From baseline 
to four months, the efficacy enhancing strategies (skill mastery, modeling, 
reinterpreting symptoms and persuasion) significantly improved health status 
(perceptions related to pain and depression) independent of the behaviours taught (p < 
.05). Research based on the ASMC and other similar programs was able to show that 
patients who had a greater sense of efficacy had less pain and functional impairment, 
less depression, less stress and better sleep (Holman & Lorig, 1992). A 12 year review 
of the ASMC by Lorig and Holman (1993) indicated, as one of six conclusions, that 
the mechanism by which the course “… affects health status appears to be more 
closely linked to changes in self-efficacy than to changes in behaviours” (p. 17). 
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Likewise, a stress-management course based on the strengthening of exercise-related 
efficacy belief demonstrated significant improvement in health status over 15 months 
(Smarr et al., 1997). This randomised three-group study provided correlational data to 
support the association between a total self-efficacy score and a reduction in 
depression and pain intensity. The study also found a significant inverse association 
between total self-efficacy and helplessness that increased over 15 months (r = -.31 to 
-.51). As self-efficacy increased, the sense of helplessness decreased. 
 
A predictive study was also supportive concurrently and prospectively (Schiaffino et 
al., 1991). The hierarchical regression analysis to determine adaptation to the onset 
(less than two years) of rheumatoid arthritis (T1 n = 101; T2 n = 65) found initial 
specific efficacy belief (total score) and perceived pain could explain concurrent and 
future functional disability (ps < .05) but not depression. Greater efficacy belief was 
associated with greater use of problem-solving coping behaviour a year later (β = .46, 
p < .01) (Schiaffino et al., 1991). Regardless of pain perception, self-efficacy was 
related to both less disability and more problem-solving coping. 
 
Contrary to these positive results, Simeoni, et al. (1995) were unable to find a 
significant difference between the control (n = 71) and intervention groups (n = 104) 
for self-efficacy, pain perception, disability index or self-management behaviours over 
six weeks or six months. Several reasons for the discordant results were evident. They 
included the lack of focus on strategies to increase self-efficacy belief, the lack of 
credible role models for vicarious and persuasive sources of efficacy information and 
the finding that the baseline self-efficacy score was higher for the intervention group 
and significantly different from the control group (p = .01). The combined lack of a 
self-efficacy focus and higher initial scores would not be conducive to producing a 
significant increase in efficacy belief.  
 
Findings from the few studies using Fibromyalgia Syndrome (FMS) patients were 
consistent with the arthritis research in general (Buckelew et al., 1998; Buckelew et 
al., 1996; Burckhardt, Woods, Schultz, & Ziebarth, 1989). That is, using the Arthritis 
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Self-Efficacy Scale (Lorig et al., 1989a) as a total score, higher efficacy beliefs were 
associated with better health outcomes.  
 
The more recent self-efficacy literature with arthritis groups tended to use very similar 
or identical instruments and the consistency of findings facilitated generalisation. 
Researchers tended to include the Arthritis Self-Efficacy Scale (ASES) developed by 
Lorig and colleagues (Lorig et al., 1989a), a variation of the ASES (Taal et al., 1993a; 
Taal et al., 1993b), or a generalised self-efficacy scale (Barlow et al., 1996).  
 
As stated earlier, the focus for most of the chronic illness studies was the association 
or prediction of behaviour and health status from the increase in efficacy beliefs. 
Although the targeted efficacy beliefs were often reported as increasing, findings from 
the few studies that provided the statistical evidence for the change in efficacy beliefs 
were inconsistent (Lorig et al., 1989a; O'Leary et al., 1988; Taal et al., 1993b). For 
example, Lorig et al. (1989a) and O'Leary et al. (1988) found that PSE (pain) and OSE 
(other symptoms) increased significantly after the ASMC intervention while efficacy 
belief about function ability (FSE) increased, but not significantly. For studies that 
included a control group, efficacy belief changes were non-significant. These findings 
support the theoretical variability in efficacy beliefs for different behaviours, contexts 
and the intervention emphasis.  
 
The power of a tailored intervention was demonstrated by Taal et al. (1993b) who 
found that FSE could be significantly improved when a homogenous sample (RA) was 
selected to test an aspect of the ASMC most resistant to change (Holman & Lorig, 
1992). Taal et al. emphasised physical exercise and used a physiotherapist, as opposed 
to lay leaders. The FSE was significantly improved at six weeks and at 14 months, but 
not at four months. The non-significant four-month result was not explained and an 
explanation was not seen in the data. Taal et al., however, indicated that less emphasis 
was placed on relaxation exercises for pain control than Lorig et al.’s (1989a) study. If 
this was the case, it could also explain their non-significant increase in PSE and OSE 
at any of the three test times. Specifically, with changes in the intervention strategy 
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and inclusion criteria, their significant and non-significant findings were the reverse of 
Lorig et al. and O’Leary et al. (1988) who used community samples from standard 
ASMCs. 
 
In summary, Bandura’s (1997) self-efficacy theory has provided explicit guidelines for 
interventions that enable people to exercise some influence over how they live their 
lives and has been used in a USA developed 12-hour Arthritis Self-Management 
Course (ASMC) for people with arthritis (Lorig, 1996). Use of the ASMC has been 
extended to Canada and Australia (Simeoni et al., 1995) and has been the focus for 
research since its inception in 1978 (Lenker et al., 1984; Lorig & Holman, 1993). 
Although inconsistency of findings were evident, research based on the ASMC has 
been able to show at least one consistent finding: That when self-efficacy increased, 
pain was reduced (Lorig & Holman, 1998) and remained so, despite arthritis-related 
disability having increased (Holman & Lorig, 1992).  
 
While the ASMC intervention is well documented and replicated in many arthritis and 
FMS studies, much of the diabetes literature either did not use an intervention or the 
intervention was not documented sufficiently for replication (Brown, 1999; Fain, 
Nettles, Funnell, & Charron, 1999). 
3.3.2 Diabetes mellitus  
The focus of diabetes research has been on educational interventions to improve 
knowledge of diabetes, self-care behaviours (skill level and compliance behaviour) 
and improvement in metabolic control (Brown, 1988; Brown, 1990; Fain et al., 1999; 
Welch, Dunn, & Beeney, 1994). Within the last two decades, however, the focus for 
diabetes research has gradually expanded to recognise the importance of psychosocial 
factors (Dunn, 1986; Fisher et al., 1982; Hunt et al., 1998) and cognitive factors such 
as self-efficacy theory (Anderson et al., 1995; Bandura, 1997; Glasgow et al., 1992; 
Hurley, 1990).  
 
The first meta-analysis conducted by Brown (1988) indicated that diabetes education 
improved patient outcomes. The second analysis, however, reflected the change from 
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conventional education programs to programs that also included psychosocial 
outcomes (Brown, 1990). In the latter review, the 14 studies (1981 – 1989) with 
psychosocial outcomes that met the criteria for homogeneity had a combined weighted 
mean effect size of 0.27 ± 0.08 SD). The comparative analysis for education as a 
global variable was moderate (0.49 to 1.05), but the effect size for specific patient 
education was only small (i.e. insulin injection skill, 0.23 with a 95% confidence level 
near zero). Similarly, Padgett et al.’s (1988) meta-analysis of 94 education and 
psychosocial intervention studies related to diabetes management found the mean 
effect size for social learning interventions (11 of 94) to be non-significant {ES = + 
0.51 (0.27)}.  
 
Of relevance to the current study was the recommendation by Brown (Brown, 1990) 
that educational programs incorporate specific strategies to improve adaptation to 
diabetes, the rationale being that such studies would result in larger effect sizes. A 
similar suggestion was also put by Beeney and Dunn (1990) who, like O'Connor et al. 
(1992), found that the significant improvement in diabetes knowledge was not 
correlated with changes in glycated haemoglobin (GHb) (r = .03). Furthermore, 
Campbell, Redman, Moffitt and Sanson-Fisher (1996) found, in a randomised trial of 
persons (N = 238) with type 2 diabetes using four treatment groups, that the 
educational program group was least able to lower their diastolic blood pressure and 
did no better than the other groups on other measures. Campbell et al.’s study 
supported the findings of Brown (1990) and suggested that outcomes should reflect 
well-being and quality of life using strategies to encourage patient empowerment 
along the lines suggested by Anderson et al. (1995).  
 
The main reason for the emphasis on the client’s behaviour and knowledge in earlier 
studies may have been related to an assumption that the right behaviour will result in a 
positive health outcome. In fact, there is evidence that this view still prevails among 
medical practitioners (Hunt et al., 1998), nurses (Michael & Sabo, 1996) and the 
research literature (Brown, 1999; Fain et al., 1999; Glasgow, 1999). To an extent the 
clinical focus can be understood, in that non-compliance with a diabetic self-care 
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regimen has serious medical consequences, including death. Diabetes education 
programs are important (Glasgow, 1999), but an increase in knowledge to predict 
behaviour change or health status has rarely been supported in the short term and its 
effect after three months is untested (Fain et al., 1999). The complexity of diabetes 
self-management is such that some individuals will need to attend several courses with 
years of guidance to learn the principles of diabetes knowledge (Brown, 1999).  
 
Two other issues were also found when the diabetes patient education research was 
reviewed. Most studies lacked a theoretical framework and there was insufficient 
detail about an intervention to replicate the research (Fain et al., 1999). This latter 
point was consistent with Brown’s (1999) review of the diabetes education literature.  
 
Apart from knowledge, the discourse in the diabetes-related self-efficacy research has 
focused on predicting one of two things. First, the prediction of diabetes related self-
care behaviours such as blood glucose management, diet, exercise, insulin use, and or 
diabetes self-care in general. Efficacy belief scores related to regimen specific 
behaviours were found to predict the related self-care behaviour (Hurley & Shea, 
1992; Kavanagh et al., 1993; Kingery & Glasgow, 1989).  
 
Secondly, the strengthening of diabetes-specific efficacy beliefs has been associated 
with various health status outcomes such as a reduction in glycated haemoglobin 
(Anderson et al., 1995; Rubin et al., 1989) or weight (Glasgow et al., 1992). In those 
studies in which glycated haemoglobin (GHb) has been measured, blood glucose self-
management (BGSM) behaviours were more often found to be independent (Glasgow 
et al., 1987; Glasgow et al., 1992; Glasgow et al., 1989; Padgett, 1991; Toobert & 
Glasgow, 1991). In diabetes research (type 1 & 2), the link between efficacy beliefs 
and self-care behaviours has proven to be stronger than the relationship between these 
behaviours and subsequent improvement in glycemic control (Glasgow et al., 1989; 
McCaul et al., 1987).  
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This point was made even clearer in a randomised control trial of a group of persons 
described as either using or not using insulin (Anderson et al., 1995). This study had a 
patient empowerment focus with the aim of improving psychosocial self-efficacy in 
eight areas relevant to the diabetes course content. Although a significant increase was 
found for only four of the self-efficacy subscale measures, all of the mean scores 
increased for the intervention group (n = 22) but not the control group (n = 23). 
Furthermore, in relation to health outcomes, the intervention group showed 
significantly greater reduction in GHb (p = .05) and negative attitude (p = .01) that was 
attributed to significantly increased efficacy beliefs related to the ability to set goals, 
manage stress, make decisions and obtain social support. Compliance behaviour itself 
was not improved. 
 
There are, however, inconsistencies in the literature. For example, Kavanagh et al. 
(1993) found that self-efficacy could predict post-test behaviours, and that both 
behaviour and self-efficacy could explain post-test GHb for a sample of type 2 
diabetics (N = 63). By contrast, Padgett (1991) found that glycaemic control was not 
significantly correlated with either adherence ratings or with self-efficacy belief for a 
type 2 diabetic group. When a measure of general belief in ability was used (Sherer et 
al., 1982) in testing the association between self-efficacy and glycaemic control, a type 
1 diabetic group was found to have a significant negative correlation (r = -.31) with 
GHb (better) while no association was found for the type 2 group (Rapley, 1991).  
 
On balance, however, it can be argued that self-efficacy theory has proven to be a 
useful heuristic to explain health status outcomes associated with the management of 
diabetes (Anderson et al., 1995; DiClemente, 1986; Shillitoe, 1995). However, the 
degree to which the diabetes-specific self-efficacy measure is able to detect changes in 
efficacy beliefs is not clear. Most authors have reported the stability statistics of the 
measure without regard for the change statistics (Hurley & Shea, 1992; Kavanagh et 
al., 1993; Kingery & Glasgow, 1989; McCaul et al., 1987; Sallis et al., 1988; Skelly et 
al., 1995).  
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The few diabetes studies that measured the change in efficacy beliefs were either non-
significant (Glasgow et al., 1992; Skelly et al., 1995) or reported on the stability of the 
measure over time (Kavanagh et al., 1993; Kingery & Glasgow, 1989). An exception 
was Rubin et al. (Rubin et al., 1989), whose study involved a five day intensive 
education course for types 1 and 2 diabetics (n = 122). The mean self-efficacy score 
(one score) increased significantly from pre-course to post course (1 week) and six 
months later (p < .001).  
 
Considerable variability existed within these studies as to the mix of diabetes type, age 
range and diabetes-specific self-efficacy measures. In addition three studies did not 
have an intervention but relied upon normal clinic visits and the passage of time (two 
to four months) for the diabetes-specific efficacy beliefs to increase (Kavanagh et al., 
1993 54; Kingery & Glasgow, 1989; Skelly et al., 1995). Of the two studies that 
reported non-significant changes in behaviour-specific efficacy beliefs, at least one 
result could be attributed to the lack of an intervention and small sample. Skelly et 
al.’s (1995) study had 118 adults with an average illness duration of 10 years. Any 
reciprocal effect of successful behavioural influence on efficacy beliefs would have 
been minimal. Hence, the small increase in mean scores and large standard deviations 
that were reported indicated insufficient power to reject the null hypothesis.  
 
Rarely was statistical power to reject the null hypothesis discussed as a possible cause 
for non-significant results. For example, the non-significant change in diet and 
exercise efficacy beliefs for two groups over six months after an intervention 
(immediate n = 52; delayed n = 50) could have been due to inadequate power to detect 
a difference (Glasgow et al., 1992). Alternatively, the intervention itself has been 
implicated in non-significant findings. Rubin and colleagues (Rubin et al., 1989) 
suggested that courses that focus on an overview of diabetes knowledge without self-
care psychomotor and coping skills are less likely to make a difference in health 
outcomes. 
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The variability in the diabetes research in terms of interventions, diabetes-specific self-
efficacy measures and lack of standard behavioural or health-outcome measures 
(Brown, 1990) limits the ability to generalise the findings. Padgett et al.’s (1988) 
review of studies between 1978-86 concluded that the “quality of methodology for 
each study was inversely related to the mean effect size (ES) (r = -.28, p < .05), i.e. 
weaker studies were significantly associated with higher ES values “ (p. 1023). It 
could be argued that this result reflects the early stage of instrument development and 
associated measurement difficulties. For example, nearly a third of the studies 
included a health-related compliance measure. More recently, researchers have come 
to accept that non-compliance is the norm (Blackwell, 1992; Glasziou et al., 1994; 
Hunt et al., 1998; Thorne, 1990). Diabetes knowledge measures were used in 26 (28%) 
of the studies reviewed by Padgett, et al., yet knowledge alone does not lead to 
behaviour change for the person with diabetes (Beeney & Dunn, 1990; Dunn, Beeney, 
Hoskins, & Turtle, 1990), or for health promotion in general (Paul & Redman, 1997).  
 
Although adjustment to diabetes is a process of behavioural self-regulation (Gonder-
Frederick & Cox, 1991; Wing et al., 1998), there has been limited research on the 
usefulness of one of the more powerful cognitive control variables, such as self-
efficacy, that can facilitate self-regulation. Studies have not been replicated and the 
focus has been on regimen behaviour change.  
 
Despite the limitations of the various methods used, the findings at least indicate a 
trend. Self-efficacy is associated with behaviour change, whether it was analysed as a 
single behaviour efficacy belief score or multiple efficacy beliefs were combined as a 
composite score (Hurley & Shea, 1992; Kingery & Glasgow, 1989; McCaul et al., 
1987; Padgett, 1991; Skelly et al., 1995). Furthermore, supportive evidence for the role 
of self-efficacy in improving the health status of persons with diabetes resulted in a 
recommendation for diabetes educators to incorporate self-efficacy strategies into self-
care education programs (Anderson et al., 1995; Glasgow & Osteen, 1992; Hurley & 
Shea, 1992).  
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3.4 PSYCHOSOCIAL ADAPTATION TO ILLNESS 
Conceptually, psychosocial adjustment and psychosocial adaptation have both shared 
distinguishing features (Livneh & Antonak, 1997). Livneh and Antonak saw 
psychosocial adjustment to chronic illness as the theoretical endpoint in the unfolding 
process of adaptation to chronic illness. Adaptation as a process, was manifested 
differently depending upon the chronic illness and the long-term implications.  
 
Although empirical evidence was not available to support any particular model of 
adaptation, Livneh and Antonak (1997) suggested that psychosocial adaptation 
occurred on a continuum from maladaptation to successful adaptation. Features related 
to the maladaptation end included anxiety, depression, anger, denial and negative self-
esteem. The adaptive end of the continuum reflected positive self-esteem, self-
efficacy, personal mastery and adaptive coping. Support for this conceptualisation 
came from the association of distinct psychological reactions with onset of illness 
through to adjustment (Livneh & Antonak, 1997).  
 
For the purposes of the current study, the term ‘adaptation’ is used unless referring to 
the full name of the Derogatis and Derogatis instrument PAIS (1990). (See 
Explanation of Terms, p. xi) It could be argued that the target population for the study 
was still coping with the impact of the illness experience and therefore adaptation as a 
process, rather than adjustment as an endpoint, was more appropriate. 
 
The individual’s psychosocial adaptation to chronic illness, as a health outcome, 
depends upon the person’s perception of the burden of the illness and its intrusiveness 
(Devins et al., 1992). The degree to which a chronic illness becomes overly intrusive 
depends upon the severity of the illness itself and the person’s response to the illness. 
Personal resources such as coping skills or belief in one’s ability to manage will 
determine the response. Fulfilling social roles is also important to psychological well-
being (Blalock et al., 1998; Newman, 1990). According to Derogatis & Lopez (1983), 
psychosocial adaptation is correlated with the individual’s role competence. It is not 
surprising, therefore, that studies have found that the best index of adaptation to 
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chronic illness is the person’s perception of the limitations to their lifestyle, not the 
type or severity of the disease (Felton et al., 1984; Westbrook & Viney, 1982). 
 
Pollock (1993) found that psychosocial adaptation did not differ among adults (N = 
597) with hypertension, diabetes, cancer or rheumatoid arthritis. Other studies also 
supported the notion that psychological response to chronic illness is independent of 
diagnosis (Cassileth et al., 1984; Pollock et al., 1990). Similarly, psychological 
response to chronic illness was found to be independent of disease severity for 
rheumatoid arthritis patients (Eberhardt et al., 1993).  
 
It has been suggested that psychological and physiological well-being for individuals 
with arthritis was facilitated by improving arthritis specific-efficacy beliefs (Bowsher 
& Keep, 1995; Holman & Lorig, 1992; Lorig et al., 1989a; Schiaffino et al., 1991). 
Likewise, emotional adjustment to arthritis has been associated with a greater sense of 
personal control over the condition (Affleck, Tennen, Pfeiffer, & Fified, 1987). 
Individuals who were identified as being better adapted, believed they could control 
their symptoms, believed in and understood their treatment, and were more likely to 
carry out self-care. Hence, educational interventions for the arthritis groups should 
include effective coping strategies as part of enhancing arthritis-specific efficacy 
beliefs (Freeman et al., 1996). 
 
In the diabetes literature, the relationship between self-efficacy and psychosocial 
adaptation has been studied sporadically (Livneh & Antonak, 1997). In fact, a review 
of psychosocial problems in diabetes and possible interventions did not mention self-
efficacy theory (Rubin & Peyrot, 1992), but commented on the scarcity of research 
addressing coping and stress reduction strategies. Concomitantly, the psychosocial 
impact of diabetes has been found to be a better predictor of mortality than many 
clinical and physiological variables (Davis, Hess, & Hiss, 1988). The positive 
influence of psychosocial adaptation on metabolic control, however, has been a 
consistent finding (Dunn et al., 1990; Mazze, Pasmantier, Murphy, & Shamoon, 1985; 
Pollock, 1986; Rapley, 1991). Of equal importance is the finding that the negative 
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effects of stress on blood glucose levels can be buffered by psychosocial variables 
(Griffith et al., 1990). And yet, conversely, increased stress associated with negative 
diabetes-related experiences and the onset of complications has been demonstrated to 
lead to psychosocial problems (Cox & Gonder-Frederick, 1992). In fact, Pollock 
(1993) found that 34% of the variance in predicting PAIS for individuals with one of 
four chronic illnesses (diabetes type 1, arthritis, hypertension and multiple sclerosis) 
was accounted for by five variables, including the ability to tolerate stress.  
 
In chronic illness in general, stress has been associated with the loss of social and or 
vocational roles, permanent changes to life-style, uncertainty of the future and threats 
to self-esteem (Feldman, 1974; Livneh & Antonak, 1997). Furthermore, a perceived 
lack of control or sense of helplessness is itself stressful (Buckelew & Parker, 1989). 
These factors, alone or in combination, contribute to the adaptive demands made by 
chronic illness. Nevertheless, it has been accepted that the person’s response to a 
stressor determines health outcomes more accurately than the type of stressor 
(Lazarus, 1974). For example, the individual’s capacity to give up false hope 
(Feldman, 1974) and adapt to the chronic illness has a direct effect on the successful 
outcomes of the illness (Adams & Lindemann, 1974; Davis et al., 1988; Holman & 
Lorig, 1992).  
 
Unfortunately, only a few studies have used the instrument PAIS with a diabetic group 
(Connell et al., 1995; Landis, 1991; Pollock, 1993; Trief, Elbert, Grant, & Weinstock, 
1998; White et al., 1992; Willoughby et al., 2000). Less often, studies used PAIS with 
an arthritis group (Blalock et al., 1998; Pollock, 1993). Studies could not be found that 
used PAIS and an illness-specific efficacy scale. 
 
It has, however, been suggested that since self-efficacy belief can mediate the 
relationship between competence and a sense of well-being (Bandura, 1977; Bandura, 
1986; McAuley et al., 1993), future health-related self-care studies should include a 
combination of perceived self-efficacy and psychosocial adaptation (White et al., 
1992). The purpose of the current study was to explore this relationship further. 
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3.5 CONCLUSION 
Studies into self-efficacy theory have demonstrated it has the potential to improve 
health outcomes and facilitate behaviour change in chronic illness, both concurrently 
and in the future. Few studies have specifically included newly diagnosed individuals 
as part of their methodology or considered the individual’s efficacy beliefs about their 
abilities in general during the period when task-specific efficacy beliefs are 
developing. The current study seeks to address both issues in the belief that task-
specific efficacy beliefs need time to develop for effective self-care. Differences 
between these two efficacy beliefs at initial diagnosis, when the person is being 
assisted with the self-care regimen, may be clinically significant. 
 
Self-efficacy theory suggests that people with strong efficacy beliefs are more likely to 
persist with difficult tasks, even after experiencing an initial setback or failure. This is 
important as chronic illness regimens to manage the symptoms of diabetes and 
arthritis, as well as prevent further complications, are psychologically and 
behaviourally demanding (Freeman et al., 1996; White et al., 1992). Comparing the 
differential effect of efficacy belief in ability in general, and the more task-specific 
efficacy beliefs as they develop over time, may assist in the development of clinically 
relevant strategies for chronic illness management programs. Furthermore, self-
management programs that facilitate increased confidence in specific self-care 
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CHAPTER 4: METHOD 
The purpose of the study was to determine the relative impact of general versus task-
specific self-efficacy on psychosocial adaptation to illness over nine months for three 
chronic illness groups. A secondary purpose was to explore the degree of and change 
in association between general and task-specific self-efficacy for selected illnesses 
over this time. 
 
This chapter describes the research design, sampling method and plan, instruments, 
data collection procedures and the planned statistical analysis. Ethical considerations 
are also discussed. Sample letters of invitation to participate in the study, consent form 
and instruments are attached as Appendices A to G. 
4.1 STUDY DESIGN 
The study design was a longitudinal, parallel group study that employed an 
exploratory predictive design to examine general and illness-specific efficacy beliefs.  
The study had two stages. The initial stage was to provide information on the ease of 
recruitment into the main study, information for improving the data collection 
procedure as a whole and the appropriateness of the wording for the condition-specific 
scales for the accessible target groups. The second stage was a nine months, 
longitudinal, parallel group study. The study did not include a specific intervention 
and participants acted as their own controls for comparison of the dependent variable, 
psychosocial adaptation to illness over time and repeated measure analysis. The 
longitudinal nature of the study helped to reduce the influence of extraneous variables 
that may account for psychosocial adaptation to illness – for example, skill at regimen 
tasks. Hence, changes in variables of interest were expected to reflect the real-life 
situation giving the study stronger external validity compared to a clinical trial 
(Drummond & Jefferson, 1996). The testing threat to internal validity was considered 
in the use of three data collection points over nine months. Carmines and Zellor (1979) 
suggested that the influence of memory was not a threat when two tests are more than 
one month apart. General self-efficacy (GSE - Appendix D) and condition specific 
self-efficacy (diabetes - Appendix E; arthritis - Appendix F) measures were 
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administered at three points in time over nine months. The self-report version of the 
Psychosocial Adjustment to Illness booklet (PAIS-SR) was administered at the second 
and third data collection points only (Appendix G – see attached).  
4.2 INITIAL STAGE – TRIAL OF INTENDED STUDY PROCEDURES  
Once ethics approval was received from the first major teaching hospital and the 
Arthritis Foundation, volunteers were sought for the trial of study procedures. 
Participants for this stage were not included in the main study (see Table 4.1) but the 
same sampling criteria were used.  
4.2.1 Purpose 
Protocol testing was used as a trial run for the main study to ascertain the ease of 
recruitment into the study, obtain information for improving the data collection 
procedure as a whole and the appropriateness of the wording for the condition-specific 
scales. Both scales to be used at this stage had previously been developed and tested in 
the United States of America and needed to be tried locally. Results on ease of access 
to the target groups would also give an indication of the maximum sample size that 
could be expected in the time available.  
4.2.2 Instruments 
The relevant disease-specific scale was discussed with a Diabetes Educator at a major 
teaching hospital and the Education Officer at the Arthritis Foundation in Western 
Australia. They were reviewed for content validity and appropriateness of wording for 
the local target populations. The Arthritis Self-efficacy Scale (Lorig et al., 1989a) did 
not require changes for the protocol trial. Some minor changes to the Insulin 
Management Diabetes Self-efficacy Scale (Hurley, 1990) were made for the protocol 
trial and are discussed in the instrument section to follow (4.5.4). In short, the 
questions related to insulin were removed for the N-IU participants in the trial run and 
removal of one other diet related question was recommended. 
 
The questionnaire booklet consisted of a demographic section (Appendix C) used in a 
previous study (Rapley, 1989), a General Self-Efficacy Scale (Sherer & Adams, 1983) 
and the relevant condition-specific self-efficacy scales. These instruments formed the 
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questionnaire for baseline data (T0). The PAIS was not included in the protocol trial 
for two main reasons. First, the researcher had used it in an earlier study involving 
individuals with type 1 and type 2 diabetes and had determined its reliability for a 
similar local sample (Rapley, 1989). Secondly, to ensure a reasonable return rate, the 
initial questionnaire booklet for T0 could not be too large. Hence, the decision to 
measure PAIS only in the second and third wave of data collection was based on the 
time that would be needed to complete an additional five page questionnaire booklet if 
included with the other T0 questionnaires. The demographic questionnaire would not 
be needed at the later test times, allowing more time for completion of the PAIS 
booklet. Of less importance but nevertheless relevant to the rationale for not including 
PAIS at T0, copyright restrictions did not allow questions from the PAIS to be changed 
or deleted.  
4.2.3 Participants and procedure 
Twenty participants were recruited from the Arthritis Self-Management Course 
(ASMC) conducted by the Arthritis Foundation. During the refreshment time of the 
two-hour class in week two of the ASMC, participants were invited by the researcher 
to join the study. Using the main study protocol for informed consent, volunteers were 
asked to complete the arthritis T0 questionnaire. Similarly, ten diabetes type 2 
participants (N-IU) from Diabetes Education classes conducted by the Diabetic Clinic 
of a major teaching hospital completed the baseline diabetes (T0) questionnaire. (See 
Explanation of Terms, p. xi for overview of self-management courses.) 
 
Opportunities were provided for questions to be asked of the researcher directly 
(telephone number given) or through the relevant health care professional contact in 
the class. No ambiguities were evident and questions that were asked did not indicate a 
need to change any instructions or instrument wording.  
4.2.4 Findings of the protocol trial 
Based on the results from this part of the study, no changes to the questionnaire or data 
collection procedure were necessary for the main study. The protocol and 
questionnaires used were subsequently used in the main study. Recruitment for the 
trial indicated that samples of 100 or more in the N-IU and the arthritis group would 
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take approximately two years to obtain within Western Australia. Without a self-
management class as a recruitment point, the IU group could take longer.  
4.3 MAIN STUDY – SECOND STAGE  
4.3.1 Sampling criteria 
Inclusion criteria were adults (over 18 years) and able to read English. Apart from a 
lower limit of 18 years, age was not restricted to enable a broad range of ages 
representative of the target population. The target populations included individuals 
who had been diagnosed by a General Practitioner or Rheumatologist within the last 
three to six months preceding their invitation to participate in the study or were 
attending a self-management class for the first time. It was argued that the decision to 
attend a self-management course and ‘recently diagnosed’ could be equated in terms of 
the individual’s level of efficacy belief or confidence to make the necessary behaviour 
changes. 
 
In relation to the ‘three to six months’ criterion, advice from several Diabetes 
Educators indicated that, in their experience, individuals needed at least three months 
to come to terms with the diagnosis and that intention to undertake a recommended 
behaviour change may not occur within the first few months after diagnosis. This 
suggestion is also supported by the literature on behaviour change when efficacy belief 
is low (Prochaska, 1995). 
 
In relation to the criterion ‘attending a self-management class for the first time’, it was 
also recognised that “entrenched habits rarely yield to a single attempt at self-
regulation” (Bandura, 1997, p. 281). Habit change has been found to be circular as 
people spiral through the change phases in response to both success and relapse 
experiences (Basler, 1995; Maddux, 1995a; Prochaska, 1995). The change phases 
include: disregarding the need to change, considering change, initiating change and 
finally, maintaining the change. An assumption was therefore made that attendees at 
the self-management classes for this study would be at least ready to change 
(DiClemente et al., 1991; Prochaska et al., 1993). For example, individuals may have 
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tried to make the behaviour change but attempts were not successful and were now 
seeking professional help. Alternatively, people may be working hard to change, as 
evidenced by their attendance at the classes, but were still monitoring their perceived 
successes and failures. That is, it could be argued that participants at the self-
management classes were still developing their illness-specific efficacy beliefs and 
adjusting to their new health status (Maddux & Lewis, 1995).  
 
Sampling criteria were chosen so that the total study sample would be as homogeneous 
as possible in relation to changes in the variables of interest across the three illness 
groups. Extraneous variable influences would be reduced as participants acted as their 
own controls. Participants were excluded if they had other medical problems or 
complications. 
 
The relevant diagnoses included individuals with either insulin dependent or insulin 
requiring diabetes who made up the insulin using (IU) group, and the non-insulin using 
(N-IU) or diabetes type 2 group. The third group included individuals with rheumatoid 
arthritis (RA), osteo-arthritis (OA) or fibromyalgia syndrome (FMS). Individuals with 
FMS were included because research has demonstrated that, when compared to the 
findings of Lorig and colleagues, they had “… average self-efficacy scores that were 
similar to scores obtained in a normative, mixed arthritis sample” (Buckelew et al., 
1996, p. 101).  
4.3.2 Representativeness of sample 
An attempt was made to obtain a sample that would be representative of the target 
population: individuals with diabetes or arthritis whose illness-specific efficacy beliefs 
were still developing. Nevertheless, individuals who did not attend the classes may 
differ in some significant personal characteristic from those who did attend. 
Representativeness of the study sample is therefore not reliable. 
4.3.3 Sample size 
A minimum of 100 participants per group was required for factor analysis (Hair et al., 
1998). With N = 100, a significance level of .05 and an effect size of .4, the power 
would be .88 for one-tailed tests (Cohen, 1988). A subgroup sample of 100 would need 
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to have an effect size of .4, equivalent to a 7.7 point difference for the dependent 
variable PAIS. This is based on a standard deviation of 19.2 from an earlier study 
using a similar diabetes group sample (Rapley, 1989).  
 
The trial study had indicated recruitment of at least 100 in each group would take two 
years. To account for attrition of approximately 20% from this longitudinal study, the 
projected initial sample size aimed for was 120 for each of the three groups. The initial 
sample (T0) included 104 IU, 122 N-IU and 135 arthritis participants (see Fig 4.1).  
 
 IU  N-IU  Arthritis 
      
T0 104  122  135 
      
T3 89  105  119 
      
T9 81  100  109 
Figure 4.1: Sample size for groups at each test time. 
 Key: IU = Insulin using group. N-IU = Non- Insulin using group 
  T0 = baseline data; T3 = 3 month data; T9 = 9 month data. 
 
4.4 PROCEDURES FOR MAIN STUDY 
Collection of data for the main study extended over 42 months. The investigator was 
solely responsible for the distribution, collection and collation of all questionnaires. 
All questionnaires were distributed and collected in the same way for the three groups.  
4.4.1 Sampling procedures 
The sampling plan for the three-group cohort study was purposive from the accessible 
populations. The target population for the study included individuals either recently 
diagnosed or attending a self-management class for the first time. The accessible 
population was drawn from self-management classes or by letter from relevant health 
professionals (see Fig 4.2). In the case of the self-management classes, time was 
allowed during refreshments for the researcher to explain the study. Those interested 
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were given a letter with details of the research, consent form and a return addressed 
envelope (Appendix A). This allowed individuals to take the information home, think 
about the commitment and return the consent form if still interested. The self- 
management classes approached were those conducted by the Arthritis Foundation in 
two Australian States, the Diabetes Association and several teaching and community 
hospitals in one State.  
 
To maintain the recruitment for the arthritis group, Rheumatologists were also 
contacted in 1997 when the Arthritis Self-Management classes in Western Australia 
(AF-WA) were cancelled due to restructuring of the organisation. The classes were 
resumed in 1998 but approval to access the classes for study participants was only 
continued for the remainder of that year. An explanation for this was not provided nor 
sought. Volunteers with arthritis from the ASMC conducted by the Arthritis 
Foundation of Victoria were included when it appeared that the target number could 
not be reached in Western Australia before the ethics approval from AF-WA expired at 
the end of 1998.  
 
Attendance at all self-management classes was voluntary in response to community 
advertisements placed by the relevant organisations and did not rely upon a 
recommendation from a health care professional. Neither a formal or informal 
relationship existed between the self-management courses and this study. Class 
participants were approached in week two of the six-week course and were requested 
















    
Group 1 
(IU) 
n = 104 
 Group 2 (N-IU) 
n = 122 
 Group 3 
(arthritis) 
n = 135 
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Figure 4.2: Source of sample recruitment – accessible sample. 
Key:  * Letters sent on behalf of researcher. 
 DAWA – Diabetes Australia (Western Australia). 
 
The self-management courses were a convenient source of potential participants for 
the research. It could, however, be argued that the difference in strategies used by both 
types of self-management classes would impact differently on the development of 
individual efficacy beliefs. Only the arthritis self-management course (ASMC) 
purported to be based on the four sources of efficacy information previously described 
in Chapter 3. The ASMCs in both Australian states from which participants were 
selected used the Arthritis helpbook (Lorig & Fries, 1990) developed to guide course 
content with emphasis on Bandura’s (1977) efficacy enhancement strategies. By 
contrast, the diabetes self-management course did not purport to include self-efficacy 
strategies.  
 
The Diabetes Association of Western Australia (DAWA), four Diabetes Educators and 
three Rheumatologists assisted by sending out letters to suitable patients explaining the 
research. The DAWA was able to identify newly diagnosed type 1 individuals from 
the register of members. Attached to the letter sent out by these groups was a consent 
form with return, postage paid envelope addressed to the researcher (see Appendix B). 
This meant that all of the insulin dependent / requiring (IU) diabetic group and 41 
participants of the arthritis group were recruited through personal letters.  
4.4.2 Data collection 
Baseline data were collected on entry (T0) to the study and at the first follow-up after a 
further three months (T3) to measure early changes in efficacy beliefs specific to the 
person’s condition. Nine months (T9) was selected as the final data collection point 
after entry to the study in an attempt to balance the expected high attrition rate with a 
sufficient time period that would demonstrate change in the variables of interest. 
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Once the researcher received the consent form, the individual’s details were entered on 
the code sheet for the appropriate group. The questionnaires were colour coded by 
illness group and data collection round. A covering letter that repeated the research 
details was sent with the appropriate colour-coded questionnaire and a return, self-
addressed, postage paid envelope. The prepaid, commercially printed self-addressed 
envelope was A4 size with the University Logo and the address in large letters.  
 
Each individual was tracked by the date of the questionnaire sent and returned. If the 
questionnaire was not returned within three weeks, a reminder telephone call was 
made to reduce attrition. Every effort was made to find missing mail, track participants 
who had moved and to prevent late return of questionnaires as attrition threatens the 
internal validity of a study. 
 
Questionnaires that were sent out for the initial contact (T0) included demographic 
information, the general Self-Efficacy subscale (common to all groups) and one of 
three specific self-efficacy scales. The arthritis group completed the Arthritis Self-
Efficacy Scales (ASES) related to self-efficacy pain (PSE), self-efficacy function 
(FSE) and self-efficacy for ‘other’ arthritis symptoms (OSE). The IU group completed 
the Insulin Management Diabetes Self-Efficacy Scale (IMDSES) that covered diet, 
insulin and general management. The 11-item scale related to insulin use was modified 
(see 4.5.4.1) for the N-IU group by removing the four insulin-related items; otherwise 
the scales were the same. The questionnaires sent out at three months (T3) and at nine 
months (T9) included the GSE and the specific self-efficacy scales together with the 
self-report version of the Psychosocial Adjustment to Illness (PAIS-SR) booklet. 
 
Table 4.1: Stages in Data Collection 
1995  
Ethics approvals  June through to December 
Protocol trial: type 2 (n = 10)   Sept    
Protocol trial: arthritis (n = 20)    Oct   
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1996 Main Study started T0 T9 
 Type 2 group data May     
 Type 1 group data  June    
 Arthritis group data   July   
1999 Data collection completed      
 Type 2 group data    February  
 Type 1 group data     November 
 Arthritis group data    
* 
 November 
Key: * Individuals were tracked and contacted after three months in the study and again at nine months. 
 T0 = entry to study. T9 = final data collection at nine months. 
 
4.5 INSTRUMENTS 
The demographic questionnaire is described first, followed by the two scales that are 
common to all three groups and then the condition-specific scales. The two common 
scales were chosen because of their reported reliabilities in different studies. The 
disease specific scales were chosen because at the time they were the most 
appropriately worded for the target population, although psychometric testing was 
incomplete for the self-efficacy scale for the diabetes group. Only this latter scale 
needed to be modified to meet local content validity requirements. Factor analysis and 
reliability statistics from the extant literature is presented for each instrument. 
4.5.1 Demographic questionnaire 
Two variations of the demographic questionnaire were used - one for the arthritis 
group and one for each diabetic group. Questions were essentially the same, differing 
only to reflect the condition specific areas. Demographic data collected at baseline (T0) 
included: Gender, age, age at diagnosis, education level, marital status, perception of 
life stress, body mass index (BMI) and type of diabetes/arthritis. Duration of illness 
was computed from age minus age at diagnosis.  
 
The Body Mass Index was collected because of its importance in the self-care 
management of these illnesses. Weight reduction is often recommended for over 
weight people with arthritis to reduce the strain on weight-bearing arthritic joints. 
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Individuals with type 2 diabetes who can control their weight reduce the likelihood 
that insulin will be required.  
 
The inclusion of a question about the type of diabetes or arthritis enabled verification 
of the study group. This was also used to limit the arthritis group to people with 
rheumatoid arthritis, osteoarthritis and fibromyalgia syndrome.  
4.5.2 Psychosocial Adaptation to Illness 
The Psychosocial Adjustment to Illness Scale (PAIS) (Derogatis & Derogatis, 1990) is 
a 46-item self-report scale developed to measure a person’s adjustment to medical 
illness assessed on behavioural patterns or roles represented by the seven subscales 
and referred to as measures of functional domains (See Appendix G). The seven 
domains include health care orientation (8 items), vocational environment (6 items), 
domestic environment (8 items), sexual relationships (6 items), extended family 
relationships (5 items), social environment (6 items) and psychosocial distress (7 
items). According to Derogatis and Derogatis (1990), the scale development process 
used a combination of rational-deductive and empirical strategies resulting in domains 
that contain relatively homogeneous items.  
 
The self-report version of the scale Psychosocial Adjustment to Illness (PAIS-SR) 
included comprehensive instructions for participants. For example, participants were 
advised that the questions refer to the last 30 days, how to answer if hospitalised in this 
period, how to answer if they did not have a permanent partner, and how to interpret 
questions if they are not employed in the paid workforce as implied by many of the 
questions. The use of the word ‘illness’ was, however, not commented on. Previous 
research with this instrument (PAIS-SR) (Rapley, 1989) and anecdotal comments from 
current respondents indicated that individuals in these target populations do not see 
themselves as ill or having an illness. Prior to starting this study, a request to the 
copyright owners to change the word ‘illness’ to ‘condition’ throughout the 
questionnaire was denied.  
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An example of a typical verbal or written comment came from participant #190, who 
wrote:  
I found the questionnaire very depressing because I do not consider having 
arthritis as an ‘illness’. It is, in my humble opinion an ‘ailment’ which can be 
controlled. 
 
Factor analysis to confirm the PAIS structure was established on a lung cancer group 
(N=120) using varimax rotation that resulted in seven factors accounting for 63% of 
the variance. Although a few items were found to correlate with a factor representing 
another domain, the authors considered that the hypothesised structure was supported. 
Each factor (domain) included items relevant to individuals as well as to their 
interaction with others. For example, Derogatis & Derogatis (Derogatis & Derogatis, 
1990) reported that the Health Care Orientation (HCO) items covered subjects’ 
expectancies about the disorder and treatment together with their attitude towards 
doctors and treatment in general. Psychological distress measured feelings of 
depression, anxiety, lowered self-esteem and body image problems.   
 
The reported external criterion measures for development of the PAIS included Global 
Adjustment to Illness Scale, SCL -90-R General Severity Index, Affect Balance Scale 
(ABS) Index and Patient’s Attitudes, Information and Expectancies Scale. Derogatis et 
al. (1979) administered these scales and PAIS at the same point in time to 27 breast 
cancer patients (cited by Derogatis & Derogatis, 1990). All scales correlated with 
PAIS domain scores as the authors expected and in a pattern consistent with the 
construct definitions for each domain. The authors also reported several other studies 
that were able to demonstrate convergent relationships with scales that could be used 
as external criteria. 
 
Support for the validity of the PAIS was provided also by the national Diabetes 
Control and Complications Trial (DCCT) in a report prepared by four authors on 
behalf of the DCCT Research Group (Jacobson, Barofsky, Cleary, & Rand, 1988). 
Specifically, PAIS was used as an alternate test for convergent validity of the 46-item 
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Diabetes Quality-of-Life (DQOL) measure. Significant (p < .01) correlations with the 
DQOL (total score) measure ranged from .34 to .63 for each of the domains when 
tested on a sample of 134 adults with type 1 diabetes. The Impact generated by 
diabetes subscale of the DQOL was also found to be significantly correlated with all 
PAIS subscales (rs = .35 to .58; p < .01). Only the PAIS subscale Psychological 
distress was significantly correlated with all DQOL subscales (rs = .46 to .55; p < .01).  
 
One hundred and twenty patients, who screened positive for lung cancer and 86 
patients who screened negative, were used to determine the predictive validity of 
PAIS. Comparisons on the PAIS domain and total scores indicated that “the majority 
of PAIS scales were able to discriminate between the psychosocial adjustment of a 
seriously ill group of patients and a procedurally similar control group...” (Derogatis & 
Derogatis, 1990, p. 29). In addition, Derogatis and Derogatis cited several studies that 
used more diverse illness groups as evidence for the sensitivity and predictive validity 
of the PAIS. 
 
Reliability coefficients for PAIS subscales and a cardiac patient group (N = 69), renal 
dialysis group (N = 269) and a lung cancer group (N = 89) ranged from .62 to .93 
(Derogatis & Derogatis, 1990) with two exceptions. The two exceptions included α = 
.47 for Health Care Orientation (HCO) subscale (cardiac group) and α = .12 for 
extended family relationships (lung cancer group). The Psychological Distress 
subscale was consistently high for the three groups (αs = .85; .80; .81 respectively).  
 
The reliability coefficients for a study (Rapley, 1991) involving type 1 and type 2 
diabetes participants (N = 98) achieved alpha scores between .67 and .90 for the seven 
subscales with .94 for the overall scale. Similar to the reliability coefficients for the 
separate studies involving cardiac (N = 69) and renal dialysis (N = 269) groups 
discussed by Derogatis and Derogatis (1990), Rapley found HCO had the lowest 
coefficient score (α = .67) and Psychological Distress the highest (α = .90). This 
pattern did not fit the lung cancer group (Derogatis & Derogatis, 1990). 
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Items in the PAIS are rated on a four-point scale (0-3) of adjustment with higher 
ratings intended to indicate poorer adjustment. However, for this study the PAIS 
scores were reversed to provide consistency with other scales in the current study 
(higher equals better) and ease in interpreting the regression equation. Alternate items 
were reverse scored and the range changed to 1 to 4.  
 
The developers believe that three levels of PAIS data can be used. The total score, the 
domain scores, and individual item scores can be used to form a comprehensive view 
of each person’s adjustment to illness in general, as well as to particular domains of 
life. The reported usage of the instrument has included a total mean score (45/46 
items) (Courts, 2000; Pollock, 1989; White et al., 1992; Willoughby et al., 2000), and 
its use as an individual domain score (Gerber et al., 1987). It has also been used as a 
reduced scale in which sexuality and health care orientation domains were excluded 
(Gilbar, 1997; Pollock, 1993). Most studies scored the items so that high scores on the 
0-3 scale equated with poor adjustment, whereas White (1992) reversed the order so 
that low scores equated with poor adjustment. White’s method is consistent with use of 
the scale in the current study.  
 
In summary, the PAIS was considered a reliable and valid instrument that was 
appropriate to use in the current study. 
4.5.3 General self-efficacy scale.  
The general subscale of the Self-Efficacy Scale (GSE) (Sherer & Adams, 1983; Sherer 
et al., 1982) used in this study is a 17-item, five-point, Likert scale (See Appendix D). 
Higher scores equated with higher personal expectations of ability to initiate and 
persist with a course of action. The scale was reported to be based on Bandura’s work 
(Bandura, 1977; Bandura, 1982), but was designed to measure self-efficacy unrelated 
to specific situations or behaviour. Items for the GSE were written to reflect the 
strength of efficacy belief as a willingness to initiate and persist with behaviour in 
difficult situations as well as with a willingness to make an effort to complete the task.  
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The original version of Sherer et al.’s (1982) 23-item self-efficacy scale (SE) had 36 
items, which were reduced after psychometric testing. The factor analysis for the SE, 
using principal components analysis with varimax rotation was based on data from 376 
introductory psychology students (Sherer et al., 1982). In that study, items belonging 
to a single factor were required to have a loading of .40 or above. Factor I (α = .86) 
explained 26.5% of total variance and was labelled general self-efficacy (17 items). 
Factor 2 (α = .71) explained 8.5% of the total variance and included items related to 
social situations (social self-efficacy – 6 items). The reduced 23-item scale was 
confirmed when administered to a new sample of 298 introductory psychology 
students. Sherer et al. (1982) suggested a possible split in the 17 item, general subscale 
to reflect efficacy in the face of adversity and initiation / persistence.  
 
Construct validity testing was assessed with scales that measured other personality 
characteristics related to personal efficacy. Scales cited by Sherer et al. (1982) 
included Internal-External Control Scale (I-E Scale), Personal Control Subscale of I-
E Scale, Marlowe-Crowne Social Desirability Scale, Ego Strength Scale, 
Interpersonal Competency Scale, Self-esteem Scale. From the modest Pearson 
correlation results, the authors did not believe that the scales were measuring the same 
constructs. In addition, the expected positive and negative correlations were 
confirmed. For the general subscale, the six significant Pearson correlation scores 
ranged from r = -.29 to -.51 (p < .01). Five of the six external criteria scales were also 
significantly correlated with the social subscale (r = -.13 to .43; p < .01). Ego strength 
was significantly correlated with the general subscale only. Overall, the highest 
correlation (r = -.51) was for the general subscale and Self-esteem. Low scores on the 
self-esteem scale indicated high self-esteem was moderately associated with high 
general self-efficacy. Further construct validation was also provided with another 
sample of 101 introductory psychology students and three other personality measures 
(Sherer & Adams, 1983). Similarly, Woodruff and Cashman (1993) were also able to 
confirm the scale’s construct validity.  
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In relation to criterion validity, Sherer et al. (1982) reported that the general subscale 
was able to predict past success in vocational, educational, and military areas while the 
social subscale predicted past vocational success only. However, Sherer and Adams 
(1983) indicated that additional criterion validity studies were needed to evaluate the 
clinical utility of the Self-Efficacy Scale (p. 901). 
 
Woodruff and Cashman (1993) repeated the reliability and factor analysis with 400 
introductory management students. Their Cronbach alpha coefficients of .84 and .69 
for the general and social subscales respectively, concurred with those of Sherer et al. 
(1982) (α = .86 and .71). In the factor analysis, although Woodruff and Cashman 
found the items to load on the same factors with only slight differences in correlation, 
the scree plot suggested a five or six factor solution (eigenvalues greater than 1.0). 
Their findings, after a five-factor solution and a varimax rotation, resulted in three 
factors within the general subscale items and two within the social subscale items. 
While the foci for the two subscales remained general and social, the additional sub-
groupings of items were seen by the authors to represent magnitude, strength, and 
competence related to general efficacy belief together with strength and competence 
related to social efficacy belief. Woodruff and Cashman (1993) considered their 
findings from the factor analysis to be consistent with Bandura’s idea of efficacy 
belief. Their suggestion of a split in the general subscale is also consistent with the 
tentative suggestion by Sherer et al. (1982).  
 
By contrast, Earley and Lituchy (1991) found that their principal component analysis 
with varimax rotation of the 17-item subscale (GSE) suggested a single component 
explaining 48% of the variance with another three smaller components explaining only 
an additional 9% of the variance. This study sample included undergraduate business 
students (N = 100). The Cronbach’s alpha for the 17-item subscale was reported to be 
.89. 
 
Both Sherer (1990) and Woodruff and Cashman (1993) suggested more development 
of the SE scale and that it be tested outside the vocational / educational arena. 
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Concomitantly, Hays and Buckle (1992) sought to test the SE measure with 
hospitalised, mentally ill patients (N = 105). The psychiatric sample data were 
compared to the combined introductory psychology student data (N = 477) used by 
Sherer and colleagues (1982; 1983). When the mean scores for the patient and the 
student groups were compared, both subscales were found to differ significantly 
(general t = 3.76; social t = 2.74, ps < .01). The psychiatric patients had a lower mean 
with a larger standard deviation for both subscales when compared to the psychology 
students. The results suggested that hospitalised psychiatric patients were less 
confident about their abilities in general and about their ability in social situations. 
 
In summary, the PAIS was considered a reliable and valid instrument that was 
appropriate to use in the current study. 
4.5.4 Condition specific self-efficacy scales 
4.5.4.1 Diabetes Mellitus 
The Insulin Management Diabetes Self-Efficacy Scale (Hurley, 1990) measures 
people’s belief in their self-management ability related to insulin administration, 
blood-glucose monitoring and other diabetes activities of daily living. It was designed 
to be used as an assessment guide to complement diabetes education programs so those 
individuals with low efficacy beliefs could be assisted with specific competence 
building strategies. 
 
The Insulin Management Diabetes Self-Efficacy Scale (IMDSES) (Hurley, 1990) was 
based on a 25-item, Likert-type, Diabetes Self-Efficacy Scale (DSES) developed for 
adults with diabetes, whether using insulin or not (Crabtree, 1986, with advice from 
Bandura, cited by Hurley, 1990 and Padgett, 1991). The instrument used with 
permission in the current study (IMDSES) was developed as a further refinement of 
the DSES for adults who use insulin. Access to the original DSES was not possible – 
Crabtree’s unpublished 1986 doctoral dissertation. 
 
Hurley (1990) reported that refinement of the six-point Likert-style scale included 
modifying Crabtree’s original DSES using a literature review, information from 
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diabetes content experts and five patients who reviewed it for clarity and meaning with 
subsequent further evaluation by diabetes experts after patient input. Six experts 
reviewed the scale for its relevance to self-efficacy theory, conceptual distinction and 
clarity.  
 
The two phases of empirical testing that followed (Hurley, 1990), using four different 
samples, included internal reliability (α ≥ .6), test retest stability, construct validity 
and exploratory factor analysis. Paired t-test indicated the scale means were unchanged 
(t (24) = .59, p < .56) from the test (M = 4.95) to the retest (M = 5.01) over mean 
duration of 22 days.  
 
The construct validity of the IMDSES (total scale) was based on its correlation with 
GHb (biochemical marker of diabetes control) as well as its association with a 
behaviour scale (Hurley & Shea, 1992). The behaviour scale, also used as a total score, 
equated with the three domains of diet, insulin management and general diabetes 
management of the IMDSES. Since construct validity requires consistent findings 
from different studies using different theoretical structures (Carmines & Zeller, 1979), 
it may be too early to say that construct validity for IMDSES can be fully supported.  
 
Based on published information, it would appear that the factor analysis for the 
IMDSES was completed with 4.5 participants per item (Hurley, 1990). Nine factors 
with an eigenvalue equal to or greater than one explained 69% of the variance. Hurley 
reported that five factors were interpretable and labelled them as dietary control, 
insecurity, general confidence, treatment decision, and discipline. Details about 
Bartlett’s test of sphericity, which is useful when ratio is less than 5:1 (Tabachnick & 
Fidell, 1996), method of factor extraction, rotation method or item loading were not 
given.  
 
In a later study, a 26-item IMDSES was reported by Hurley and Shea (1992) to have 
three internally consistent scales: general diabetes management (6 items, α = .67), diet 
(7 items, α = .78), and insulin (9 items, α = .77). Two exercise and two foot-care items 
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complete the 26-item scale. Two insulin related items were removed from the 28-item 
version because “… almost all subjects strongly agreed with both items” (p.148). More 
recently, Cronbach’s alpha for the 26-item scale was reported to be greater than .70 for 
each of the three scales in an adult Hispanic (N = 97) sample of insulin requiring 
persons (Bernal, Wooley, Schensul, & Dickinson, 2000).  
 
As mentioned in the protocol trial discussion, the only change to IMDSES was the 
deletion of one diet-related item from the 28-item scale on advice from local Diabetes 
Educators as it referred to food exchange. This concept was not used in self-
management classes for the local population. Items in the IMDSES were scored from 1 
to 6 using a Likert format of strongly disagree to strongly agree with higher scores 
equating with higher specific efficacy beliefs. A ‘not applicable’ choice was available 
and recorded as missing data (Hurley & Shea, 1992). Although Hurley reported that a 
total score from the three scale scores could be used, the scale was not used in this way 
in the current study. 
 
Hurley (1990) reported that during the development of the IMDSES items were 
worded as an act, not an outcome, items referred to one behaviour and were relevant to 
the present. For example, “I can recognise when my blood sugar is too high” or “I 
don’t think I can follow my diabetes routine every single day”. In addition, the word 
‘diabetic’ was used as an adjective, not a noun and ‘insulin’ was used to replace the 
generic term ‘medication’.  
 
Preparation for the protocol trial involved checking the wording for relevance to the 
local target population. The 28-item self-efficacy scale (IMDSES) that was sent by 
Hurley for use in this study had three scales with two additional items each for 
exercise and foot-care. The three scales were labelled general management (6 items), 
diet (7 items) and insulin administration (11 items). Apart from the deletion of one 
diet-related item referred to on the previous page, changes made to the IMDSES prior 
to the protocol trial included the deletion of ‘or urine’ from three items. The 11-item 
insulin administration scale had four questions specific to insulin use and seven 
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questions related to frequency of blood-glucose self-management, recognition and 
treatment of blood glucose level variations. The final questionnaire used the 27-item 
IMDSES for the insulin using group (IU) and a reduced 23-item DSES for the non-
insulin using group (N-IU). Only the reduced 23-item DSES was tested at step one of 
the study (see Appendix E). 
 
In summary, modification of the IMDSES for use with the diabetes type 2 (N-IU) 
group in the protocol trial and the main study involved the removal of the four insulin 
specific items to create a 23-item questionnaire. The two questionnaires used for the 
IU (27 item) and the N-IU group (23 items) were identical except for the four insulin 
specific items excluded for the later group. 
4.5.4.2 Arthritis 
Arthritis Self-Efficacy Scales (Lorig et al., 1989a) refers to three separate self-report 
questionnaires: a 5-item self-efficacy pain scale (PSE), a 9-item self-efficacy function 
scale (FSE) and a 6-item self-efficacy for other symptoms scale (OSE) (see Appendix 
F).  
 
Development of the ASES started with a 43-item self-efficacy questionnaire using 
participants recruited for an Arthritis Self-Management Course (ASMC) in 1984 (N = 
97) and replicated in 1985 (N = 144) (Lorig et al., 1989a). Twenty-three items from a 
rheumatologist were tested and modified by three patient focus groups that also added 
an additional 20 items. The initial study to test the 43-item questionnaire, reduced the 
number of items to 25 by removing items that were not related to the total score, and 
by using the results of the principal component analysis with varimax rotation. The 
two components identified by the analysis were labelled self-efficacy for physical 
function (FSE) and self-efficacy for managing other arthritis symptoms (OSE). Item 
loadings ranged from .41 to .82. The eigenvalues or variance of the factors within each 
scale were 4.83 and 4.76 for FSE and OSE respectively. Internal reliability coefficients 
were found to be .93 and .90 respectively (Lorig et al., 1989a). 
 
Chapter 4: Method 
 87
Correlations between three health status measures (Pain, Disability, Depression) at 
baseline and 4-month self-efficacy data established that the measures acted as self-
efficacy theory predicted. That is, construct validity was supported with significant 
correlations (p < .01) between all measures at both times with FSE most highly related 
to disability and OSE most highly related to depression (Lorig et al., 1989a). 
 
The concurrent validity test used a new arthritis sample of 43 people who completed 
the FSE scale by mail. A trained observer, blinded to FSE responses, observed actual 
performance compared with the person’s perceived ability as measured by the FSE. A 
moderate correlation between the two was achieved (r = .61, p < .01) (Lorig et al., 
1989a). 
 
The replication study (n = 144) re-analysed the 43-item questionnaire in a second 
factor analysis which resulted in three factors from the 20 items retained. The factors 
were labelled FSE (9 items), OSE (6 items) and a new factor labelled pain 
management self-efficacy (PSE) (5 items). Eigenvalues were 4.47, 3.61, 2.11 for FSE, 
OSE and PSE respectively. Internal reliability alpha scores were .89, .87 and .76 
respectively. Again, the three scales were correlated with present and future health 
status as predicted by self-efficacy theory. The three scales identified in the replication 
study were then applied to data from the initial 97-person sample. The scales were said 
to be supported by results from a confirmatory factor analysis (details not given) and 
internal reliability estimates (Lorig et al., 1989a). 
4.6 ANALYSIS OF DATA 
The SPSS statistical package (version 7.5) was used for descriptive and inferential 
statistics. The explore command was used to assess violations of normality of 
distributions, homogeneity of variance and univariate outliers. To test the five 
hypotheses non-parametric tests, one-way repeated measures MANOVA and 
regression analyses were used. See Fig 4.3 for the plan of hypothesis testing. 
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 T0 T3 T9 
  PAIS PAIS 
 GSE GSE GSE 
 SpSE SpSE SpSE 
Figure 4.3: Plan of hypothesis testing 
Key: GSE = general self-efficacy, SpSE = Illness-specific self-efficacy, PAIS = Psychosocial 
adjustment to illness.  
 
 Hypothesis 1 
 Hypothesis 2 




The hypotheses from Chapter 1 are restated for convenience. 
1. General efficacy belief will be stable over time.  
2. Illness-specific efficacy belief will increase over time. 
3. The strength of the relationship between general and illness-specific efficacy 
beliefs will increase over time. 
4. A general efficacy belief (trait) is a better predictor of future adaptation to 
illness than illness-specific efficacy belief. 
5. The influences of illness-specific efficacy beliefs, relative to general efficacy 
belief, are better predictors of concurrent adaptation to illness. 
 
Power-efficiency of the non-parametric tests was a consideration as it was assumed 
that many of the variables would depart substantially from normality. Use of 
distribution free tests results in decreased power. According to Siegal (1956), power-
efficiency for Mann-Whitney and Kruskal-Wallis tests approach 95.5% as N increases. 
Similarly, Spearman’s rho is about 91% as efficient as Pearson correlation in rejecting 
the null hypothesis for an equivalent sample size.  
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An adjustment for multiple comparisons in the current study was not considered 
necessary since all statistically significant and non-significant results will be reported. 
Regardless of the number of data sets, Rothman (1986; 1990) recommends the 
reporting of all findings regardless of ‘statistical significance’ rather than using an 
adjustment strategy. Rothman (1986) indicates that it is a mistake to believe that “… 
interpretation can be improved by adjusting the P-value or changing the criteria for 
“significance” ” and, furthermore, that “… it merely produces a smaller Type I error at 
the expense of a greater Type II error” (p. 149). Rothman, however, does suggest that 
the number of false positive associations could be ascertained by multiplying the 
number of tests per hypothesis (a priori) by the level of significance. For example, 
Ntest x .05 = number of “… statistically significant associations that occur only by 
chance” (p. 147). Most of the analyses for the current study will not involve 
simultaneous multiple analyses within the same comparison. For those that will, a 
notation about expected significant associations would be reported with the relevant 
table in the Results chapter.  
 
Principal component (PC) analysis was used to determine component structures of 
each instrument. This process was guided by statistical and a priori criteria. The 
internal consistency (Cronbach’s alpha) for all instruments was estimated. “Alpha 
provides a conservative estimate of a measure’s reliability” (Carmines & Zeller, 1979). 
 
Hierarchical multiple regression analysis was carried out after determining that the 
assumptions of linearity, normality and homoscedasticity and independence of error 
term could be met. In addition, potential multicollinearity of predictor variables or 
evidence of suppressor variables were considered (Hair et al., 1998). In order to 
control for the influence of illness duration on the variables of interest, duration was 
considered in each of the regression analyses.  
4.7 ETHICAL CONSIDERATIONS 
This study received the approval of the Curtin University of Technology Human 
Ethics Committee based upon NH&MRC guidelines, relevant ethics committee within 
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seven hospitals, the Arthritis Foundation (Western Australian and Victorian branches) 
and Diabetes Australia (WA). Ethical considerations included beneficence, respect for 
human dignity, justice, informed consent and protection of vulnerable participants. 
There were no costs to participants, other than their time to complete the 
questionnaires. The study procedures did not involve any foreseeable risks or harm 
beyond that associated with completing a questionnaire. All questionnaires were 
mailed to participants and returned in pre-paid, self-addressed envelopes. 
 
Informed consent was obtained through a letter to all potential participants, disclosing 
details of the study, its purpose and procedures, potential benefits, expectations of 
participants, time commitments and telephone numbers to ask questions. An 
explanation about confidentiality and the right to withdraw from the study at any time 
without effecting treatment was also mentioned in the letter. Return of the signed 
consent form provided with the letter of invitation to join initiated the person’s coded 
entry to the study. At the time of starting the study, participants’ signatures were only 
required to be witnessed by one of the ten agencies from which permission was 
obtained. Hence, for the agency that required it, the researcher witnessed and signed 
the consent forms as they were completed during the class refreshment break. 
 
Assurance of anonymity and confidentiality were maintained through the use of sealed 
envelopes for completed questionnaires and coding of data. The participants’ forms 
were coded and stored separately from consent forms. One list of codes and 
corresponding names was held by the investigator and kept separate from the 
questionnaires. Access to the data was limited to the investigator and research 
supervisors. As required by Curtin University of Technology policy, all data will be 
kept locked in a secure place for five years from the date of completion of the study. 
Publications that arise from the study will not identify individuals.  
4.8 SUMMARY 
The reliability and validity of three scales to be used in the current study have been 
established and they will be used as intended by the developers. These include the 
Chapter 4: Method 
 91
Psychosocial Adjustment to Illness Scale (Derogatis & Derogatis, 1990), Sherer et 
al.’s (1982) general self-efficacy subscale and the Arthritis Self-efficacy Scale (Lorig 
et al., 1989a). The only instrument to be modified is the Insulin Management Diabetes 
Self-efficacy Scale (Hurley, 1990). The change was needed to meet content validity 
for the local study participants. According to Nunnally (1978), cited by Redland and 
Stuifbergen (1993), content validity is sufficient when the intent is to show group 
differences. In the current study the repeated measures analysis will provide an 
opportunity for more testing of the scale and all instruments will be tested (reported in 
Chapter 5) to ensure they are reliable and valid before testing of the hypotheses occurs.  
 
As part of the conclusions for this chapter, it should be said that the prior use and 
testing of instruments to be used in the current study varied considerably. The 
Psychosocial Adjustment to Illness Scale has been used in a variety of chronic illness 
studies. It has undergone extensive psychometric testing by Derogatis and Derogatis 
(1990), and further reliability and validity testing by others, including being used to 
test for convergent validity of the Diabetes Quality of Life scale (Jacobson et al., 
1988). By contrast, Sherer et al.’s (1982) Self-Efficacy Scale has rarely been used in a 
chronic illness study, but its structure, reliability and validity have been confirmed in 
several vocational / education-based studies. The limited use of the scale in chronic 
illness research, however, is suggestive of its relevance beyond the vocational domain.  
 
Likewise, the two illness-specific self-efficacy scales also have different histories. The 
20-item Arthritis Self-Efficacy Scale (ASES) has been used over a decade or more by 
more than one research team involving a variety of arthritis groups and contexts. Its 
predictive validity and reliability was confirmed in each study. Most of the arthritis 
self-efficacy research has used the ASES. On the other hand the Insulin Management 
Diabetes Self-Efficacy Scale (IMDSES) started as an instrument for both insulin-using 
and non-insulin-using persons with diabetes. Both Hurley (1990) and Padgett (1991) 
modified the scale. The former developed the scale for use with an insulin-using 
sample, and the latter for use with a non-insulin-using sample. Of the two very 
different second-generation scales, only the IMDSES was subjected to further 
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psychometric testing (Hurley, 1990; Hurley & Shea, 1992). During the time in which 
the current study was undertaken, neither of the scales had been tested further. The 
IMDSES used in one recent study reported adequate internal reliability scores greater 
than .7 but their report of a “… confirmatory principle (sic) factor analysis …” (Bernal 
et al., 2000, p. 676) did not indicate factors as identified by Hurley. In essence, while 
the arthritis self-efficacy literature is based on a confirmed scale used in a variety of 
studies, the diabetes self-efficacy literature has rarely replicated studies and a 
consistently reliable and valid diabetes self-efficacy scale is yet to emerge.  
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CHAPTER 5: RESULTS 
The purpose of the study was to examine the relative impact of general and illness-
specific efficacy beliefs on psychosocial adaptation to illness. Descriptive, non-
parametric and multivariate statistics were used to describe the sample and test the 
hypotheses stated in Chapters one and four. Results of the psychometric tests for the 
four instruments will be discussed prior to the presentation of tests of hypotheses.  
5.1 INITIAL ANALYSIS 
The results of the univariate analyses are presented first. A significance level of alpha 
equal to .05 was used for all statistical tests and the SPSS default settings were used 
unless stated otherwise.  
 
Non-parametric techniques were used for bivariate analyses as the significance level 
for the Kolmogorov-Smirnov statistic (with Lilliefors correction) was less than .05 for 
all but two subgroup demographic variables. For example, demographic variables that 
were assumed to be normally distributed included age for the IU group and for males 
in the total study sample. However, the only demographic variables to have a 
significant Levene statistic, unequal variance, were gender and illness group 
comparisons for both duration of illness and education.  
 
Transformations were undertaken to improve normality for hypothesis testing and 
reduce outliers that would influence the regression analysis. The method of 
transformation chosen was to square the variable. Although outliers were reduced, 
normality statistics were only partly improved. Fox (1991) suggested that when values 
are stacked at the boundary, transformations do not usually work. After 
transformation, normality could be assumed for the arthritis group’s GSE scores at 
each time, ASSE at each time and PAIS at T3. The IU group could be assumed to have 
a normal distribution for PAIS at T9.  
 
After transformations, equality of variance could be assumed for most variables 
compared across the three illness groups, across the diabetic and arthritis groups or by 
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gender. Variables not found to have equal variance included the diabetic group 
comparisons of the self-treat subscale for DSES at T0 and T3, together with PAIS at T9 
for the three illness groups. 
 
Missing values were not replaced in this study. From the participants who returned the 
questionnaire at each test time, three cases (one from each group) were deleted 
because all of their responses to one of the key variables of interest were missing. One 
IU and one N-IU participants did not complete the relevant diabetes specific self-
efficacy scale at T9. One arthritis participant did not complete the GSE at T0 . This was 
not noticed until data collection was completed. Pairwise deletion (SPSS option) was 
used to manage missing cases.  
 
Post hoc analysis of variables created to compare the group of respondents (n = 323) 
who completed all items with the group with incomplete data (n = 38) indicated a 
significant difference in relation to duration of illness (Mann-Whitney Z = -3.07, p = 
.002). The ‘complete-respondent’ group had a duration of illness mean score of 3.93 
years (SD = 7.48), compared to a mean of 11.11 years (SD = 14.03) for the 
‘incomplete’ data group. No significant differences were found between the complete 
and incomplete data groups for age in years, gender, illness group, duration of illness, 
education level, marital status, BMI or perception of life stress. 
 
Furthermore, comparing the group who responded to all GSE items (n = 345) with the 
group with one or more missing responses (n = 16), no significant differences were 
found in relation to age, gender, illness group, duration of illness, education level, 
marital status, level of perceived life stress or BMI. The GSE scale was used for the 
comparison analysis, as it was the only instrument common to all groups when the 
initial data were collected. 
5.1.1 Sample Description 
The final sample consisted of 361 adult participants. The sample composition included 
104 insulin using individuals (IU group: insulin dependent type 1 diabetes mellitus or 
insulin requiring type 2 diabetes mellitus), 122 non-insulin requiring type 2 diabetes 
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mellitus (N-IU group), and 135 participants in the arthritis group (see Table 5.1). The 
arthritis group included rheumatoid arthritis (n = 54), osteoarthritis (n = 67) or 
fibromyalgia (n = 14).  
 
The response rate was variable. For example, when volunteers were sought through 
direct contact with the researcher at the self-management classes, the response rate 
was 60-90% per class. Letters from diabetes educators or medical practitioners, on 
behalf of the researcher, were least effective at around 25 – 40% response rate per 
health care professional. In the case of the IU group, this rate was based on verbal 
feedback from the diabetes educators who had made personal approaches. The 
researcher withdrew seven participants recruited through arthritis self-management 
classes because they did not fit the inclusion criteria for arthritic conditions. The 
conditions excluded were systemic lupus (n = 1), ankylosing spondylitis (n = 2), and 
psoriatic arthritis (n = 4).  
 
Table 5.1: Number of participants in the study at entry, three months and nine 
months 
Group 0 mths 3 mths 9 mths % Retained 
Insulin using# 104 89 81 77.88 
Non-insulin using 122 105 100 81.97 
Arthritis (total) 135 119 109 80.74 
 Rheumatoid (54) (45) (42)  
 Osteo-arthritis (67) (63) (56)  
 Fibromyalgia (14) (11) (11)  
Total 361 313 290 80.33 
Key: (arthritis subgroups). 
# Refers to newly diagnosed insulin using diabetics (insulin dependent type 1 individuals and type 2 
insulin requiring individuals). 
 
Reasons for individuals withdrawing before completing the questionnaires at three and 
nine months included insufficient time to complete a large questionnaire or a major 
change in health status. In addition, participants were lost to the study because they 
changed their address or telephone number, return of questionnaires by the participant 
was more than two months late or the questionnaires were not received. In the latter 
case, when contacted, some participants declared it had been posted, while others took 
the opportunity to withdraw.  
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5.1.2 Age and Gender Demographics 
The age range for the study sample (N = 361) was 18 to 82 years (M = 53.57; SD = 
14.67 years) with the assumption of normality not met as data were negatively skewed. 
The age ranges for each of the three illness groups were 28-82 years (M = 56.72) for 
the arthritis group, 18-81 years (M = 44.31) for the insulin using (IU) group and 26-81 
years (M = 57.98) for the non-insulin using (N-IU) group. The mean age for the 
combined diabetic group was 51.69 years. See Table 5.2 for means and standard 
deviations by group. The mean age for the arthritis and the N-IU group reflect the 
increasing incidence with age. The mean age for the IU group, however, was higher 
than was expected with only newly diagnosed type 1 participants because of the 
inclusion of insulin using type 2 participants. An upper age limit was not used, as this 
would have extended the time for recruitment and would not have enabled 
comparisons across the wide age-range relevant to the target population. The 
descriptive statistics for each group reflected population statistics relevant to the target 
population for this study.   
 
The gender balance was approximately equal for two of the three illness groups. Males 
in the IU group represented 54.8%, with N-IU males 51.6%. The percentage of males 
in the arthritis group was 29.5%. A significant difference was found in gender 
composition for the arthritis group (χ2 {1, N = 135} = 43.92, p < .001).  
 
Table 5.2: Mean & standard deviation (SD) for selected demographic variables by group. 
Variable  Arthritis (n=135) IU (n=104) N-IU (n=122) Diab (n=226) 
 M (SD) M (SD) M (SD) M (SD) 
Age (years) 56.72 (12.58) 44.31 (16.20) 57.98 (11.71) 51.69 (15.51) 











* See table 5.3 for missing values. 
BMI = Body Mass Index, ordinal variable (1-4) based on the formula kg/m2. 
Diab = combined IU and N-IU groups. 
 
5.1.3 Duration of Illness 
One of the inclusion criteria for the study was to include individuals diagnosed for less 
than one year. This was only partially achieved in the time frame. The sampling 
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method, however, resulted in the duration of illness being positively skewed (M = 4.67 
years, median = 1 year, SD = 8.64 years, range = 0-69 years). Although the mode for 
the three illness groups was zero, indicating less than one year since diagnosis, the 
median for the arthritis and IU groups was two years and one year respectively (see 
Table 5.2). The variability evident in the large standard deviation reflects the inclusion 
of participants who were not recently diagnosed but attending a self-management 
course. The one missing case was a male from the arthritis group, aged 82 years, who 
did not report age at diagnosis and for whom duration could not be computed.  
 
When combined, the mean duration of illness for the two diabetic groups was 2.73 
years compared to the arthritis group mean of 7.94 years. Duration of illness was 
found to be significantly different for the three illness groups (Kruskal Wallis χ2 (2) = 
42.68, p < .01). Further analysis using Mann-Whitney test indicated a significant 
difference (z = -5.55, p < .01) for duration of illness between the total (combined) 
diabetic group compared to the arthritis group. Similarly, a significant difference was 
found between the two diabetic groups (z = -3.53, p < .01).  
5.1.4 Body Mass Index 
The BMI is an ordinal scale of 1 to 4 representing underweight, normal, over-weight 
and obesity respectively. Table 5.2 shows that the N-IU diabetic group had the highest 
mean BMI (3.26) indicating 40.2% who were overweight and 41.8% who were obese. 
See Table 5.3 for the BMI category differences. More than one third (41.3%) of the IU 
group were within the normal BMI range with 24.0% and 21.2% in the overweight and 
obese categories respectively. The high number of missing data for this question, 
especially for the arthritis group, was because these individuals were not able to 
provide weight and or height details to enable the BMI to be calculated.  
5.1.5 Education Level 
The question related to education level had nine categories that ranged from less than 
year 10 high school, to postgraduate diploma or higher. The educational level for each 
chronic illness group was predominantly year 12 or less. Specifically, 51.9% of the IU 
group, 64.2% of the N-IU group and 52.2% of the arthritis group indicated their 
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education level to be year 12 or less (See Table 5.3). Given the mean age for the total 
study sample and for each of the groups, this finding was to be anticipated.  
 
Table 5.3: Frequencies and percentages (%) for selected demographic variables by 
group. 
Variable IU N-IU Arthritis 
Gender - males  57 (54.8) 63 (51.6) 29 (21.5) 
Education: 
 Year 12 or less 
 Apprenticeship / trade 
 Certificate (non-trade) 
 Diploma 
 Bachelor degree 






























Body Mass Index: 
 <20 (underweight) 
 20-25 (normal) 
 25.1-30.0 (overweight) 
 >30 (obese) 
Missing 
 


















5.1.6 Perception of life stress 
The question related to perception of life stress at T0 used an ordinal scale that ranged 
from one (not at all) to six (excessively). The mean score for the sample was 3.26 (SD 
= 1.35).  
 
Chi-square analysis of perception of life stress by the three illness groups indicated a 
significant difference (χ2 {10, N = 360} = 21.35, p = .019). Specifically, the two 
diabetic groups were significantly different in relation to stress (χ2 {5, n = 225} = 
14.61, p = .012) with the non-insulin using group (N-IU) having the lower mean for 
the two diabetic groups. Perception of life stress was significantly lower for the N-IU 
group than the IU group. Perception of life stress for the arthritis group was not 
significantly different from either of the two diabetic groups with a mean between that 
of the two diabetic groups. Further analyses of stress found no significant gender 
differences for the two diabetic groups, analysed together or separately, but a 
significant gender difference for the arthritis group (χ2 {5, N = 135} = 11.58, p = .041) 
was found. The mean score for the larger female group was 3.41 (SD = 1.31) 
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compared to the male group with 3.03 (SD = 1.43), suggesting that perception of life 
stress was greater for females in the arthritis group.  
 
Additional analyses explored the influence of duration of illness and perceived life 
stress. A Spearman’s rho indicated the correlation between perception of life stress 
and duration of illness was non-significant for the study sample or for each illness 
group and gender.  
5.2 FACTOR ANALYSIS 
Statistical and a priori criteria, as suggested by Hair et al. (1998) were used to guide 
the factor analysis process for the instruments discussed in Chapter 4. All variables in 
the scales were interval level (Likert-type), not substantially heterogeneous and were 
not themselves causally related (Graetz, 2000).  
 
Principal component (PC) analysis was chosen as the extraction method as its purpose 
is to “… summarize most of the original information (variance) in a minimum number 
of factors for prediction purposes” (Hair et al., 1998, p. 100). The discussion of the 
process, however, will refer to factors for consistency with literature discussed in this 
section. Although the processes of principal component and factor analysis are similar, 
it is recognised that they are not the same. Principally, all of the variance is analysed in 
PC compared to only shared variance for factor analysis.  
 
The choice of rotation method was balanced between two. First, an orthogonal 
(varimax) solution would be better for subsequent use in the regression analysis, but 
the solution may not be meaningful. Secondly, a meaningful solution is more likely 
from an oblique rotation method (Hair et al., 1998). Initial PC extractions with 
orthogonal and oblique rotations did not show marked differences in initial analyses 
for each instrument. Varimax rotation was chosen because of the desirability to have 
orthogonal data for the regression analysis. For each scale, the iterative process 
continued until statistical adequacy, simple structure and meaningful factors were 
obtained. Missing values were handled by pair-wise deletion.  
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Determination of factors was based on statistical and a priori criteria. An eigenvalue 
greater than 1.0 at first rotation and Cattell’s scree test (1966) were used initially. The 
final solution was influenced by theoretical support (interpretable) and previous 
research findings. A desirable aim was to have the minimum number of factors that 
would explain the most variance. 
 
Significant loading was based on sample size with factor loadings of .30 being 
acceptable when sample size is greater than 350 (Hair et al., 1998). However, Comrey 
and Lee (1992) suggested that a factor loading of .32 was poor, regardless of sample 
size. In addition, Stevens (1992) advocated that larger samples still needed factor 
loadings of .5 or higher to be considered strong. With this ambiguity, a factor loading 
of .5 was considered significant for this study. Sample size for all analyses were 
greater than the minimum of 100 suggested by Hair et al. 
 
After determining a simple solution and interpretable factors, the item scores for each 
factor were summed and the mean used as the factor/scale score (Hair et al., 1998). 
Hair et al. suggested that the creation of a summed scale should meet four criteria. 
Specifically, the scale should have a theoretical basis, that items in the scale represent 
a single concept and that the scale has internal reliability and validity. The first three 
criteria, as they relate to this study, will be discussed in the relevant section for each 
scale. Scale validity was discussed in the previous chapter.  
5.2.1 Statistical adequacy for scale factorability  
The criteria for sufficient evidence for factorability of scales included a significant 
Bartlett test of sphericity and the Kaiser-Meyer-Olkin (KMO) measure of sampling 
adequacy that was greater than 0.6. Furthermore, the measure of sampling adequacy 
for individual variables needed to be greater than 0.6. See Table 5.4 for initial analysis 
details about the instruments Psychosocial Adaptation to Illness (46-item PAIS), 
General Self-Efficacy (17-item GSE), Arthritis Self-Efficacy Scale (20-item ASES) 
and the Diabetes Self-Efficacy Scale (20-item DSES).  
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Table 5.4: Factorability statistics for each of the scales in the study: 
Principal component analysis with varimax rotation. 
 GSE PAIS a ASES DSESb 
Bartlett test χ2 =1652.26 
df = 136,  
p < .001 
 
χ2 =4720.53 
df = 1035,  
p < .001 
χ2 =1449.94 
df = 190,  
p < .001 
χ2 =1330.65 
df = 190,  
p < .001 
KMO .852 .908 .838 .794 
MAS ≥ .78 ≥ .43 ≥ .72 ≥ .65 
Eigenvalue 4 10 4 5 
Scree test 2 9/10 4 5 
Ratio  21:1 5.8:1 a 6.5:1 11:1 
a  T3 based on the 46-item scale 
b rationale for the 20-item DSES is explained in section 5.2.4  
KMO = Kaiser-Meyer-Olkin measure of sampling adequacy. 
MAS = measure of sampling adequacy for individual variables. 
Eigenvalues = number of factors suggested by eigenvalues greater than 1.0. 
Ratio = subject to variable ratio at T0.  
 
5.2.2 General Self-Efficacy (GSE) 
The 17-item general subscale of Sherer et al.’s (1982) 23-item scale was used in the 
analysis. The study group (N = 361) had an acceptable subject to variable ratio of 21:1 
for the GSE instrument at T0 (Tabachnick & Fidell, 1996). 
5.2.2.1 General Self-Efficacy factors and statistical adequacy 
In the initial analysis, the eigenvalues greater than 1.0 criterion indicated four factors 
explaining 52.91% of total variance. The eigenvalues were 5.24, 1.62. 1.09 and 1.04 
respectively. The last two factors only added a further 12.5% of explained variance. 
Cattell’s scree test (1966) suggested two factors. There was one complex variable 
(variables with a significant loading on more than one factor) and there were no 
significant loadings on the variable with the lowest communality. The communality 
(multiple R2) values after extraction for each variable in the set ranged from .35 to .71. 
The four-factor solution was not interpretable. 
5.2.2.2 A priori criterion  
The developers of the 23-item General Self-Efficacy Scale (Sherer & Adams, 1983; 
Sherer et al., 1982) determined a two-factor solution and that the first factor in their 
analysis (general subscale) accounted for 26.5% of the variance. The authors also 
made a tentative suggestion that this 17-item subscale could be two factors reflecting 
“initiation / persistence” and “efficacy in the face of adversity” (Sherer et al., 1982 p. 
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666). Using the a priori criterion, the analysis for the 17-item scale to be used in the 
current study was respecified as a two-factor solution.  
 
In the current study, after respecifying the analysis, simple structure was achieved with 
16 of the 17 variables having one significant loading on one factor. Variables loaded 
on the same factor regardless of rotation method. Variable 2 did not have a significant 
loading on either factor (I = .31; II = .40) and was removed. This variable also had the 
lowest (.39) factor loading in Sherer et al.’s (1982) study. Similarly, although not the 
lowest, variable 2 was low (.38) in the Woodruff and Cashman (1993) study. See 
Table 5.5 for results of the two-factor structure - without variable two.  
 
No complex variables were evident at the significance level determined. Of relevance 
to later discussion, variable 14 had the lowest communality at T0 for the whole sample 
(.29) and for the female group (.26). Nevertheless, it was retained as it had MSAs 
greater than .70 and had significant factor loadings for the whole group at each test 
time as well as for the male group. 
 
The two factors reflected negative and positive belief in one’s ability. Factor one 
included variables suggestive of “negative belief about initiation or persistence 
behaviours”. Factor two variables reflected “positive belief in one’s ability”, including 
perceived ability to cope with problems. The two-factor solution for the 16-item scale 
explained 41.62% variance in GSE and both had eigenvalues greater than two after 
rotation. This finding concurred with 26.5% explained variance for the equivalent 
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Table 5.5: Results of principal component analysis with varimax rotation of the 16 
general self-efficacy variables.  


















I avoid trying to learn new things when / look too difficult for me. 
I give up easily. 
If something looks too complicated, I will not even bother to try it. 
When unexpected problems occur, I don’t handle them well. 
When trying to learn something new, I soon give up if I am not / 
I give up on things before completing them. 
I do not seem capable of dealing with most problems that come up/ 
I avoid facing difficulties. 
When I set important goals for myself, I rarely achieve them. 
I feel insecure about my ability to do things. 
 
When I decide to do something, I go right to work on it. 
If I can’t do a job the first time, I keep trying until I can. 
When I have something unpleasant to do, I stick to it until I finish. 
When I make plans, I am certain I can make them work. 
Failure just makes me try harder. 






























Explained Total Variance = 41.62%   Eigenvalues = 4.03 2.63 
Total scale α = .85    Alpha for each factor .84 .70 
a Rotation converged in 3 iterations 
/ = words left out of table. Full wording in Appendices. 
I = negative initiation / persistence belief. 
II = positive belief in one’s ability. 
 
There could, however, be an alternative interpretation for the two-factor solution 
(Carmines & Zeller, 1979). Carmines and Zeller suggested that a method artefact, such 
as a response set, accounted for this type of result. When variables that formed a factor 
were worded in a similar way (“can do” or “can’t do”), it was likely that a single 
theoretical dimension had been contaminated by the response set. Carmines and Zeller 
suggested that construct validity testing was needed to resolve the ambiguity. 
Construct validity testing was not an option in the current study. Others, however, 
have confirmed the construct validity for the univariate 17-item scale (Sherer & 
Adams, 1983; Sherer et al., 1982; Woodruff & Cashman, 1993). 
5.2.2.3 Stability of General Self-Efficacy structure 
Replication of T0 structure at T3 and T9 indicated that the two-factor structure was 
stable. All items consistently loaded highly on the same factor. At T3 and T9 the two 
factors together explained 44.38% and 46.36% of variance in GSE respectively. Using 
the same level of significance for loadings, three variables at T3 did not meet the .5 
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significance level (variables 1, 10 & 13). Each loaded correctly but just below selected 
significance level (.490 - .493). Similarly, at T9, two variables (1 & 5) loaded below 
significance (.45 and .49). Although these loadings were not deemed to be significant 
in this study, other researchers with a similar sample size had used .40 as a significant 
loading (Sherer et al., 1982; Woodruff & Cashman, 1993). 
 
To test the robustness of the 16-variable factor structure the sample was divided by 
gender. Using PC with varimax rotations resulted in similar factor loading to the total 
sample at T0. For the female group (n = 212), variable 14 loaded correctly on factor I 
(.47) but below the designated significance level for the current study. Variable 14 
loaded correctly (.61) for male participants. In addition, three variables in the smaller 
male group (n = 149), loaded below the .5 significance level (.44 to .48). Nevertheless, 
the PC for both gender groups resulted in factor variables that had their major loading 
on the same factor as the overall sample. It could, therefore, be argued that the scale 
was robust. 
5.2.2.4 General Self-Efficacy Reliability 
The internal consistency analysis (Cronbach’s alpha) for the total 16-item GSE 
exceeded the generally accepted threshold level of .70 for acceptance at each testing 
time (.85; .87; .88 respectively). See Table 5.6 for comparisons with other studies. 
Relative standard deviation is reported because of the variability in range of scores 
between Sherer et al.(1982) and subsequent reports. 
 
The scale alpha was not improved by the removal of variables at any of the testing 
times. The Cronbach’s alpha for the 10-item and 6-item factors (.84; .70 respectively) 
were also acceptable at each test time (Hair et al., 1998). Specifically, the alpha scores 
for the larger, negative efficacy belief factor (I) ranged from .84 at T0 to .86 at T9. The 
alpha scores for the positive efficacy belief factor (II) ranged from .70 at T0 to .76 at 
T9. Moreover, the average measure of intraclass correlation coefficient of reliability 
for the 16-item scale was .88 (F {284, 568} = 8.34, p < .01). Specifically, the test-
retest indicated stability of GSE over nine months. 
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Table 5.6: Cronbach’s alpha reliability analysis of GSE scale as determined by others 
compared to T0 data for the current study 
 Items (N) Alpha Mean score Rel SD Age range 
Sherer et al., 1982  17 (376) .86 172.65 * 15.82  
Sherer & Adams, 1983 17 (101)  64.31 13.34  
Rapley, 1989 17 (99) .85 82.1 13.28 17-91 
Hays & Buckle, 1992 17 (105)  57.5 21.04 18-73 
Woodruff & Cashman, 1993 17 (400) .84    
Current study # 16 (361) .85 62.94 16.52 18-82 
# Alpha was not improved by the deletion of items. 
* 14 point scale. Remainder were 5-point scales. 
 
5.2.3 Arthritis Self-Efficacy (ASES) 
The arthritis group (n = 135) had an acceptable subject to variable ratio for the 20-item 
ASES (Tabachnick & Fidell, 1996). The significant factor loading criterion was 
retained at .5 or greater.  
5.2.3.1 Arthritis Self-Efficacy factors  
Initially, both the scree test and eigenvalues greater than 1.0 criterion indicated four 
factors explaining 64.84% of total variance. Initial eigenvalues were 7.49, 2.53, 1.66 
and 1.29 respectively. The communality (multiple R2) values after extraction for each 
variable in the set ranged from .40 to .81. The variables with communalities less than 
.5 may need to be deleted. The four-factor solution was not interpretable. In addition, 
the .5 loading criteria was not met for variable three. 
 
The analysis was re-specified as a 3-factor solution to reflect scales used in the 
literature. However, to achieve simple structure that was interpretable using PC 
extraction method with varimax rotation, the 20-item scale needed to be reduced. 
Specifically, to achieve a single significant loading for each variable on only one of 
the three factors, the ASES scale needed to be reduced to 17 items.  
5.2.3.2 A priori criterion 
The developers of the 20-item Arthritis Self-Efficacy Scale (Lorig et al., 1989a) 
initially found a 2 factor solution (N = 97) using PC with varimax rotation. (Detail 
discussed previously in methods chapter – section 4.5.4.2.) Their later analysis with 
another sample (N = 144) determined a three factor solution with factor loadings 
greater than .40. Since the three-factor structure did not replicate well for the sample 
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collected for the current study, the two-factor structure was explored. Lorig et al. 
(1989a) had stated their preference was for a three subscale instrument but also that 
“… the choice between 2 or 3 instrument subscales was largely arbitrary.” (p. 44).  
 
After respecifying as a two-factor solution, simple structure was achieved with all 20 
variables having a significant loading on one of the two factors, both of which were 
interpretable. Complex variables were not evident. This structure replicated the 
original two factor structure of the ASES (Lorig et al., 1989a) with similar 
eigenvalues, after rotation, for both factors (see Tables 5.7 and 5.8). The FSE 
(function) factor did not change its structure with either solution. The second factor 
included variables from PSE (Pain) and OSE (Other) and was renamed “arthritis 
symptom management” (ASSE) for this study. The items in the factor referred to the 
person’s perceived level of confidence in the ability to manage arthritis symptoms 
generally - fatigue, pain and frustration.  
5.2.3.3 Stability of Arthritis Self-Efficacy structure 
Repetition of T0 analysis for T3 and T9 data indicated that a two-factor solution best 
suited the data. All items consistently loaded on the same factor. Although variable 1 
had the lowest communality at T0 and T9 (.243; .299 respectively), and it only loaded 
.486 at T0, its MSAs were greater than .6 at both times (.77; .81 respectively). It was 
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Table 5.7: Results of principal component analysis with varimax rotation of the 20 
Arthritis Self-Efficacy Scale variables.  






















Cut 2 bite-size pieces of meat with a knife and fork in 8 seconds. 
Put on a long-sleeved front-opening shirt or blouse / 8 seconds. 
Button and unbutton 3 medium size buttons / in 12 seconds. 
Get in and out of the passenger side of the car without assistance/ 
Turn an outdoor faucet all the way on and all the way off. 
Scratch your upper back with both your right and left hands. 
Walk 100 feet on flat ground in 20 seconds. 
Walk 10 steps downstairs in 7 seconds. 
Get out of an armless chair quickly, without using your hands/ 
 
How certain / you can manage your arthritis symptoms so that / 
How certain are you that you can control your fatigue. 
How certain / regulate activities / without aggravating arthritis. 
How certain / you can deal with the frustration of arthritis. 
/ how certain / you can manage arthritis pain / daily activities. 
How / make a large reduction / methods other than / medication. 
How certain / you can continue most of your daily activities. 
How / make a small-to-moderate reduction / other / medication. 
How certain / can keep arthritis pain from interfering with sleep. 
How certain / can do something to help yourself feel better / 































Explained total variance = 50.081%  
 Eigenvalues 
5.07 4.95 
(Total scale α = .9062)    Alpha for each factor .885 .877 
 a Rotation converged in 3 iterations  / = word left out of table. Full wording in Appendix. 
I = Functional ability efficacy belief (FSE). II = Arthritis symptom management efficacy belief 
(ASSE). 
 
5.2.3.4 Arthritis Self-Efficacy Reliability 
The internal consistency analysis (Cronbach’s alpha) for the 20-item ASES met the 
generally accepted lower limit of .70. By way of comparison with other studies, the 
alpha values for the Lorig et al. (1989a) scales of FSE, PSE and OSE at T0 were .88; 
.78; .88 respectively. The Cronbach’s alphas for the two factors identified by principal 
component analysis in the current study were equally strong at each testing time. The 
combined OSE-PSE renamed ASSE achieved alphas of .88, .87 and .90 from T0 to T9. 
The scale FSE, which was the same in the three-factor as the two-factor solution, 
achieved .89 and .85 for T3 and T9 respectively. The scale alphas could not be 
improved by the removal of variables at any of the testing times. See Table 5.8 for 
comparison with Lorig et al.’s study. According to Carmines and Zeller (1979), scales 
with an alpha of .80 or more have very little random measurement error.  
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Table 5.8: Cronbach’s alpha reliability analysis of ASES scales as 
determined by Lorig et al. Compared to T0 data for the 
current study 
ASES Items (N) PSE OSE FSE 
2 factor ASES      
Lorig – initial 20 (97) Na .90 a .93 
Current study # 20 (121) Na .88 .88 
3 factor ASES     
Lorig – replication  20 (144) .76 .87 .89 
Lorig – confirmatory 20 (97) .75 .87 .90 
Current study b # 20 (121) .78 .88 .88 
a OSE refers to the label used by Lorig et al. (1989a) but includes all items from OSE and PSE in her 
study and the same items re-labelled arthritis symptom management self-efficacy (ASSE) in the 
current study. 
b Comparative analysis of the 20-item, 3 scale ASES structure (Lorig et al., 1989).  
# Alpha was not improved by the deletion of items. 
 
5.2.4 Diabetes Self-Efficacy (DSES) 
The instrument Insulin Management Diabetes Self-Efficacy Scale (IMDSES) was 
developed for individuals using insulin and was reported as being stable and internally 
consistent (Hurley, 1990; Hurley & Shea, 1992). Testing of the IMDSES involved 
individuals with type 1 or type 2 diabetes who used insulin to control their blood 
glucose. The factor structure for the IMDSES had not been reported and in the current 
study, the sample size for the IU group was insufficient for factor analysis of the 
IMDSES.  
 
It was, however, possible to determine an instrument that was common not only to 
both diabetic groups but which could also be stable across time. The factor analysis 
process was initiated with the 23 questions that were common to both questionnaires – 
the DSES. Levene’s test for equality of variance across the two diabetic groups 
indicated that responses for 20 of the 23-item Diabetes Self-Efficacy Scale (DSES) 
could be said to be from the same population. Only variables 15,18 and 20 were found 
to be significantly different across the two diabetes groups (p > .05). In addition, a 
Mann-Whitney U test indicated a significant difference between the two groups at T0 
for two of the three questions in which variance was unequal, and one other (z = -2.40, 
-2.37, -4.03, ps < .02). Since the Levene Statistic is the more conservative, it was 
decided to use the Mann-Whitney U results to determine the variables to be removed 
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before factor analysis. The factor analysis process was undertaken after the removal of 
the three questions that were significantly different at T0 (variables 5, 15 & 20).  
 
The diabetic group (n = 226) had an acceptable subject to variable ratio of 11:1 for the 
subsequent 20-item DSES (Tabachnick & Fidell, 1996). The significant factor loading 
for this scale was retained at .5 or greater (Hair et al., 1998). 
5.2.4.1 Diabetes Self-Efficacy factors 
Initially, both the scree test and the eigenvalues greater than 1.0 criterion indicated five 
factors explaining 57.34% of total variance in DSES. Initial eigenvalues were 4.98, 
2.17, 1.69, 1.50 and 1.14 respectively. The communality values after extraction for 
each variable ranged from .45 to .72. Variable 21 had the lowest communality and did 
not correlate with any other variable more than .3. It did not add significant 
information and was considered for deletion. In addition, the correlation coefficient 
indicated that two more variables could be redundant in that they only correlated with 
each other (.38). After rotation, variables 21 and 14 loaded at less than .5 and only four 
of the five factors were interpretable. Variables 21 and 14 were removed and the 
analysis repeated for an 18-variable solution.  
 
Varimax rotation resulted in a five-factor solution that was interpretable (see Table 
5.9). The five factors explained 60.73% of total variance at T0. The factors were 
labelled efficacy beliefs about ability to carry out diabetic routines (4 variables), 
confidence in the ability to self-treat (5 variables), certainty belief (4 variables), 
efficacy belief about diet (3 variables) and belief about ability to exercise (2 variables). 
These labels are similar to those mentioned by Hurley (1990) and are referred to in 
section 5.2.4.2. 
 
Four of the labels for the current study describe the task-related nature of the derived 
efficacy factors. Confidence in the ability to undertake tasks associated with being able 
to “follow diabetic routines and fit into lifestyle”; being able to “self-treat when 
remedial action is required”; “follow diet”; and “exercise”. The positive form of 
Hurley’s “insecurities” was used for the fifth factor. Although the four variables that 
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formed this factor were negatively worded, the sample used in this study had a high 
factor mean indicating that most participants were more certain than uncertain about 
self-care. A response set was not seen to be implicated as one other negatively worded 
variable consistently loaded with its positive counterpart (exercise). See Table 5.9 for 
specific loadings. Factor loadings ranged from .58 to .83 and no complex variables 
were evident. 
5.2.4.2  A priori criterion 
The report of the factor analysis for the IMDSES (Hurley, 1990) was limited by the 
research design in that the analysis had 127 participants for the 28 items; less than the 
minimum requirement for factor analysis. The author reported that the eigenvalue 
greater than one rule suggested nine factors explained 69% of the variance. Although 
no details were given about the method of analysis or rotation method used, it was 
reported that five factors were interpretable. The only details provided were the labels 
for the five factors: “… dietary control, insecurity, general confidence, treatment 
decision, and discipline” (p. 39).  
5.2.4.3 Stability of the Diabetes Self-Efficacy Scale structure 
Repetition of T0 analysis for T3 and T9 data indicated that a five-factor solution had a 
stable structure. The 18 variables replicated the factor structure at T9, although one 
variable loaded correctly but at less than .5 (.45). The five-factor solution explained 
62.51% of total variance – sacrificing 5.8% by being reduced from six to five factors. 
At T3 the 18 variables explained 61.81% of total variance with five factors (unforced). 
Four factors replicated the T0 solution. The fifth (routines) factor only had two primary 
loadings although it had two correct secondary loadings at less than .5. The latter two 
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Table 5.9: Results of principal component analysis with varimax rotation of 18 DSES 
variables at T0.  









I can fit my diabetes self-treatment routine 
into my usual lifestyle. 
I think I’ll be able to follow my diabetes plan 
even when / routine changes. 
I can carry out practically all of the self-care 
activities in my daily routine. 




















I can recognise when my blood sugar is too 
high. 
When I feel sick, I can test my blood more 
than I routinely do. 
I can do what was recommended to prevent 
low blood sugar reactions. 
I can figure out what self-treatment to 
administer when my blood sugar / 
I can figure out when to call my doctor about 



















I feel unsure about having to use what I know 
/ self-treatment every day. 
I don’t think I can follow my diabetes routine 
every single day. 
I’m not sure I’ll be able to follow my diabetic 
diet every day. 
I’m not sure / my diabetic diet when the 
people around me don’t know that/ 














I can stay on my diabetic diet when I eat in 
familiar / (such as a friends house).  
I can stay on my diabetic diet when I eat in 
unfamiliar places. 
When I go to parties, I can follow my diet 
plan. 








I can’t exercise unless I feel like exercising. 
I can exercise several times a week.  




Total scale α = .816;  Alpha for each factor  .75 .72 .72 .76 .61 
Explained variance = 60.73% Eigenvalues 13.94 13.36 12.59 12.44 8.40 
 a Rotation converged in 7 iterations  / = words left out of table. Full wording in 
Appendices. 
I = Efficacy belief about ability to follow diabetes routines. 
II = Efficacy belief related to perceived ability to self-treat. 
III = Belief related to certainty with diabetes management. 
IV = Efficacy belief about ability to manage diet. 
V = Efficacy belief about ability to exercise. 
 
5.2.4.4 Diabetes Self-Efficacy reliability 
The internal consistency analysis (Cronbach’s alpha) for the total 18-item DSES scale 
at T0 was .82. Four of the five subscale alphas at T0 were above .7 and ranged from .76 
(3-item diet) to .61 (2-item exercise) (see Table 5.10). The only alpha value below .7 
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at T3 and T9 was for the two-variable factor exercise (.58 and .55 at T3 and T9 
respectively). The low alpha levels for the exercise factor reflected the average inter-
item correlation of .4 for a two variable scale (Carmines & Zeller, 1979). The more 
modest alpha value indicated random measurement error was greatest for the two-
variable factor. The greater the random error the harder it is to detect associations and 
therefore the greater the risk of a Type II error.  
 
The higher alpha values for diet confirmed prior reliability tests of the scale (Hurley, 
1990; Hurley & Shea, 1992). Furthermore, the alpha for the diet scale could be 
increased from .7 to .8 by the deletion of the same question at each test time. The 
question so identified was: “When I go to parties I can follow my diet plan”. 
 
Table 5.10: Cronbach’s alpha reliability analysis of scales for current study (T0) 











  Total 
Hurley – initial a 118 .78 .62 .68   .82 
Hurley & Shea, ‘92b 142 .78 .77 .67   .86 











Current study IU c 226 .76† .72+ .75 .72 .61 .82 
a 28-item Insulin Management Diabetes Self-efficacy Scale (IMDSES). Only the 24 items that formed 
the three subscales stated above had alphas reported. The other four items in the scale were 
about foot care and exercise. 
b 26-item IMDSES. As above but two less items in the insulin management scale. 
c 18-item DSES scale based on current study sample.  
+ Alpha could be improved by more than 0.1 with the deletion of one item. 
†  Alpha could be improved by more than 0.4 with the deletion of one item.  
 
5.2.5 Psychosocial Adaptation to Illness (PAIS) 
The study group (N = 313 & 290 at T3 & T9 respectively) did not have an acceptable 
subject to variable ratio for the 46-item PAIS instrument (Tabachnick & Fidell, 1996). 
Pairwise deletions for missing values resulted in the analysis N range being reduced to 
234 from 310 and 218 from 287 respectively. The sexuality subscale items (n = 6) 
were removed because they had a high number of missing values. Consequently, the 
subject to variable ratio was able to meet the minimum level (5:1). Subsequent 
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removal of other variables for statistical reasons during the factor analysis process also 
increased the analysis N and ratio.  
5.2.5.1 PAIS factors and statistical adequacy 
In the initial analysis of T3 data, the eigenvalues greater than 1.0 criterion and Cattell’s 
scree test indicated ten factors explained 66.10% of total variance. The communality 
(multiple R2) values after extraction for each variable in the set ranged from .4 to .84. 
One variable had a communality value less than .5 and was subsequently deleted as it 
failed to load at .5 significance level. After rotation, five of the ten factors agreed with 
the findings of Derogatis and Derogatis (1990). In addition, health care orientation 
was split over two factors and two others were interpretable with the tenth factor 
consisting of one variable. While there were no complex variables, two variables did 
not meet criteria for a significant loading. Similar results were also found for the T9 
data, although, with 11 factors explaining 68.54% of variance in PAIS. 
5.2.5.2 A priori criterion 
In order to compare with the published factor structure (Derogatis & Derogatis, 1990), 
a PC extraction with varimax rotation forced a seven factor solution on the 46-item 
data for T3. This solution only explained 58.79% of variance in PAIS. However, 
except for the first factor, a similar structure emerged in that the factors sexuality, 
psychological distress and social replicated the published lung cancer patient study (N 
= 120) (Derogatis & Derogatis, 1990). Furthermore, as for the cancer study and the 
current study, health care orientation was split across two factors. In the cancer patient 
study, the most complex factor was domestic environment, which had significant 
loadings on three factors and loaded on two factors in the current study. Similarly, in 
both studies, four variables had not loaded at the .5 level. Repetition of this exercise 
for the T9 data achieved similar results but required 42 iterations. 
 
A series of analyses followed to achieve a solution that was interpretable and could 
explain maximum variance. The variables related to the subscale sexuality (n = 6) were 
removed from the analysis at this stage because all items had more than 50 missing 
cases per item and the item had previously been excluded with a similar sample 
(Pollock, 1986) and a cancer sample (Gilbar, 1997). Missing values create power 
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problems. Other variables were removed from the analysis for each iteration if they did 
not have a significant loading on one factor or if classified as a complex variable with 
two significant loadings. The MSAs for two variables were less than .5 but were 
retained as they consistently formed an interpretable two-variable factor, self-care 
adjustment. They only correlated with each other (.391). Variables with low 
communalities (< .5) after extraction were also considered for deletion, but if variables 
met factor-loading criterion they were retained. Removal of too many variables is 
more of a threat to scale validity than to reliability (see Table 5.11 for details of T3 
analysis). 
 
The final 31-item solution included seven factors at T3 (65.21% variance), but 
subsequently reduced to six factors (61.81%) to match T9 analysis. The factors 
confirmed four of the six domains (psychosocial distress, social environment, health 
care orientation, extended family) (Derogatis & Derogatis, 1990). The 5-item extended 
family domain also included two additional items from another domain (domestic 
environment). These two items had theoretical relevance to extended family as “social 
support within the family”. A further five-variable factor, consisting of items from two 
of the original domains, was interpretable as adjustment in role functions. The sixth 
factor consisted of two variables from the original health care orientation (HCO) 
domain and was interpreted as self-care adjustment. These two variables differed from 
the other items in the HCO domain that were more related to service and resources 
provided by health care practitioners. See Table 5.12 for comparison of T3 data with 
published factor structure (Derogatis & Derogatis, 1990). The Spearman’s rho 
correlation coefficient for the 46-item scale and the 31-item scale at T3 and T9 
indicated the reduced scale was an adequate substitute (rs = .97; rs = .96, p < .01 
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Table 5.11: Results of principal component analysis with varimax rotation 
of 31 PAIS variables at T3. 
Var # I II III IV V VI 
7.2 .778      
7.6 .764      
7.1 .760      
7.4 .757      
7.5 .690      
7.3 .672      
5.1  .757     
5.5  .754     
5.3  .684     
5.2  .677     
3.4  .592     
5.4  .578     
3.6  .538     
2.1   .782    
3.7   .711    
2.2   .696    
3.3   .687    
2.5   .617    
6.2    .735   
6.1    .734   
6.5    .697   
6.4    .595   
6.6    .590   
6.3    .498   
1.6     .722  
1.3     .717  
1.4     .712  
1.8     .708  
1.7     .590  
1.2      .812 
1.1      .812 
Components: I = Psychosocial distress II = Extended family support III = Role function
 IV = Social environment V = Health care orientation IV = Self-care 
# See attached questionnaire for full details of question wording. 
 
5.2.5.3 PAIS Reliability 
This analysis was carried out on two instruments. First, the 46-item scale for 
comparison with other studies and secondly, the 31-item scale used in multivariate 
analyses for the current study. The internal consistency analysis (Cronbach’s alpha) of 
the seven subscales that formed the 46-item PAIS (T3) exceeded the threshold of .70 
and were in accordance with other studies (Derogatis & Derogatis, 1990; Pollock, 
1986; Rapley, 1989) (see Table 5.13).  
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The reliability coefficients (Cronbach’s alpha) for the 31-item PAIS at T3 and T9 were 
also acceptable (.93; .94 respectively). Furthermore, five of the six factors identified 
for this study met the accepted minimum .70 threshold at each test time. The alpha for 
the two-variable factor at T3 was only .55, but increased to .65 at T9. 
 
Table 5.12 Comparison of principal component analysis with varimax rotation 
for PAIS in the current sample and one other study 
 Current study (T3)a  Lung cancer b 
Analysis N 266-309 120 
Number of items 31 45  
KMO .915  
Total scale: Factors / % 
Explained variance 
6  61.81% 7 63% 
PAIS dimensions: Factor % Factor % 
Health care orientation V (n = 5) 9.37 I (n = 8) 18 
Vocational environment II (n = 6) 10 
Domestic environment 
III (n = 5) 
Role function 
11.91 
 III (n = 8) 9 
Sexual relationships - - IV (n = 6) 8 
Extended family  II (n = 7) 11.93 V  (n = 4) 7 
Social environment IV (n = 6) 11.24 VI (n = 6) 7 
Psychological distress I (n = 6) 12.67 CII (n = 7) 5 
Self-care * VI (n = 2) 4.69   
a Rotations converged in eight iterations.  b Derogatis & Derogatis (1990).  
* new factor (eigenvalue = 1.45 after rotation). 
 = one variable did not load at .35 or higher: Derogatis & Derogatis (1990) replaced it with two 
others. 
Reduced combination of two original factors. 
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Table 5.13: Comparison of Cronbach’s alpha for PAIS in the current study (T3) compared to 
others 
 Current a Current b Cardiac c  Lung Cac Rapley d Pollock e 
Analysis N 157 – 308 259 – 310 69 89 99 60 
Items (range) 46 (1-4) 31 (1-4) 46 (0-3) 45 (0-3) 46 (1-4) 31 (0-3) 
Mean score  154.76 102.0   23.6 14.70 
SD 21.23 14.77   19.2 11.16 
 α  α α  α  α α 
Total scale .95 .93   .94 .89 
Health orient’n .73+ .78 .47 .83 .67 - 
Vocation envir’t .80 .76 .87 .78 
Domestic envir’t .80 
.87 
Role funct .77 .68 .85 
.83 
Sexual rel’ships .86+ - .83 .93 .88  
Ext’d family  .83 .83 .62 .12 .73 
Social environ’t .87 .87 .80 .93 .89 
.82 
Psych distress .88 .88 .85 .81 .90 .80 
Self-care - .55 †     
* = range of Analysis N for T3; +  scale α increased if one item deleted. 
a  Current 46-item for comparison only;  b Current study 31-item scale  
c  Derogatis & Derogatis, 1990;  d Rapley, 1989; e  Pollock, 1986. 
†  α = .65 at T9. 
Reduced combination (n = 5) of two original factors. 
 
5.3 INDEPENDENT VARIABLE ANALYSIS 
5.3.1 General Self-Efficacy (GSE) 
The scores for the five-point, 16-item, general self-efficacy scale (GSE) ranged from 
two to five and high scores indicated higher general efficacy belief. The total sample 
mean scores were 3.93 (SD = 0.65), 3.91 (SD = 0.68), 3.92 (SD = 0.69) for respective 
times. Mann-Whitney tests of GSE at T0 to T9 indicated no significant differences 
between the arthritis and diabetic group as a whole or separately or between the two 
diabetic groups.  
 
Based on a median split of mean GSE scores at T0, the characteristic high general self-
efficacy was found in 186 participants with 175 in the low self-efficacy group. A 
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crosstabs analysis of percentage of the three illness groups in each of the high / low 
GSE categories at each test time was non-significant. Levene’s test indicated equality 
of variance for the high and low GSE groups in relation to age, duration of illness, 
education, marital status but not BMI. By comparison, a Mann-Whitney U test found 
no significant differences between the two GSE groups in relation to age, duration of 
illness, marital status or BMI. Perception of life stress (six categories) was found to be 
significantly different (z = -2.22, p = .03; 2-tailed) with the high general efficacy group 
having a lower mean for stress. The education level of the study sample (nine 
categories) was also significantly different for the two groups (z = -2.19, p = .03; 2-
tailed). The high GSE group had the higher education mean. In summary, individuals 
with a general belief in ability that was greater than the median GSE score were more 
likely to perceive life stress as less and to have attained a higher level of education. 
5.3.2 Diabetes Self-Efficacy (DSES) 
The five scales identified in the factor analysis for this study were efficacy beliefs 
about ability to manage diabetic diet, ability to carry out diabetic routines, certainty 
associated with diabetes management, beliefs about ability to exercise, and to self-
treat. The scale scores ranged from one to six with higher scores indicating higher 
diabetes-specific efficacy beliefs. The mean for each of the scales ranged from 4.3 
(exercise T3) to 5.35 (routines T0) indicating data that were negatively skewed. Seven 
of the 15 scales had a median score of 5.0 or more. The standard deviation ranged 
from 0.82 (routines T0) to 1.5 (exercise T0).  
 
One of the five DSES subscales (routines) had left skewed data with a concentration of 
maximal scores at the boundary (ceiling effect) at each test time. Although participants 
were chosen soon after diagnosis to take advantage of changes in scores over time, 
most participants scored highly on the routines scale at each test time (M = 5.35; 5.32; 
5.34 respectively). 
 
Mann-Whitney tests of the five diabetes-specific scale scores (squared) by diabetes 
type were non-significant for all variables, although, gender differences were 
identified at T3 and T9. Specifically, for all T0 DSES scales, no significant differences 
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were found. Significant gender-related differences (2-tailed) were found for efficacy 
beliefs about diet at T3 (z = -2.10, p = .036), exercise at T9 (z = -2.71, p = .007) and 
certainty belief at T9 (z = -2.34, p = .019). Descriptive statistics for gender mean 
scores indicated that females had significantly higher (better) efficacy belief about diet 
at T3, whereas, males had significantly higher efficacy belief about exercise (more 
positive) and were significantly more certain about diabetes management abilities at 
T9.  
 
See Table 5.14 for a summary of significant differences for each of the diabetes-
specific scale scores. Given the factor analysis process previously described, it is not 
surprising that no significant differences were found for T0 data in relation to diabetes 
type, but gender-related differences were also not evident at T0.  
 
Table 5.14: Summary of significant differences for each of the DSES subscales 
(squared) by gender for the combined diabetic group # 
DSES  
Score range 1-6 
N items Mean (SD) Grouping variable a 
Self-treat T0 5 23.75 (10.03)  
  T3  24.64 (9.80)  
  T9  25.23 (9.88)  
    
Certainty T0 4 20.81 (10.72)  
  T3  22.38 (10.79)  
  T9  23.09 (10.57) Gender b ; z = -2.34, p =.019 
    
Diet  T0 3 20.97 (9.93)  
  T3  21.0 (9.97) Gender; z = -2.10, p = .036 
  T9  21.21 (9.89)  
    
Routines T0 4 29.26 (7.63)  
  T3  29.09 (8.02)  
  T9  29.24 (8.04)  
Exercise  T0 2 20.96 (11.75)  
  T3  20.61 (11.81)  
  T9  21.58 (11.27) Gender; z = -2.71, p = .007 
a No significant differences by diabetes type.  b  Mann-Whitney test (2-tailed). 
# 15 tests x .05 = 0.75 significant results expected by chance. 
After transformation, only efficacy beliefs about diabetic routines continued to have 
outliers (13 outliers represented by 11 cases) across the three testing times. It could be 
argued that the large number of outliers for routines was due to the concentration of 
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maximal scores at the boundary with very high mean scores. By contrast, however, 
outliers were not evident for exercise, which, after transformations, also had 
concentrations of maximal scores at the boundary but the mean scores were lower. 
Transformation for 12 of the 15 variables had drawn outliers toward the rest of the 
data (Fox, 1991).  
5.3.3 Arthritis Self-Efficacy (ASES) 
The two scales identified in the factor analysis for this study were arthritis efficacy 
belief about functional abilities (FSE) and management of arthritis symptoms  (ASSE). 
The scale scores ranged from one to six and higher scores indicated higher arthritis-
specific efficacy beliefs. The mean scores for the three ASSE variables ranged from 
3.92 (SD = 1.14) at T0 to 4.15 (SD = 1.12) at T9. The mean scores for the three FSE 
variables ranged from 4.49 (SD = 1.33) at T0 to 4.73 (SD = 1.07) at T9. A Mann-
Whitney test of gender comparisons for the arthritis specific scales found no 
significant differences. 
5.3.4 Hypothesis testing (1 – 3) 
Hypotheses one to three were applied, as appropriate. That is, to the total sample, to 
the arthritis group and to both diabetic groups combined into one group. Type of 
diabetes might be considered to be a confounding variable since the majority of 
participants were in the N-IU group. A Mann-Whitney test indicated no significant 
differences between the scores for the two diabetic groups in relation to the 15 
diabetes-specific scales and GSE at each test time. The two diabetic groups were 
therefore combined for hypothesis testing.  
 
The 16-item GSE was used as a total score (squared) for hypothesis testing for two 
reasons. First, the part played by method artefact in the two-factor solution for the 
GSE scale (positive and negative aspects of general efficacy beliefs) was not tested in 
this study. Secondly, the construct validity of the univariate 17-item scale had been 
established by others (Sherer & Adams, 1983; Sherer et al., 1982; Woodruff & 
Cashman, 1993).  
 
Hypothesis 1 
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General efficacy belief will be stable over time. 
To test this hypothesis a repeated measures MANOVA was conducted. The general 
efficacy belief scores (squared GSE) over time were used as the multiple dependent 
variable and the impact of age, gender, education, perceived life stress and three illness 
groups were the independent variables. As required for a general linear model, the 
independent variables were categorical (Munro & Page, 1993). Sphericity and equality 
of variance for GSE over time was assumed as neither Mauchly’s test of within-
subject effects nor Levene’s test were significant. However, the assumption of 
multivariate homogeneity (Box M Test) was not met (M {12, 332038} = 22.95, p = 
.031). Munro and Page (citing Finn & Mattson, 1978) suggest that if “… the 
assumptions of the univariate model are met, the univariate analysis should be used, 
because it is more powerful and requires fewer subjects” (p. 164). Therefore, the 
univariate tests of significance were used.  
 
The univariate between-subject effects indicated that education and stress were 
significant (Fs {1, 278} = 7.79 and = 19.05, ps < .01 respectively). The repeated 
measures analysis suggested that there was no change in general efficacy belief over 
time, but that variations in general efficacy belief were related to the perceived level of 
stress or education level. 
 
Before accepting the null hypothesis in relation to the change in general efficacy belief 
over time, the probability of making a Type II error was explored using Solo Power 
Analysis (Hintze, 1991). The lowest bivariate correlation coefficient for GSE at each 
test time (T0:T9 = .6) and the T9 sample size were used in the analysis. Specifically, 
with a sample of 289, effect size set at .2 and α = .01, the probability of rejecting the 
null hypothesis when it was false was .98. The probability of a wrong decision was 
.02.   
 
The hypothesis that general efficacy does not change over time was supported. 
Furthermore, age, gender and illness group did not have an impact on GSE.  
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Hypothesis 2 
Illness-specific efficacy beliefs will increase over time. 
A Wilcoxon signed-rank test was used to test this hypothesis, as several variables were 
not normally distributed. This test was used to compare the means between baseline 
(T0) and T3 and between T0 and T9. In relation to the arthritis-specific variables 
(squared), a significant difference (z = -2.118, p = .034; 2-tailed) between T0 and T9 
efficacy belief related to symptom management (ASSE) was found. The means for 
FSE and ASSE increased at each test time but the only significant increase was for 
ASSE between T0 and T9 (see Table 5.15).  
 
Table 5.15: Wilcoxon signed-rank test comparison of mean scores for illness-specific 
variables (2 groups) separated by three and six months (T0, T3, T9). 
Specific efficacy beliefs M rank -ve M rank +ve Z (T0-T3) Z (T0-T9) 
Arthritis group:        
FSE (function) T0: T3 47.2 50 55.63 52 -.890  
  T0: T9 40.9  45 50.10 45  -.833 
ASSE (symptom) T0: T3 51.73 50 55.99 57 -.940  
  T0: T9 46.56 41 53.24  59  -2.118* 
Diabetic group #:        
 Diet  T0: T3 78.77 71 71.57 78 -.009  
  T0: T9 72.21 70 69.81 71  -.101 
 Self-treat T0: T3 78.32 75 81.50 84 -.836  
  T0: T9 69.83 71 81.47 80  -1.449 
 Certainty T0: T3 77.09 72 85.88 91 -1.877  
  T0: T9 71.06 59 76.78 89  -2.528* 
 Routines T0: T3 62.48 63 62.52 61 -.152  
  T0: T9 59.86 70 68.04 56  -.463 
 Exercise T0: T3 66.12 65 62.83 63 -.403  
  T0: T9 59.56 60 62.42 61  -.303 
* p < .05 (2-tailed) # 10 tests x .05 = 0.5 significant results expected by chance. 
 
A comparison of the diabetes-specific variables (five) indicated a similar trend of 
increasing means over time. However, only the certainty variable increased 
significantly from T0 to T9 (z = -2.53, p = .011; 2-tailed). The means for three of the 
five diabetes-specific efficacy beliefs increased between each test time. By contrast, 
the mean for routines was marginally (.01) lower than T0 at T9. The mean for exercise 
was lower at T3 than T0 but increased at T9.  
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The hypothesis that illness-specific efficacy beliefs will increase over time was only 
partially supported. Certainly a trend in the predicted direction was evident but not 
sufficient to remove the risk that results were due to chance. The negatively skewed 
data, especially the ceiling effect for exercise and routines variables for the diabetic 
group, made it harder to demonstrate a significant increase over time. The long left tail 
caused by a few individuals with low scores resulted in estimated standard deviations 
that perhaps overstated the true variance in scores. Consequently, larger effects 
between scores were needed to demonstrate statistical significance.  
 
Hypothesis 3 
The strength of the relationship between general and illness specific efficacy 
will increase over time. 
To test the above hypothesis, a Spearman’s rho correlation coefficient of GSE 
(squared) with illness specific variables (squared) indicated that, overall, the strength 
of the relationship between concurrent general and illness-specific efficacy beliefs 
increased over time (see Table 5.16). For example, the correlations between arthritis 
symptom management (ASSE) and general efficacy belief increased from T0 (rs = 
.243, p < .01) to T9 (rs = .552, p < .01). By contrast, for confidence related to 
functional abilities (FSE), the correlation was low, but significant at T0  (rs = .217, p < 
.05), non-significant at T3 and returned to an increased correlation with GSE at T9 (rs = 
.245, p < .05).  
 
Variations to the trend for the diabetic group related to the variables certainty and 
diabetic routines. Significant correlations for the two variables with GSE increased 
from T0 to T3 but remained the same for certainty at T9 and lower for beliefs about 
routines at T9. Nevertheless, the increased correlation with GSE from T0 to T3 for 
routines was substantial, with T9 stronger than T0 data. A non-significant correlation 
between GSE and diet at T0 and T3 was also lower at T3 than T0. However, the 
increased correlation between diet and GSE for T9 was significant (rs = .240, p < .01).  
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Table 5.16: Spearman rho correlation for general and illness 
specific variables over time (T0, T3, T9) #. 
 GSE-T0 GSE-T3 GSE-T9 
Arthritis grp (n = 131) a (n = 116) a (n = 109) a 
FSE .217* .175 .245* 
ASSE .243** .343** .552** 
    
Diabetic grp (n = 226) (n = 191) a (n = 178) a 
Diet .127 .059 .240** 
Exercise .234** .313** .351** 
Certainty .288** .305** .305** 
Routines .195* .266** .239** 
Self-treat .123 .191** .201** 
* p < .05; ** p < .01  a   minimum N for the analysis. 
# number of tests x .05 = 0.3 and 0.75 respectively: significant results expected by chance 
 
The hypothesis was supported because the correlation between all illness specific 
variables and GSE increased from T0 to T9.  
5.4 DEPENDENT VARIABLE ANALYSIS  
The 31-item PAIS will be used as a total score (squared) for hypothesis testing. The 
developers of the scale intended it to be used either as an individual domain scores or 
as a total scale score that reflected adjustment to illness in several domains (Derogatis 
& Derogatis, 1990).  
5.4.1 Psychosocial Adaptation to Illness 
In this study the scores for the PAIS scale ranged from one to four, and higher scores 
indicated better psychosocial adaptation to illness. The total sample means for the two 
31-item PAIS variables (T3 and T9) were 3.30 (SD = 0.47) and 3.34 (SD = 0.45) 
respectively. 
 
The Mann-Whitney Tests that compared PAIS (squared) mean ranks by gender at T3 
and T9 were significant (zs = -3.44; -2.55, ps ≤ .01). Males had the higher mean scores 
for both times. Similarly, a significant difference was found between PAIS scores for 
the two illness groups, arthritis and diabetes (zs = -6.59; -6.60, ps < .01 at T3 and T9 
respectively) and between the two diabetic groups for PAIS at T3 and T9 (zs = -4.37; -
3.80, ps < .01 respectively). In addition, a Kruskal-Wallis test found a significant 
difference in ranks between the three illness groups for PAIS at T3 and T9 (χ2 (2) = 
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59.70; 56.69, ps < .01 respectively). Further examination of both PAIS scores 
indicated the mean was higher for the diabetic group and within this group, the mean 
was higher for the N-IU group. In summary, the higher mean PAIS scores indicated 
psychosocial adaptation to illness was highest for the N-IU group and for males. 
 
In relation to univariate changes in PAIS over time, an initial analysis using the 
Wilcoxon signed-rank test indicated no significant differences between the mean 
scores at T3 and T9. Similar within group comparisons for the arthritis and diabetes 
groups also indicated no significant differences between PAIS at T3 compared to T9 
(see Table 5.17 for means (M) and standard deviations (SD) for PAIS squared). 
Between group comparisons, however, were found. A Kruskal-Wallis test indicated 
that there was a significant difference at each test time when PAIS was compared 
across the three illness groups (χ2 (2) = 60.16; 57.80, ps < .01 respectively). Further 
analyses using Mann-Whitney U test to identify which groups differed indicated that 
the arthritis group compared to the diabetic group as a whole differed at each test time 
(z = -6.58; z = -6.60, ps < .01 respectively). In addition, the two diabetic groups were 
significantly different (z = -4.37; z = -3.80, ps < .01 respectively). Considering that the 
IU group had a higher mean PAIS score than the arthritis group but less than the N-IU 
group, the IU and arthritis groups were also tested and found to be significantly 
different (z = -3.47; z = -3.54, ps < .01 respectively). Thus, psychosocial adaptation 
was significantly different between the three illness groups with the N-IU group 
significantly more adapted than the IU group, and the diabetic group as a whole was 
significantly more adapted than the arthritis group. Further, the IU group was 




Table 5.17: Means (M) and standard deviations (SD) for PAIS (squared) at T3 and T9 by group 
Variable: N Study sample N Arthritis N IU N N-IU 
  M (SD)  M (SD)    M (SD) 
PAIS T3 307 11.10 (2.95) 119 9.72 (2.81) 86 11.15 (2.55) 102 12.68 (2.62) 
PAIS T9 286 11.37 (2.83) 108 9.94 (2.94) 78 11.46 (2.55) 100 12.91 (1.98) 
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To reduce the probability of making Type I errors (deciding there is a difference when 
there is none), a repeated measures MANOVA (general linear model) was used to 
explore the change in PAIS over time (6 months). As part of the analysis, the influence 
of four covariates was tested with the three illness groups as the between-subjects 
design. The four categorical independent variables were age, gender, education and 
perception of life stress. Mauchly’s test of sphericity was not applicable, as there were 
only two levels for PAIS. Box’s test of equality of covariance matrices was not met (p 
< .05) and Levene’s test of equality of error variances was only met for PAIS at T3. 
Therefore multivariate statistics were used, as they are sufficiently robust when 
assumptions are not met.  
 
The multivariate statistics for between-subject effects indicated that, with a non-
significant F statistic and observed power less than .15, there was insufficient evidence 
that age, education, stress and illness group had an effect on psychosocial adaptation 
to illness. The possibility of making a Type II error was considered. Gender was, 
however, found to have a significant F value to support the hypothesis that it 
influenced changes in psychosocial adaptation to illness (F {1, 271} = 6.0, p = .015). 
Nevertheless, the Eta squared value indicated that the gender effect on psychosocial 
adaptation to illness over time was small (Eta2 = .02).  
 
Since repeated measures analysis is sensitive to outliers and their impact on Type I 
error, the analysis was rerun without the two cases identified as univariate outliers for 
PAIS at T9. No difference was detected and cases were retained.  
 
Bivariate correlations for the total sample, using Spearman’s rho, indicated significant 
associations (ps < .01, 2-tailed) between the dependent variable PAIS at T9 (squared) 
for duration (rs = -.339), stress (rs = -.402), GSE T0 (rs = .266), GSE T3 (rs = .339) and 
GSE T9 (rs = .354). Strength of GSE correlation with PAIS increased over time. 
Furthermore, small negative and significant associations (ps < .05, 2-tailed) were 
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found between PAIS at T9 for gender (rs = -.15) and education (rs = -.14). Variables 
age and age-group were not significantly correlated with PAIS. 
 
The effect of duration of illness on PAIS at T3 and T9 was further analysed by illness 
group. The Spearman’s rho found no significant association for the IU and the N-IU 
groups. For the arthritis group, PAIS at T3 was not influenced by duration, but 
duration had a small significant and negative association at T9 (rs = -.25, p < .05). 
Thus, at nine months, individuals with the longer duration of arthritis were more likely 
to be less adapted psychosocially. 
 
Bivariate correlation coefficients (Spearman’s rho) of PAIS at T9 with each of the 
variables of interest by illness group are included in Table 5.18. Perception of life 
stress was negatively associated with PAIS for the three illness groups, but no 
significant association was found in the IU group. Although gender and education for 
the total sample had a negative significant association with PAIS, comparisons by 
illness group were all non-significant. General efficacy was significantly associated 
with PAIS at T9 for each of the illness groups, with the arthritis group having the 
strongest association. Furthermore, the six arthritis-specific variables were 
significantly associated with PAIS at T9 but variations existed for the two diabetic 
groups. The N-IU group, as the better psychosocially adapted group, had a significant 
association for 11 of the 15 diabetes-specific variables, compared with only seven for 
the IU group.  
 
It should also be noted that the seven significant IU group associations were common 
to the N-IU group. In particular, that the strength of association for the situation-
specific belief related to diabetic routines at each test time and diet at T0 were greater 
for the IU group than the N-IU group. By contrast, the strength of the associations for 
exercise at T0 and T9 were greater for the N-IU group - that is, five of the seven 
significant PAIS-DSES associations for the IU group were stronger than for the N-IU 
group equivalent. 
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Table 5.18: Bivariate Spearman’s rho correlation coefficients for potential 
predictors of psychosocial adaptation to illness by illness group. 






Stress -.598** -.180 -.356** 
Duration -.246* -.203 -.120 
GSE3  .591** .280* .222* 
ASSE   T0 .521**   
  T3 .559**   
  T9 .651**   
FSE  T0 .329**   
  T3 .427**   
  T9 .401**   
Diet   T0  .311* .250* 
  T3  .218 .173 
  T9  .213 .231* 
Exercise  T0  .271* .303** 
  T3  .190 .280** 
  T9  .231* .428** 
Certainty T0  .057 .378** 
  T3  .009 .345** 
  T9  .304** .285** 
Routines T0  .235* .226* 
  T3  .279* .250* 
  T9  .250* .217* 
Self-treat T0  .086 .149 
  T3  .027 .060 
  T9  .178 .100 
* p < .05 (2-tailed); ** p < .01 (2-tailed). 
a = 0.45; d = 0.9 significant results expected by chance 
GSE3 composite variable explained in section 5.4.2.1  
 
5.4.2 Prediction of dependent variable 
In the previous section (5.3), the hypothesised relationships for general and illness-
specific efficacy beliefs were, in the main, supported. Data pertaining to these 
variables were subsequently employed in sequential (hierarchical) regression analyses 
to investigate, concurrently, two further hypotheses per illness group. Hypothesis 4 
related to future predictions of PAIS based on general and initial illness-specific 




A general efficacy belief is a better predictor of future adaptation to illness than 
illness-specific efficacy beliefs. 




The influence of illness specific efficacy beliefs, relative to general efficacy 
belief, are better concurrent predictors of adaptation to illness. 
Hierarchical regression (sequential) analyses were carried out to determine if 
information about illness-specific efficacy beliefs improved the prediction of 
psychosocial adaptation to illness over general efficacy belief. The process was guided 
by Hair et al.’s (1998) suggestion for regression analysis. The square of the summed 
scores representing the 31-item PAIS questionnaire, the 16-item GSE (squared) and 
the relevant illness-specific efficacy variables (squared) were used. Given the sample 
size and that clinical utility of interaction effects would be minimal, only main effects 
were considered. According to Jaccard, Turrisi and Wan (1990), critics of 
multiplicative terms have recommended against their use because of the 
multicollinearity effects they cause. 
 
The sequence of entry was theoretically and statistically driven by variables that were 
more distant to the dependent variable being entered first. Potential predictor variables 
were not included if they were not significantly correlated with the dependent variable. 
Although it is preferable for the relationship between the independent variables to be 
uncorrelated, in this study, correlations were more likely to be low to moderate than 
uncorrelated. Correlations for dependent and independent variables identified in the 
regression analyses are presented in sections 5.4.2.2 (Arthritis group) and 5.4.2.3 (N-
IU group). 
 
The ratio of cases to independent variables met the minimum criteria suggested by 
Hair et al. (1998). The number of participants in the arthritis group at T9 (n = 108) and 
the N-IU group (n = 100) indicated sufficient power (.80) to detect small (10-15%) R2 
values with up to 10 independent variables (α = .05). The number of participants in the 
IU (n = 78) group was insufficient for regression analysis.  
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5.4.2.1 Initial analysis for arthritis and N-IU groups 
Variables found to be independent of PAIS at T9 were not considered for the 
regression analysis. These included age and gender for both illness groups, duration 
for the N-IU group and four diabetes-specific variables – self-treat at each test time 
and routines at T3. The potential negative confounding effect is low, but a 
disadvantage with this method. More generally, Achen, (1982) suggested that 
exclusion of variables because they were not significant had its dangers. The result 
may be regression chosen for irrelevant reasons rather than substantive thinking. 
“Significance tests are sensitive only to the unique variance an independent variable 
adds to R2.” (Tabachnick & Fidell, 1996 p. 161).  
 
Correlation coefficients between independent variables were also examined. 
Correlation coefficients for illness-specific variables in the initial regression model 
were below .7, indicating that the variables were not redundant to the scale. 
Tabachnick and Fidell (1996) suggested removal of variables with a correlation equal 
to or greater than .70. The stability of the GSE variable over time, as hypothesised, 
meant that a high correlation for these variables was not unexpected. The significant 
Spearman’s rho correlation coefficient between the three variables ranged from .67 
(T0:T9) to .73 (T3:T9) with ps < .01. To avoid multicollinearity effects, Tabachnick and 
Fidell (1996) suggested a composite variable be created. In the current study a mean of 
the three GSE (GSE3) scores was used in subsequent regression analyses for both 
groups. Normality could be assumed for the squared GSE3 data for the three illness 
groups. Levene’s test for variance comparisons by illness group and gender indicated 
that the scores for this variable could have been sampled from the same population. 
Pearson correlation coefficients between GSE at each test time and the new computed 
variable ranged from .89 to .90 (ps < .01), indicating it was an acceptable substitution. 
 
The assumptions underlying regression analysis included multivariate normality, 
linearity, homoscedasticity and independence of error term. The normal probability 
plot of residuals indicated multivariate normality for all regression analyses. 
Furthermore, partial regression plots of independent variables to the dependent 
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variable (squared PAIS) at T9 indicated normality, linearity and homoscedasticity 
assumptions were met. In relation to independence of error term for both analyses, the 
scatterplot of studentized residual regression indicated time-based dependence but the 
Durbin-Watson statistic for each analysis was non-significant (p > .05). The data were 
not autocorrelated and the assumption for independence of error term was satisfied. 
The Durbin Watson statistic was 2.01 and 1.89 for the arthritis and N-IU groups 
respectively. 
 
Additionally, as recommended by Hair et al. (1998), the tolerance values for all 
variables should be greater than .10 with a variance inflation factor (VIF) of less than 
10.0. However, with all potential predictors in the analysis, the condition indices at the 
last step for both groups were greater than 15 but less than 30, which indicated 
possible collinearity problems (Hair et al., 1998). Final collinearity diagnostics are 
discussed with the final model for each illness group. 
 
Evidence of suppressor variables was checked in each analysis. For example, absolute 
values of all correlations should be larger than the relevant beta value and the signs 
consistent for correlations and beta values. A variable sign that changed after the entry 
of other variables indicated that a suppressor variable was active (Tabachnick & 
Fidell, 1996).  
5.4.2.2 Prediction equation: Arthritis group 
Variables considered as predictors for the arthritis group included stress, duration, 
GSE3 and the six arthritis-specific variables. In the one-tailed Pearson correlation of 
linear regression, duration was not significantly correlated with PAIS at T9 (r = -.15, p 
= .06) but was included in the initial analysis because of its previous significant two-
tailed association using Spearman’s rho. Variables were entered in successive steps as 
separate time-related blocks of variables. The initial hierarchical (sequential) 
regression analysis, with all variables in the equation, explained 54% (Adjusted R2 = 
.54) of the variance in PAIS at T9.  
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The six ASES variables significantly correlated with PAIS at T9 (p < .01). For 
example, ASSE at T9 had the highest Pearson correlation coefficient (r = .65) with 
function (FSE) at T0 the lowest (r = .31). The three FSE variables had correlation 
coefficients equal to or less than .40. In addition, GSE3, and stress each had a 
correlation coefficient of .57, with stress negatively correlated.  
 
Two outliers were evident in one univariate arthritis group variable. Casewise 
diagnostics in the regression analysis, however, did not identify multivariate outliers.  
 
Successive regression model analyses eliminated independent variables according to 
two main criteria. If the t-test statistic for a variable was non-significant (p > .05) on 
entry or if the R2 change statistic was less than .01. Each variable, however, was 
reintroduced one at a time to test if still non-significant. This iterative process 
continued until statistical and interpretation value of the equation was greatest with the 
smallest set of independent variables.  
 
In the final analysis, after step 1, with stress and GSE3 in the model, the adjusted R2 = 
.44 (F▼ {2, 102} = 41.94, p < .01). After step 2, with ASSE at T0 added to the model, 
the adjusted R2 = .48 (F▼ {1, 101} = 8.55, p < .01). At step 3, the addition of ASSE at 
T9 to the model resulted in an adjusted R2 = .53 (F▼ {1, 100} = 12.25, p < .01). See 
Table 5.19 for results of Pearson correlation of variables in the final model and Table 
5.20 for the Adjusted R2 , R2 change (R2 6), unstandardised regression coefficient (B), 
standard error of B (SE B) and standardised regression coefficient (beta).  
 
Of the possible six arthritis-specific efficacy belief variables, the only variables able to 
continue to make significant contributions were initial and concurrent beliefs about the 
management of arthritis symptoms (T0 and T9). Together, the four variables in the final 
model were able to explain 53% (Adjusted R2 = .53) of the variance in psychosocial 
adaptation to illness. 
 
Chapter 5: Results 
 133
Table 5.19: Arthritis group: Pearson correlation results for 
variables in the final model. 
Variable: PAIS T9 Stress GSE3 ASSE T0 
PAIS T3     
Stress -.567**    
GSE3 .569** -.432**   
ASSE T0 .530** -.453** .441**  
ASSE T9 .647** -.453** .554** .674** 
* p <.05;  ** p < .01 (2-tailed) 
 
Table 5.20: Arthritis group hierarchical multiple regression analysis: Significance 
of selected variables in explaining the variance in psychosocial adaptation 
to illness. 
Model Variable entered Adjusted R2 R2 6 B SE B Beta 
 
1 Perceived life stress 












2 Perceived life stress 
GSE3 

















3 Perceived life stress 
GSE3 
ASSE T0 





















** p < .01:   * p < .05 
a = squared variables. 
ASSE = arthritis symptom management (squared). GSE3 = mean of GSE over time. 
 
 
The beta coefficient in the final model indicated that, when the other variables were 
held constant, concurrent efficacy beliefs about management of arthritis symptoms 
(ASSE at T9) had the most impact on psychosocial adaptation to illness, followed by 
perception of life stress. Furthermore, the impact of general efficacy belief on 
psychosocial adaptation to illness continued to be more than initial belief about ability 
to manage arthritis symptoms (ASSE T0). This is related to the higher bivariate 
correlation of ASSE T9 with T0 (r = .67) than for GSE3 (r = .55) (see Table 5.19). In 
effect, ASSE T9 subsumed the importance of ASSE T0. In combination with ASSE T9, 
the effect of ASSE at T0 was not significant (β = .07, p = .45). 
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The negative beta coefficient for perceived life stress indicated that as it increased, 
psychosocial adaptation to illness decreased. Also of interest was the finding that 
perception of life stress and general efficacy belief together contributed 45% of the 
variance in PAIS in the first model and continued to make a significant contribution 
after the addition of the two illness specific variables. In fact, the addition of the two 
illness-specific variables only added a further 9% explained variance to the final 
model. Stress and GSE3 contributed equally, although inversely, to the variance in 
model one.  
 
The condition index and other collinearity diagnostics did not indicate a problem with 
multicollinearity. The only condition index to be more than 15 was the last dimension 
of step 3 (15.32). The tolerance values, VIF and the variance proportions for 
coefficients associated with the last condition index met criteria previously discussed 
(5.4.2.1). 
5.4.2.3 Prediction equation: Non-insulin using group 
A sequential multiple regression analysis was repeated for the larger of the two 
diabetic groups – the N-IU group. Potential predictors of PAIS at T9 for the N-IU 
group were stress, GSE3, diet (T0 – T9), exercise (T0 – T9), certainty (T0 – T9), and 
routines (T0 & T9). Self-treat, routines at T3 and duration were not significantly 
correlated with PAIS at T9. One case was identified in the initial analysis as a 
multivariate outlier and removed.  
 
The initial hierarchical (sequential) regression analysis, with all variables in the 
equation, explained 23.3% (Adjusted R2 = .233) of the variance in PAIS at T9. 
Exercise at T9 had the highest Pearson correlation coefficient (r = .42) of all variables. 
In addition, of the T0 variables, certainty at T0 had the highest correlation (r = .37) with 
PAIS. By contrast, diet at T3 had the lowest significant correlation with PAIS (r = 
.184, p = .034). 
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A suppressor variable was, however, active. Variable signs changed for models three 
and four after the entry of T3 variables. They were removed as F change for these 
models were no longer significant and R2 change had only increased by one percent. 
Elimination of further independent variables occurred if the t-test statistic for the 
variable was not significant (p > .05) on entry or if the R2 change was less than .01. 
Each variable was reintroduced one at a time to test if still non-significant.  
 
Although there were several univariate outliers for routines variable at each test time, 
the initial regression casewise diagnostics did not indicate multivariate outliers. One 
multivariate outlier was identified by casewise diagnostics in a later regression 
analysis. A balance between impact of outliers on the regression model and the loss of 
clinically important data were considered. Nevertheless, the increase in adjusted R2 
after exclusion of the multivariate outlier was sufficient to exclude the case from 
further regression analysis.  
 
The results of the secondary analysis indicated that the variables in the final model 
were able to explain 33% (Adjusted R2 = .33) of the variance in psychosocial 
adaptation to illness. All variables except GSE3 made a significant contribution in the 
final model. From the model summary, GSE3 was entered at step 1 with an adjusted 
R2 = .05 (F▼ {1, 96} = 5.64, p = .02). The addition of stress to the model resulted in an 
adjusted R2 = .18 (F▼ {1, 95} = 16.53, p < .01). The addition of certainty at T0 into the 
model (step 3) resulted in an adjusted R2 = .24 (F▼ {1, 94} = 8.57, p < .01). In the final 
model, the addition of exercise at T9 resulted in an adjusted R2 = .33 (F▼ {1, 93} = 
14.37, p < .01). See Table 5.21 for bivariate Pearson correlations (2-tailed) for each of 
the variables in the model. Table 5.22 displays the Adjusted R2 , R2 change (R26), 
unstandardised regression coefficient (B), standard error of B (SE B) and standardised 
regression coefficient (beta).  
 
 
Table 5.21: Non-insulin using group: Pearson correlation 
results for variables in the final model. 
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Variable: PAIS T9 GSE3 Stress Certainty 
GSE3 .236*    
Stress -.389** -.067   
Certainty .352** .370** -.089  
Exercise T9 .457** .255* -.137 .315** 
* p <.05;  ** p < .01 (2-tailed). 
 
Table 5.22: Non-insulin using group hierarchical multiple regression analysis: 
Significance of selected variables in explaining the variance in psychosocial 
adaptation to illness. 
Step Variable entered Adjusted R2 R2 6 B SE B Beta 
 
1 GSE3 a .05 .06 .10 .043 .24* 















3 GSE3  
Stress 


















4 GSE3  
Stress 
Certainty T0 

























** p < .01:   * p < .05 
 a = squared variables. 
GSE3 = mean of GSE over time. 
 
In the final model, exercise belief at T9 had the highest beta value, indicating it had the 
most impact on psychosocial adaptation to illness when the other variables in the 
equation were held constant. Stress was a close second. The negative beta coefficient 
for stress indicated that as it decreased, psychosocial adaptation to illness increased. In 
relative terms, general efficacy belief had less impact than certainty belief at T0. All 
predictor variables, except GSE3, were significant in the final model. The strength of 
the correlation between GSE3 and exercise (see Table 5.21) is such that exercise 
subsumed GSE3.  
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It should be remembered that the two-item exercise scale at each test time had barely 
adequate alpha coefficients of reliability and more random error than was desirable. As 
such, the scale’s ability to significantly contribute to the explanation of psychosocial 
adaptation to diabetes reflected positively on its usefulness as a predictor. 
 
The condition index and other collinearity diagnostics did not indicate a problem with 
multicollinearity. The condition indices were less than 15, tolerances for all variables 
were greater than 0.8 and VIF less than 2.0. The variance proportions for coefficients 
were less than .5 for all condition indices. 
5.4.3 Hypothesis results  
The order of entry for each of the hierarchical regression analyses was theoretically 
driven. Variables such as stress and GSE3 were entered first, as they were the most 
distant from the dependent variable. In each analysis, the illness specific variables 
were able to improve prediction of psychosocial adaptation. General efficacy belief 
was also a significant predictor of future psychosocial adaptation, but its influence 
varied between the groups. 
 
Hypothesis 4 was partially supported. Evidence in support of hypothesis 4 can be 
found in model 2 for the arthritis group (Table 5.20). Information about general 
efficacy belief improved the prediction of future psychosocial adaptation to illness 
over illness-specific efficacy beliefs for the arthritis group. The moderate beta 
coefficient for general efficacy at T0 (β = .32) indicated it had relatively greater impact 
than the arthritis specific efficacy belief of symptom management (β = .24) at T0. 
However, the relationship was reversed for the N-IU group: certainty at T0 had a 
relatively greater impact (β = .28) than the non-significant general efficacy belief (β = 
.11) (see Table 5.22, Model 3). In the N-IU analyses, general efficacy belief had the 
lowest correlation with PAIS at T9. By contrast, in the arthritis analysis, general 
efficacy belief had the second highest correlation with PAIS at T9. Suggestions and 
implications for this relative difference will be discussed in the next chapter. 
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Hypothesis 5 was supported for both illness groups. Information about concurrent 
illness-specific efficacy belief explained more variance in psychosocial adaptation to 
illness than general efficacy belief could. The evidence to support hypothesis 5 can be 
found in the final regression models for each group. The relative impact of a 
concurrent illness-specific variable on PAIS was greater than the more stable general 
efficacy belief. For the arthritis group, concurrent belief about arthritis symptom 
management was important in explaining psychosocial adaptation to arthritis. For the 
N-IU group, concurrent belief about exercise ability was important in explaining 
psychosocial adaptation to diabetes.  
 
For each illness group, information about the person’s perception of life stress was 
able to explain psychosocial adaptation. The inverse relationship in each analysis 
remained significant after the addition of efficacy belief variables. The unstandardised 
regression coefficient for stress in each equation indicated that perception of life stress 
explained more of the unit change in PAIS for the arthritis group than the N-IU group. 
5.5 SUMMARY 
The research design for this study was aimed at collecting data related to the change in 
efficacy beliefs and their impact on psychosocial adaptation to chronic illness over six 
months. In particular, recently diagnosed individuals were targeted. The mean 
duration of illness, however, was significantly different between each of the illness 
groups with mean duration being lower for both diabetic groups compared to the 
arthritis group.  
 
Psychometric tests used in the study were limited to principal component analysis and 
assessment of internal reliability using Cronbach’s alpha. Three of the four scales met 
a priori standards. The DSES scale, a shortened version of the IMDSES, was used in 
accordance with the underlying constructs indicated by the factor analysis for this 
sample.  
 
Chapter 5: Results 
 139
The six arthritis-specific efficacy beliefs were positively associated with adaptation to 
illness. By contrast, only 11 of 15 diabetes-specific efficacy belief variables were 
positively associated with adaptation to illness in the N-IU group and seven for the IU 
group. Efficacy beliefs about self-treatment ability were not correlated with adaptation 
to illness for the IU or N-IU groups. Furthermore, in this study, there was insufficient 
evidence that age, education and stress influenced adaptation to illness.  
 
This chapter also presented the findings from tests of five hypotheses. Hypotheses 1 to 
3 were consistent with self-efficacy theory. Specifically, that general efficacy belief 
for the adult was stable over time and that specific efficacy belief increased over time. 
The increase in illness-specific beliefs, however, was only significant for one of the 
variables in the arthritis and diabetic groups. The current study was able to confirm 
that the associations between general and specific efficacy beliefs, as measured in this 
study, were significant and the associations increased over time.  
 
The findings for the arthritis and N-IU groups in relation to hypothesis 5 were 
consistent with self-efficacy theory. They indicated that concurrent psychosocial 
adaptation to chronic illness, for the study sample, was best explained by concurrent 
illness-specific efficacy belief. Specifically, the arthritis group efficacy belief about 
concurrent symptom management was a better predictor of psychosocial adaptation to 
illness than, general efficacy belief or initial belief about symptom management. 
Similarly, concurrent diabetes-related belief about exercise ability contributed more to 
explained variance in psychosocial adaptation to illness than earlier certainty belief or 
general efficacy belief.  
 
There was some inconsistency in the data in relation to hypothesis four and the ability 
to predict future psychosocial adaptation to illness based on an initial general belief 
rather than initial illness-specific efficacy beliefs. Results from the arthritis group 
supported the hypothesis but the N-IU data did not. Possible reasons for the findings 
and implications for clinical practice will be discussed in the next chapter.  
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The findings also indicated that an individual’s perception of life stress had an inverse 
relationship in explaining psychosocial adaptation to illness and was consistent for the 
arthritis and N-IU groups in this study. Overall, psychosocial adaptation to illness was 
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CHAPTER 6: DISCUSSION 
Chapter five presented the findings related to the five hypotheses tested to determine 
their support of self-efficacy theory. The assertion in this study, that general efficacy 
belief has an influence on psychosocial adaptation to illness soon after diagnosis had 
not previously been tested in a longitudinal study. The study groups used to test the 
hypotheses were individuals with diabetes or arthritis. By measuring general and 
illness-specific efficacy beliefs concurrently over time, the study sought to explore the 
degree to which these variables explained the variance in future and concurrent 
psychosocial adaptation to illness. In addition, the study sought to explore the period 
during which it was expected that illness-specific efficacy beliefs were still developing 
by comparing them to the more stable general efficacy belief.  
 
The principal findings and the implications for existing diabetes and arthritis self-
management programs are discussed in relation to self-efficacy theory and 
psychosocial adaptation. Strengths and limitations of the current study are reviewed 
separately. Finally, clinical applications and recommendations will be suggested. 
Clinical applications are also addressed in relation to the fifth National Health Priority 
Area for Australia (NHPA): Diabetes mellitus.  
6.1 BACKGROUND TO FINDINGS 
The need for this study was twofold. First, little or no self-efficacy research has been 
conducted on the recently diagnosed chronic illness groups. Findings from studies in 
which the mean illness duration was five or more years cannot expect to be clinically 
useful for self-management programs that target the recently diagnosed. Secondly, 
given that behaviour-specific efficacy beliefs develop as experience with the illness 
regimen increases, the value of concurrent general efficacy belief has not been tested. 
In the early period of learning to manage a chronic illness, general efficacy may 
facilitate the rate at which illness-specific beliefs develop and could be an additional 
resource when confidence in the ability to undertake self-care and cope with the 
normal daily hassles is further taxed in times of undue stress. The first step, however, 
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was to ascertain if there is a role for general efficacy belief in chronic illnesses such as 
diabetes and arthritis. 
6.2 PRINCIPAL FINDINGS 
The contribution of this study to current knowledge of self-efficacy theory is that the 
longitudinal design of the current study was able to provide empirical evidence of the 
change in contribution for general and illness-specific efficacy beliefs to psychosocial 
adaptation in two chronic illnesses requiring very different regimen attributes. That is, 
while the characteristics of the regimens for arthritis and diabetes are complex, there 
are differences in regimen attributes that could account for the findings of the study.  
 
The diabetes regimens for types 2 and 3 diabetes could be described as set daily 
routines with recognised proactive strategies to prevent hypoglycaemia or 
hyperglycaemia before symptoms occur. Individuals may describe their life as being 
controlled by strategies to keep their blood glucose within a set physiological range all 
day, every day. By contrast, the arthritis symptoms are considered to be less 
predictable and more variable in their response to the same stressors, resulting in a 
self-care regimen that is ambiguous and more reactive than proactive.  
 
The study has provided empirical evidence to confirm the notion that general efficacy 
belief is important when the regimen is more ambiguous (Sherer et al., 1982). Based 
on results from the current study, the increasing strength of illness-specific beliefs 
subsumes more of the effect of general efficacy belief when the regimen is well 
defined. Furthermore, the stability of general efficacy belief was established over nine 
months for individuals from three illness groups.  
6.2.1 Prediction of psychosocial adaptation to chronic illness 
Chronic illness management emphasises therapeutic self-care and the need to promote 
the acquisition of personal resources to maintain health-related behaviour 
modification. Cognitive resources such as efficacy belief about ability influence the 
likelihood of engaging in health-promoting or illness prevention behaviours. For 
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example, Pollock (1993) found that people who were more psychosocially adapted 
were more likely to participate in health promoting activities.  
 
Equally, in relation to chronic illness regimen activities, the current study has provided 
empirical evidence in support of the relationship between efficacy beliefs and 
psychosocial adaptation in five domains of functioning as measured in this study. For 
the arthritis group, general efficacy expectation was able to explain more of the 
variance in future psychosocial adaptation than the initial ‘arthritis symptom 
management’ self-efficacy belief. Although this situation was reversed as arthritis 
symptom management belief increased, general confidence in ability remained a 
significant predictor after nine months. Specifically, hypotheses four and five had 
relevance for the arthritis group and are restated here for convenience.  
4. A general efficacy belief (trait) is a better predictor of future adaptation to 
illness than illness-specific efficacy belief. 
5. The influences of illness-specific efficacy beliefs, relative to general efficacy 
belief, are better concurrent predictors of adaptation to illness. 
By contrast, among the type 2 diabetes participants, only hypothesis five was relevant 
in that information about concurrent exercise belief and prior certainty belief, 
contributed more to the understanding of psychosocial adaptation than general efficacy 
belief. Unlike the arthritis group, a general sense of confidence in ability was only a 
significant predictor initially; before illness-specific beliefs subsumed the importance 
of the person’s general efficacy belief. A general efficacy belief was no better than the 
diabetes-specific beliefs. As a predictor of both concurrent and future psychosocial 
adaptation, diabetes-specific efficacy beliefs were better than a general efficacy belief. 
The role difference in general efficacy belief for the arthritis and diabetes type 2 
groups can be explained with reference to the regimen attributes for the illness groups 
tested in this study. 
 
For example, Sherer et al. (Sherer et al., 1982) have suggested that a general efficacy 
belief has a greater role when the behaviour requirement is more ambiguous. Findings 
from the current study suggest that this notion can explain the arthritis group results. 
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The arthritis regimen has a large component of variability in response to symptoms 
that are unpredictable (Katz, 1998; McEvoy et al., 1988). The unpredictability is both 
physiological and a reflection of the person’s psychological state (Freeman et al., 
1996). The ideal is that a balance between rest and activity is maintained at all times, 
that joint protection strategies are used at all times and that medication is taken 
routinely (Lorig & Fries, 1990). For some people, the notion of joint protection is 
confusing and the idea that activity is important sounds contradictory (Arthritis 
Foundation, 1995; Gecht et al., 1996). Given the acknowledged high prevalence of 
non-compliance, the reality of self-care routines is probably different as ‘good’ days 
are to be enjoyed and ‘bad’ days are not predictable.  
 
On the other hand, the diabetic routine is constant, clearly defined, mostly familiar and 
an immediate physiological response to remedial action occurs. It is familiar in that the 
need for a healthy diet and more exercise is well known to most of the community. 
Blood glucose self-management may not be familiar but after an educational program 
the person knows when, why and how it should be done. This is not to say that 
compliance with a diabetic regimen is any better, or that uncertainty of future health 
status is any less than for the non-diabetic population. 
6.2.2 Stability of general efficacy belief 
The current study provides evidence of the relevance of a general level of confidence 
in abilities that is stable and that has been described as a coping resource (Barlow et 
al., 1996) in the context of lifestyle changes necessitated by a complex self-care 
regimen. This finding was consistent for the three illness groups and was stable over 
nine months at a time when illness-specific efficacy beliefs were changing. Also, there 
was tentative evidence that the perceived level of stress or education level influenced 
the general efficacy belief. Variations were not influenced by age, gender or illness 
group.   
6.2.3 Strength of association between general and specific efficacy beliefs 
The association between general and specific efficacy beliefs was significant in both 
the diabetic and arthritis groups. Furthermore, the strength of the association increased 
over time. This finding supported Barlow et al.’s (1996) suggestion for arthritis 
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research and the mixed chronic illness group findings of Becker et al. (1993) and 
Stuifbergen and Becker (1994). The current longitudinal study confirmed the finding 
from both of these studies at three test-times (zero, three and nine months) and 
provided evidence to support hypothesis three. 
6.2.4 Increase in specific efficacy beliefs over time 
The extant self-efficacy literature suggests that behaviour-specific efficacy belief 
develops over time (Bandura, 1991; Stretcher et al., 1986) and is represented by 
hypothesis two. Much of the early self-efficacy research involved an intervention 
aimed at efficacy beliefs for a single behaviour. By comparison, a complex chronic 
illness regimen involves more than one type of behaviour and associated efficacy 
belief, each related to a possible mix of having to start a new behaviour, modify or 
stop an existing behaviour. Hence, chronic illness research has found that, at any one 
time, individuals vary in the strength of their efficacy belief for different behaviours 
(Bandura, 1997) - that is, the increase in behaviour-specific efficacy expectation is not 
consistent across behaviours or context. 
 
In accordance with Bandura (1997), the current study demonstrated that the sources of 
efficacy information common to each group impacted differently on different types of 
behavioural beliefs in each group. For example, the common sources of efficacy 
information included each person’s performance experiences over the study period, 
vicarious experiences from shared stories with friends and family, the level of support 
from others and physiological feedback associated with regimen enactment. Since 
people acted as their own controls, these sources of influence could be assumed to be 
constant for each person. The main efficacy information source that differed between 
the groups was the type of education strategy available in the community. That is, the 
ASMC could be said to facilitate an increase in efficacy beliefs through the 
specifically designed Arthritis Helpbook (Lorig & Fries, 1990) used by all ASMC 
groups contacted for this study. The entire N-IU group had access to a diabetes self-
management course and the smaller IU group relied on individually arranged meetings 
with a Diabetes Educator on a need basis. The diabetes management courses did not 
purport to increase efficacy beliefs but relied upon the debatable association between 
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knowledge and behaviour (Beeney & Dunn, 1990; Brown, 1999; Dunn et al., 1990; 
Rubin et al., 1989).  
 
Thus, the current study’s mix of significant and non-significant increases in arthritis-
specific beliefs was in accordance with the findings in the fibromyalgia and arthritis 
literature (Buckelew et al., 1998; Lorig et al., 1989a; Smarr et al., 1997; Taal et al., 
1993b). Furthermore, the study findings concurred with inferences drawn from the 
diabetes literature about the variability of different behavioural beliefs (Kavanagh et 
al., 1993; Kingery & Glasgow, 1989; Skelly et al., 1995). 
6.2.4.1 Arthritis group 
Although the study involved a non-representative sample of adults with mixed arthritis 
conditions, the findings are in accordance with those obtained in the United States of 
America. The increase in behaviour-specific efficacy beliefs within the other studies 
also resulted in a mix of significant and non-significant arthritis-specific efficacy 
belief findings after an Arthritis Self-Management Course (ASMC) intervention 
(Buckelew et al., 1998; Lorig et al., 1989a; O'Leary et al., 1988; Smarr et al., 1997; 
Taal et al., 1993b). Because most of the arthritis group in the current study was 
recruited through the ASMC, the aim of which was to increase efficacy beliefs, it 
could be said to have had the same result. That is, the results of the current study were 
consistent with research that was based on the standard ASMC offered to community 
participants (Lorig et al., 1989a; O'Leary et al., 1988). Specifically, that the confidence 
to manage pain and other arthritis symptoms increased over nine months as 
participants became significantly more confident in their ability to manage the various 
aspects of their arthritis symptoms. No significant changes in participants’ efficacy 
beliefs were found at three months. This was attributed to the individual’s slow, trial 
and error process of learning what worked best for each arthritis symptom and the 
gradual reciprocal increase in arthritis-specific efficacy beliefs. Smarr et al. (1997) 
found that continued reduction in pain symptoms required time for the effect of 
behaviour change and improvement in emotional response to occur. In all, this aspect 
of the study was able to provide tentative data related to the rate of increase in 
arthritis-specific efficacy beliefs. 
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The arthritis literature strongly suggests that pain perception is closely linked to the 
psychological state more than the medical status (Freeman et al., 1996). The 
intermittent nature of pain and fatigue symptoms and the associated delayed response 
to pain relief measures was something that participants in this study would have 
learned to deal with in their own way. Incremental increases in efficacy beliefs are 
gained from each positive experience with regimen behaviours. 
6.2.4.2 Diabetes group 
Contrary to self-efficacy theory, but ironically in agreement with the prevailing 
diabetes self-efficacy literature, four of the five efficacy belief measures tested in the 
study were unable to demonstrate a significant increase over the nine months of the 
study. The few diabetes studies that did measure the change in diabetes-specific 
efficacy beliefs were either non-significant (Glasgow et al., 1992; McCaul et al., 1987; 
Skelly et al., 1995) or did not report testing for differences (Kavanagh et al., 1993; 
Kingery & Glasgow, 1989). The instruments these researchers used to test efficacy 
beliefs over time may not have had “… sufficient impediment and challenge” 
(Bandura, 1997 p. 43) resulting in high initial scores and ceiling effects referred to by 
Glasgow et al., and in common with the current study’s findings.  
 
Concomitantly, however, certainty belief about diabetes management increased 
significantly in the current study, and could be a reflection of the cumulative increase 
in confidence for abilities related to the other four more situation-specific beliefs. The 
certainty scale included four negatively worded items expressing uncertainty beliefs 
that collectively were not behaviour specific. Given that the mean duration of illness 
for the diabetes type 2 group was 1.6 years, it could be assumed from the high initial 
efficacy beliefs for diet, self-treatment, exercise and diabetes-related routines that 
participants had adjusted to the demands of their condition. The demand made by 
diabetes mellitus does not ease up and can become overwhelming if people are unable 
to integrate the diabetes-related routine into their lifestyle (Fisher et al., 1982; White et 
al., 1992). It could be further argued that anxiety diminished as increased confidence 
about their ability to control the perceived threat (the diabetes) increased.  
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The clinical significance of the study’s findings, however, is greater than the statistical 
significance would suggest. For example, the significant and non-significant increases 
in illness-specific beliefs over the nine months of the study, according to self-efficacy 
theory, would have had a positive impact on behaviour, motivation, thoughts and 
emotions (Bandura, 1977). Incremental changes in efficacy beliefs can ultimately 
reduce the relapse rate (Basler, 1995; Maddux, 1995b). Nevertheless, from a clinical 
perspective, the findings suggest that increases in the various illness specific efficacy 
beliefs are not uniform and are likely to continue over a period greater than nine 
months. The length of time needs to be considered for long term management beyond 
the six-week self-management courses currently on offer. 
6.3 THEORETICAL IMPLICATIONS OF FINDINGS 
A theory provides both an organisational framework for research and clinical practice 
and suggests ideas for further research related to areas not adequately researched. One 
such area is the relevance of single-behaviour, situational specificity of self-efficacy 
theory to recently diagnosed individuals trying to manage a complex regimen of 
therapeutic self-care. That is, the theory’s ability to explain behaviour change soon 
after diagnosis does not include the effect of a general belief in ability when 
behaviour-specific beliefs related to a complex regimen with multiple behaviour 
changes are still developing.  
 
Observations from the current study suggest that general efficacy becomes a personal 
resource to sustain the person until reciprocal reinforcement from positive experiences 
increases the more behaviour-specific belief. Reciprocal in that successful enactment 
of the new behaviour strengthens existing related efficacy beliefs and increases the 
likelihood of behaviour being continued (Bandura, 1997). Since the study did not 
include an intervention, the increase in illness-specific beliefs could be attributed to 
the reciprocal behaviour effect and the outcome of that behaviour over the period of 
the study. The self-management courses attended by most of the arthritis group and the 
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diabetes type 2 group would also have influenced the development of the illness-
specific beliefs.  
 
Nevertheless, the importance of general efficacy belief, as an explanatory variable, 
decreases as behaviour specific beliefs increase and, as the regimen requirements 
become more familiar. Further, it can be postulated that once the behaviour-specific 
beliefs reach a critical point, they subsume the importance of general efficacy belief. 
 
More specifically, while behaviour-specific efficacy beliefs are developing, people’s 
confidence in their abilities in general is a cognitive resource that mediates behaviour 
change and persistence in difficult situations. Thus, a greater general belief in ability is 
more likely to lead to persistence with the requirements of a complex regimen that will 
ultimately facilitate the development of confidence in more regimen-specific abilities. 
Behavioural choices that lead to successful outcomes will build confidence as part of 
an iterative process in which both general and behaviour-specific beliefs have an 
influence. Should the outcome be perceived as less than satisfactory, a general belief 
assists with persistence in the slow trial and error process of seeking a personal 
strategy that works. Inferences about the influence of general beliefs on the slow trial 
and error approach are based on the current study’s finding that the more ambiguous 
the therapeutic regimen, the greater the need for higher efficacy beliefs in general. 
 
The contribution of the study to the theory of self-efficacy has been based on evidence 
from two self-selected illness groups. For a similar group of individuals, the degree to 
which general efficacy continues to contribute to psychosocial adaptation beyond the 
illness duration of the study sample is unknown. It is plausible that the nature of the 
arthritis disease process may require more of an ongoing strong belief in abilities in 
general compared to people with diabetes.  
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6.4 POST HOC FINDINGS OF INTEREST 
6.4.1 Stress as a predictor 
It is acknowledged in the chronic illness literature that the physiological response to a 
competently executed therapeutic regimen is not uniform. Furthermore, it has been 
shown that variations are unrelated to behaviour for the person with arthritis (Affleck, 
Urrows, Tennen, & Higgins, 1992; Nicassio, Wallston, Callahan, Herbert, & Pincus, 
1985; Smith et al., 1990) or diabetes (Cox & Gonder-Frederick, 1992; White et al., 
1992). Ambiguities and uncertainties even under normal circumstances are common in 
chronic illness (White et al., 1992) and hinder the development of routines and habits 
which would normally free up cognitive control and thereby reduce perceived stress. 
When recommended behaviours fail to achieve the desired result, cognitive control is 
important for maintenance of desired behaviour.  
 
Higher levels of self-efficacy, both general and specific, as the cognitive control 
resource explored in the current study, were associated with a lower perception of life 
stress and greater psychosocial adaptation. The IU group in the current study perceived 
life to be significantly more stressful than the N-IU group. Stress for the IU group was 
independent of psychosocial adaptation. The arthritis group’s perception of life stress 
was not significantly different from either diabetic group. In addition, strategies to 
enhance efficacy beliefs are thought to assist in the cognitive control processes 
necessary for stress management. 
 
It should, however, be noted that the relationship between stress and the disease 
process for arthritis or diabetes is complex and this study does not pretend to offer 
further clarity. Only the person’s perception of life stress, a single-item categorical 
variable, was measured in this study. Still, knowledge about the person’s perception of 
life stress was able to predict future and concurrent psychosocial adaptation to arthritis 
and type 2 diabetes. 
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6.4.2 Diet and exercise beliefs 
The variety of diabetes-specific self-efficacy scales in general use prevented direct 
comparisons between studies, but most scales include measures of beliefs about diet 
and exercise. In the current study, the diabetes group as a whole had marginally higher 
diet-efficacy mean scores than exercise scores at T0 and T3, but scores were equal at 
T9. This finding concurs with Kingery and Glasgow (1989) and Padgett (1991) who 
found individuals were least likely to believe in their ability to exercise and had higher 
beliefs about diet. Lifestyle changes such as diet and exercise are consistently found to 
be problematic in diabetic groups (Ary et al., 1986; Glasgow et al., 1987; Skelly et al., 
1995; Wing et al., 1998). 
 
In the current study, males became more confident about their diabetic diet and 
exercise ability over nine months with exercise belief scores for females consistently 
lower than for males and remained unchanged. Likewise, Skelly et al. (1995) found 
that female participants were most confident about medication and BGSM and least 
able to deal with exercise. In their study, dietary beliefs were only slightly higher than 
exercise beliefs. Since Skelly et al.’s study only involved women, the comparative 
results for males using this measure are unknown. Although Fitzgerald et al. (1995) 
and Lo and MacLean (1996) did not measure self-efficacy, both studies found that 
men with diabetes were more likely to exercise than women with diabetes.  
 
These findings were also consistent with survey statistics for the wider Australian 
community. In fact, exercise participation was found to be least likely for women, 
older people, and those with a low education level (Bauman et al., 1990). Similarly, 
the AIHW (1998) indicated that fewer females than males undertook exercise. The 
impact of inactivity becomes even more of a risk when the inactivity further 
compounds an illness condition. 
6.4.3 Duration of illness 
In the current study, psychosocial adaptation to illness did not improve with increasing 
duration of illness for the total sample or illness groups. Duration of illness was 
independent of psychosocial adaptation for the IU and N-IU groups but the arthritis 
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group had a small significant negative association at T9. Hence, duration of illness was 
not a predictor of psychosocial adaptation to illness in the regression analyses. 
Nevertheless, the negative association for the arthritis group could be explained by the 
increasing impact of the chronic illness on various domains of life contributing to 
psychosocial adaptation, together with a better understanding of the long-term 
implications of the disease.  
6.5 STRENGTHS AND LIMITATIONS  
6.5.1 Strengths of the study 
The temporal sequencing of the relationships that were observed in this longitudinal 
study enables a degree of confidence about the direction of causal relationships. 
Comparing the same individuals over time has greater rigour than comparing different 
individuals cross-sectionally. The use of repeated measures enabled participants to 
serve as their own control such that the changes in variables of interest could be 
attributed to predicted changes. The repeated measures problems of carry-over effect, 
latent effect and learning effect should not have influenced the findings as each test 
was separated by three and six months respectively (Carmines & Zeller, 1979). 
Additionally, psychosocial adaptation to illness was only tested twice, six months 
apart.  
 
Without a study intervention, findings reflect the real-life situation for individuals with 
chronic illness. Hence, any changes to practice derived from these findings may have 
more practical consequences (Schwartz & Lellouch, 1967). Findings can be easily 
incorporated into self-management courses. This aspect is discussed in more detail 
later. 
 
The study was also able to predict psychosocial adaptation to illness over an extended 
period of time for two illness groups and demonstrated that illness-specific self-
efficacy was an appropriate and modifiable psychological factor to facilitate illness 
adaptation. Given the differences in explanatory power that general and specific self-
efficacy demonstrated in the study, however, the usefulness of self-efficacy theory to 
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psychosocial adaptation for a non-insulin using diabetes group might not be as strong 
as other psychological constructs.  
 
The fourth strength relates to the instruments used in the study. The psychometric 
properties for three of the four instruments were confirmed in the current study 
through principal component analysis and Cronbach’s internal reliability coefficient. 
The structure for each instrument was stable over time and concurred with their use in 
other studies.  
 
In relation to the psychometric testing of one of these three instruments, general 
efficacy, it has been extensively tested elsewhere and comparisons between previous 
findings and this study indicated a similar outcome. The internal reliability at each test 
time and the intra-class correlation coefficient indicated that the scale was reliable and 
stable over nine months. The sample used in the current study was therefore able to 
provide further empirical evidence that efficacy belief related to abilities in general 
was stable in adulthood (Jerusalem & Mittag, 1995; Sherer, 1992). Furthermore, the 
probability of erroneously accepting the null hypothesis was small (β = .02). As 
recommended by Woodruff and Cashman (1993), the study also confirmed the 
usefulness and stability of Sherer et al.’s (1982) general subscale in a domain other 
than in which it was developed. Moreover, the concomitant increase in illness-specific 
efficacy beliefs did not influence the stability of general efficacy belief. Other 
researchers can use the instrument with confidence. 
 
The study also confirmed the work of Barlow et al. (1996) who studied participants 
with a chronic illness. Their study included a different general efficacy scale 
(Jerusalem & Schwarzer, 1992) and found general efficacy was stable over four 
months for an adult sample of mixed arthritis conditions. In addition, they also found 
that general efficacy was independent of age. In the current study, age, gender and 
illness did not influence general efficacy belief. This finding also confirmed an earlier 
result by the author in which general efficacy belief was not found to differ between 
two diabetic groups (Rapley, 1989).   
Chapter 6: Discussion 
 154
 
The fourth instrument, Diabetes Self-Efficacy Scale (DSES), was used according to 
the underlying constructs identified by the principal component analysis of the current 
study. The stability of the five component DSES structure at each test time was 
established. In addition, although the internal reliability for one scale (exercise) was 
below the accepted level for Cronbach’s alpha, it was sufficiently robust to explain 
much of the variance in psychosocial adaptation for the N-IU group.  
 
The use of two generic measures (GSE and PAIS) enables findings from the research 
to be coupled with studies of adaptation to other medical conditions. Comparing the 
results with the larger literature of health sciences and psychology is important for the 
development of knowledge specific to chronic illness research and its application to 
self-care interventions.  
6.5.2 Limitations of the study 
The between-group differences in this study could be a reflection of idiosyncratic 
illness attributes or a reflection of the differences in resources available to each group. 
For example, the arthritis group had access to a self-management course that purported 
to follow efficacy enhancement strategies. By comparison, of the two diabetes groups, 
only the non-insulin dependent group had access to a self-management program; albeit 
one that did not utilise efficacy enhancement strategies specifically. The insulin-using 
group had individual tuition. Neither the idiosyncratic illness attributes, discussed 
earlier, nor the direct impact of the differences in educational strategy were explored 
as part of the current study. 
 
Other limitations to the ability to generalise the results outside the sample relate to the 
statistical limitations of sample size and skewed data. As it was, the incidence of 
accessible individuals who could be said to want to learn how to manage their 
condition was barely sufficient in the time available for data collection. This could 
have accounted for the skewed data that transformations were unable to normalise. 
Consequently, tests of significance were largely restricted to non-parametric methods. 
The use of distribution free tests resulted in a slight loss of power and increased the 
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possibility of erroneously accepting a null hypothesis. See earlier discussion related to 
power in section 4.5: Analysis of Data. 
 
The IU group was not large enough for factor analysis of the Insulin Management 
Self- Efficacy Scale (IMDSES). Replication of the structure for the IMDSES was not 
possible and the lack of consistency in the literature related to diabetes-specific 
efficacy measures was not made any clearer by this study. For example, the underlying 
constructs for the 18-item DSES scale identified through principal component analysis 
could not be compared to other studies. Given that the DSES as used with the current 
sample has not been used in other studies, measurement error is a possible cause for its 
low to moderate correlation with psychosocial adaptation. Continued research using 
the IMDSES and DSES is needed to accrue evidence of scale validity and reliability. 
 
Another limitation associated with sample size was the inability to include interaction 
terms in the regression analyses for the arthritis or N-IU groups. Although the diabetic 
groups were combined for testing hypotheses two and three, it was not appropriate to 
combine the IU and N-IU samples in the regression analysis, even controlling for 
diabetes type, as stress was significantly different for both groups and interaction 
terms would be needed.  
 
The method used to determine duration was another limitation. Computing duration of 
illness from age minus age at diagnosis, when the latter was only recorded by number 
of years since diagnosis, created doubt as to the true variability for duration for each 
group. Also, within the IU group, duration of illness did not reflect duration of insulin 
use for the insulin requiring participants. Hence, given the insufficient sample size for 
factor analysis of the Insulin Management Diabetes Self-efficacy Scale and lack of 
data about duration of insulin use, the lifestyle focus intended for the IU group was not 
explicated sufficiently in this study. 
 
The study’s design limitations included sample selection. The population actually 
sampled may have differed from the target population. Individuals who do not attend a 
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self-management course may differ on some key variable from those who choose to 
attend. Hence, conclusions that generalise the data beyond the sample could be 
misleading and should only be applied to a similar community sample.  
 
The current study attempted to select participants who were attending self-
management classes with the intention of changing behaviour. The expectation was to 
measure changes in efficacy beliefs over nine months. Given that efficacy beliefs were 
negatively skewed, a retrospective view might now draw the conclusion that the self-
management course was only useful to confirm current behaviour and therefore 
without behaviour change, the reciprocal effect on efficacy belief did not occur. 
Another factor contributing to the outcome may be that individuals with high efficacy 
beliefs in relation to their ability to change behaviour in accordance with the illness 
regimen were more likely to choose to attend self-management classes. Certainly, the 
work of Prochaska et al. (1993) suggests that individuals who are not ready to make 
the behaviour change would not enrol in the class. Alternatively, the instruments may 
not have had sufficient discriminative power to detect the change in efficacy belief 
over nine months.  
 
Finally, issues of gender and multicultural influences on psychosocial adaptation to 
illness were not addressed in the study. Gender differences were identified for the 
diabetes-specific efficacy beliefs but not for arthritis-specific efficacy beliefs. The 
degree to which the regression models used to explain psychosocial adaptation for two 
of the illness groups were also equally relevant to gender groups could not be tested.  
6.6 PRACTICAL IMPLICATIONS OF THE FINDINGS 
The biomedical approach to chronic illness is of limited value without concurrent use 
of theory that purports to influence behaviour. Interventions that are based on theory 
derive, not only strategies from the theory, but also provide a rationale for an 
evaluation format. A recent study (Hunt et al., 1998) of practitioner perspectives in 
relation to management of type 2 diabetes found that strategies to increase compliance 
with a diabetic regimen continued to focus on education but without substantive 
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theory. The assumption was that a person’s lack of knowledge and or self-control were 
the causes of poor health outcomes. Hunt et al. found that practitioners gave minimal 
recognition to patients’ socio-economic constraints and other competing lifestyle 
choices or psychosocial factors that could be of more importance to the person.  
 
It takes a good deal of planning and effort for an individual to maintain a routine to 
manage blood glucose levels or arthritic pain. Even with occasional departures from 
the routine, the person relies on personal confidence and support from others. If non-
compliance is the norm (Blackwell, 1992; Dunn, 1986; Leventhal & Cameron, 1987), 
intervention strategies need to change from guilt-driven pressure to perform, 
regardless of choices and context, to one in which facilitation of confidence in ability 
and belief in outcome are the foci. 
6.6.1 Self-management courses 
Self-management courses that apply the principles of self-efficacy theory by building 
on the four sources of efficacy information, facilitate not only confidence in the ability 
to manage the disease process and a belief that the outcome is worth the effort, but 
pursuant to that, can also improve psychological well-being. The four sources of 
efficacy information that can contribute to this process include enactment of the 
behaviour, persuasion, vicarious learning and emotional feedback provided by the 
experience. This study has helped to resolve the original question of whether general 
efficacy belief can assist with the process of psychosocial adaptation when illness-
specific efficacy beliefs are still developing. The study found that general efficacy 
belief needs to be considered in chronic illness self-management courses, but more 
specifically, it is important when the regimen is complex and or ambiguous. 
 
Inferences from this study suggest that individuals who lack confidence in their 
abilities in general need to be given additional assistance with stress management, self-
regulation skills and coping strategies. In particular, persons with arthritis who have a 
low efficacy belief in relation to life generally and low illness-specific efficacy beliefs 
(one or more) are more at risk of relapse than individuals who at least have a higher 
general efficacy belief. Confidence in ability is susceptible to a variety of internal and 
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external influences including self-referent processes, support networks and health care 
professionals. According to self-efficacy theory, greater efficacy belief about ability or 
a belief that the disease process can be influenced regardless of ability determines the 
degree of effort or persistence in a difficult situation (Bandura, 1986).  
 
Apart from the person’s general efficacy belief, the Diabetes Self-Efficacy Scale 
(DSES), after further psychometric testing, could be used initially as a diagnostic 
measure to guide specific efficacy enhancement strategies aimed at one or more of the 
diabetes-related efficacy beliefs found to be low or in need of strengthening. The self-
efficacy literature has consistently found within-individual variations for different 
behaviour specific efficacy beliefs (Bandura, 1997). Subsequent use of the scale 
(DSES) by the Diabetes Educator could be to assess changes in efficacy beliefs and to 
assess the person’s continuing needs related to each of the efficacy beliefs.  
 
An additional challenge for self-management courses is the need to devise strategies to 
maintain behaviour change. Long-term compliance with a therapeutic regimen is more 
difficult than any short-term behaviour change (Sluijs & Knibbe, 1991; Taal et al., 
1993b; Wing et al., 1998) because most people do not want their lifestyle changed by a 
self-care regimen. Accordingly, the intervention focus needs to be on a sense of 
balance, to feel normal and to live with the illness rather than controlled by the 
regimen. By increasing the person’s confidence in their self-regulation abilities, 
maintenance of behaviour change is possible. Benefits may also accrue in other areas 
of life and co-morbidity.  
6.6.2 National Health Priority Areas: Diabetes mellitus 
The principles of a diabetes self-care regimen related to exercise and diet are also 
relevant to other health risk groups as well as to the general adult population. People 
with diabetes may have an increased risk of coronary occlusion or cerebro-vascular 
accident, but these conditions are also prevalent in non-diabetics who have 
hypertension, smoke, are overweight, do not exercise or have a high cholesterol level.  
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Diabetes and cardiovascular health were both identified as National Health Priority 
Areas (NHPA). The putative causal explanations for cardiovascular disease given in 
the literature are as equally valid for the general population as they are for the diabetic 
population, but the risk is just greater for the diabetic population. The purpose of the 
National evidence-based guidelines for the management of type 2 diabetes mellitus 
(National Health and Medical Research Council, 2000) encompasses both primary and 
secondary prevention. The first goal is to increase the community’s awareness of risk 
factors for type 2 diabetes to try and prevent new cases. The second goal is to reduce 
the number of undiagnosed diabetes type 2 individuals. Increasing the diagnosis rate of 
type 2 diabetes can help to delay the onset of diabetes-related complications by 
treating the diabetes earlier. Complications are often the trigger for diagnosis. Early 
detection of type 2 diabetes delays not only the onset of complications, but also 
reduces health care costs (Western Australian Diabetes Services Taskforce, 1999). 
 
Increasing the diagnosis rate will, however, also increase the demand for diabetes 
specific self-management courses. The challenge is that the Western Australian 
Diabetes Strategy 1999 report indicated that universal standards for diabetes education 
did not exist (Western Australian Diabetes Services Taskforce, 1999). Combined with 
results from the diabetic sample in the current study, it could be argued that more of 
the same may not be enough, and the development of a common strategy is overdue. A 
common strategy along the lines used by Arthritis Australia in each of the State 
branches would be a worthy goal.  
 
Ideally, a self-management course needs to be inexpensive and able to be replicated in 
many sites. It also needs to demonstrate more than an increase in knowledge. Results 
from the American Arthritis self-management course evaluations that were completed 
over the last decade or more have consistently indicated that a linear relationship 
between knowledge and behaviour change, or between knowledge and improved 
health outcomes does not exist (Lorig & Holman, 1993; Lorig & Laurin, 1985; Lorig 
et al., 1989b). Furthermore, the link between diabetes-specific efficacy beliefs and 
health status is stronger than the link between behaviour and health status (Anderson et 
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al., 1995; Johnson, 1992). Hence, utilisation of self-efficacy theory strategies to help 
individuals maintain and engage in therapeutic self-care skills are likely to improve 
metabolic control and or control weight to improve blood pressure.  
6.7 RECOMMENDATIONS 
There are a number of recommendations that arise from the study including those 
already discussed under practical implications. In particular, before the findings of the 
study can be considered reliable and valid, it should be replicated with the inclusion of 
intervention and control groups and, if possible, random assignment to each group. 
Alternatively, a matched sample design could be used. A multi-site study in more than 
one Australian State would also overcome the problem of low incidence of recently 
diagnosed individuals at one site. If more than one illness group is included, a 
mechanism to disentangle the effect of differences in illness and course attributes is 
also required. Or else, an efficacy enhancing self-management course that could meet 
the common needs of a variety of chronic illness regimens could be considered.  
 
The increasing age-related incidence of chronic illness in Australia and the scarce 
resources in less populated areas would suggest that a mechanism whereby efficacy 
beliefs for behaviour change common to several chronic illnesses be targeted. 
Interventions that can be proven to make a difference across chronic illness types will 
be more cost effective and more likely to meet community needs than a multitude of 
illness specific self-management courses that cannot be run frequently enough because 
of limited numbers. Knowledge about the illness and rationale for the regimen is 
important but it is the person’s belief in their own ability to carry out the behaviour, to 
problem solve, to motivate self and set realistic goals that makes the difference. These 
beliefs in coping ability are common to many self-care regimens and the basis for an 
empowerment approach using self-efficacy theory.  
6.8 CONCLUSION 
Although the results of the study can not be generalised beyond a similar community 
sample, the findings suggest that individuals who are more confident in relation to 
Chapter 6: Discussion 
 161
their illness-related behaviours and confident of their abilities in general are more 
likely to be psychosocially well adjusted.  
 
The theoretical implication that can be drawn from the study is that a generalised 
belief in self is a personal resource soon after diagnosis. Its importance to psychosocial 
adaptation, however, decreases as situation-specific confidences increase. Of particular 
relevance to chronic illness self-management courses that serve recently diagnosed 
individuals, therefore, is the need to consider their level of confidence in abilities in 
general. In addition, it could be argued that the less explicit the illness regimen, the 
more likely that general efficacy belief will be predictive of psychosocial adaptation. 
 
Efficacy beliefs are important determinants, not only of behaviour, but also of methods 
of empowerment that operate through self-efficacy mechanisms (Bandura, 1986). If 
increased efficacy belief is the desired outcome, then self-management courses 
become a process designed to improve psychosocial adaptation by enabling 
individuals to take charge of their health through informed choices and personal goals. 
The challenge for health care professionals is to devise a self-management program 
that can influence behaviour while recognising that individuals still have to find what 
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Pat Rapley 
School of Nursing 
Curtin University of Technology 
GPO Box U 1987 
Perth 6845 
Dear Sir/ Madam, 
I am a Registered Nurse and a student enrolled at Curtin University of Technology. 
This study has the approval of the University as well as the Arthritis Foundation and 
this letter is to explain the research. 
 
Persons with a condition that necessitates long term changes to diet or lifestyle in any 
way have largely been overlooked in the investigation of health-related self-care 
behaviours. Self-care behaviours are the things you do to care for your condition. 
 
If you agree to help, at three different times over the next year you will be asked to 
answer a number of written questions about self-care, and about the things you are 
asked to do by your doctor or other health care professionals. Some questions will be 
about your life in general and how you feel about the things that help or hinder your 
ability to carry out these self-care routines. 
 
The questions will take about 25 minutes to answer. You will not have to hurry to 
answer the questions. You will not be identified by any answer you give and your 
answers will not affect the health care you receive. No appointments are needed, there 
are no costs and all information is confidential. The results of this study will be 
published in a health care journal as well as being made available to the newsletter of 
the Arthritis Association. 
 
You may ask any questions to help you be clear about the study now or at any time 
over the next 12 months. My name is Pat Rapley and I can be contacted by phoning 
xxxxxxx. Should you agree to participate, you still have the right to withdraw from the 
study at any time without prejudice to your medical management. That is, your 
withdrawal will not affect any future medical contacts or treatments. 
 
You may withdraw from the study at any time by phoning the above number. 
Thank you for reading and thinking about this information. If satisfied and you would 












CONSENT FORM: Health Related Self-Care Behaviour Study. 
 
 
I _______________________________ have read the information in the letter and questions 
I have asked have been answered to my satisfaction. I agree to participate in this project, 
realising that I may withdraw at any time. I agree that research data gathered for the study 
may be published provided my name is not used.  
 
Signature:      Date: 
Address: 













A student from Curtin University of Technology is looking for people to answer some 
questions related to managing diabetes. The questions are part of a research project 
approved by this hospital and the University. Her name is Pat Rapley and she 
particularly needs people like you to volunteer.  
 
Persons with a condition that necessitates long term changes to diet or lifestyle in any 
way have largely been overlooked in the investigation of health-related self-care 
behaviours. Self-care behaviours are the things you do to care for your condition. 
If you agree to help, at three different times over the next year you will be sent a 
questionnaire about self-care, and about the things you are asked to do by your doctor 
or other health care professional. Some questions will be about your life in general and 
how you feel about the things that help or hinder your ability to carry out these self-
care routines. 
 
The questions will take about 25 minutes to answer. You will not have to hurry to 
answer the questions. You will not be identified by any answer you give and your 
answers will not affect the health care you receive. No appointments are needed, there 
are no costs and all information is confidential.  
Pat Rapley can be contacted by phoning xxxxxxx. She will answer any questions to 
help you be clear about the study at any time. Should you agree to participate, you still 
have the right to withdraw from the study at any time without prejudice to your 
medical management. That is, your withdrawal will not effect any future medical 
contacts or treatments. 
 
You may withdraw from the study at any time by phoning the above number. 
Thank you for reading and thinking about this consent information. If satisfied and you 
would like to take part, please sign the attached Consent Form and return in the 
envelope provided. A questionnaire will then be sent to you with a return addressed 
envelope. 
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   RA Identification No:   (1-3) 
    Record No:    (4-5) 
 
The first set of questions relate to demographic data to be completed at this contact 
time only. The other questions seek your views on specific matters. The questions 
may, at times, appear to be repeated but they are seeking different aspects of the same 
topic. I realise that your time is valuable and do not wish to ask any unnecessary 
questions.  
 




1 Please indicate your gender 
(Please circle one number) 
 
  Male 
  Female 
1 
2 
2 Please give your age in 
years. 
 
(Fill in boxes provided)  
3 What was your age when 
first diagnosed? 
 
(Fill in boxes provided)  
4 What is your highest level 
of education? 
(Please circle one number) 
Less than year 10 
Secondary school year 10 





Postgraduate or higher 
Other ______________ 












5 What is your marital 
status? 
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6 How stressful do you 
consider your life? 
(Please circle one number) 
 













7 What is your weight in kg? 




Office use only:  
 kg 
BMI:------------ = _____ 
 . m2 
 





  <20    = 1 
  20-25 = 2 
  25-30 = 3 
  >30    = 4 
 
 
8 What type of arthritis do you 
have? 
























Variation for Diabetic group 
 
8 What type of Diabetes do you 
have? 
(Please circle one number 
only) 
 
Insulin dependent (type 1) 
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This questionnaire is a series of statements about your personal attitudes and traits. 
Each statement represents a commonly held belief. Read each statement and decide to 
what extent it describes you. There are no right or wrong answers. You will probably 
agree with some of the statements and disagree with others. Please indicate your own 
personal feelings about each statement below by marking the number that best 
describes your attitude or feeling. Please describe yourself as you really are. 
 
Circle 1 if you disagree strongly (DS) with the statement. 
 2 if you disagree moderately (DM) with the statement. 
 3 if you neither disagree nor agree (?) with the statement. 
 4 if you agree moderately (AM) with the statement. 
 5 if you agree strongly (AS) with the statement. 
 
  DS DM ? AM AS 
1 When I make plans, I am certain I can make 
them work. 
 
1 2 3 4 5 
2 One of my problems is that I cannot get 
down to work when I should. 
 
1 2 3 4 5 
3 If I can't do a job the first time, I keep 
trying until I can. 
 
1 2 3 4 5 
4 When I set important goals for myself I 
rarely achieve them. 
 
1 2 3 4 5 
5 I give up on things before completing them. 
 
1 2 3 4 5 
6 I avoid facing difficulties. 
 
1 2 3 4 5 
7 If something looks too complicated I will 
not even bother to try it. 
 
1 2 3 4 5 
8 When I have something unpleasant to do, I 
stick to it until I finish. 
1 2 3 4 5 
9 When I decide to do something, I go right to 
work on it 
 
1 2 3 4 5 
10 When trying to learn something new I soon 
give up if I am not initially successful 
 
1 2 3 4 5 
11 When unexpected problems occur, I don't 
handle them well. 
 
1 2 3 4 5 
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  DS DM ? AM AS 
12 I avoid trying to learn new things when they 
look too difficult for me. 
 
1 2 3 4 5 
13 Failure just makes me try harder. 
 
1 2 3 4 5 
14 I feel insecure about my ability to do things. 
 
1 2 3 4 5 
15 I am a self-reliant person. 
 
1 2 3 4 5 
16 I give up easily. 
 
1 2 3 4 5 
17 I do not seem capable of dealing with most 
problems that come up in my life. 
1 2 3 4 5 
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This survey asks you to rate your degree of confidence for being able to carry out your 
diabetes-related activities. There are no right or wrong answers. After reading each 
statement, circle the number that best expresses your belief.  
1 = strongly agree.    2 = moderately agree. 3 = slightly agree 
6 = strongly disagree.   5 = moderately disagree.   4 = slightly disagree. 
Circle 0 if the statement does not apply to you. 
 
1 I can carry out practically all of the self-care 
activities in my daily diabetes routine. 
 
1 2 3 4 5 6 0 
2 I am confident in my ability to manage my 
diabetes. 
 
1 2 3 4 5 6 0 
3 I feel unsure about having to use what I know 
about diabetes self-treatment every day. 
 
1 2 3 4 5 6 0 
4 I don’t think I can follow my diabetes routine 
every single day. 
 
1 2 3 4 5 6 0 
5 I can eat my meals at the same time every day. 
 
1 2 3 4 5 6 0 
6 I can stay on my diabetic diet when I eat in 
familiar places away from home (such as a 
friend’s house). 
 
1 2 3 4 5 6 0 
7 I can stay on my diabetic diet when I eat in 
unfamiliar places. 
 
1 2 3 4 5 6 0 
8 I’m not sure I’ll be able to stay on my diabetic 
diet when the people around me don’t know 
that I have diabetes. 
 
1 2 3 4 5 6 0 
9 I’m not sure I’ll be able to follow my diabetic 
diet every day. 
 
1 2 3 4 5 6 0 
10 When I go to parties, I can follow my diet plan. 
 
1 2 3 4 5 6 0 
11 I can exercise several times a week. 
 
1 2 3 4 5 6 0 
12 I can’t exercise unless I feel like exercising. 
 
1 2 3 4 5 6 0 
13 I can figure out when to call my doctor about 
problems with my feet. 
1 2 3 4 5 6 0 
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14 I can routinely apply the recommended lotion 
to my feet. 
 
1 2 3 4 5 6 0 
15 I cannot test my blood when away from home. 
 
1 2 3 4 5 6 0 
16 I can recognise when my blood sugar is too 
high. 
 
1 2 3 4 5 6 0 
17 When I feel sick, I can test my blood more than 
I routinely do. 
 
1 2 3 4 5 6 0 
18 I can take my insulin using the recommended 
procedure. 
 
1 2 3 4 5 6 0 
19 I may have difficulty taking my insulin when 
away from home. 
 
1 2 3 4 5 6 0 
20 I can adjust my insulin dose based on the 
results of my blood test. 
 
1 2 3 4 5 6 0 
21 I’m not sure I can figure out what to do about 
my insulin dose when changes occur in my 
usual routine. 
 
1 2 3 4 5 6 0 
22 
(18) 
I can do what was recommended to prevent 
low blood sugar reactions. 
 
1 2 3 4 5 6 0 
23 
(19) 
I can figure out what self-treatment to 
administer when my blood sugar gets higher 
than it should be. 
 
1 2 3 4 5 6 0 
24 
(20) 
I’m not sure I can recognise when my blood 
sugar is low. 
 
1 2 3 4 5 6 0 
25 
(21) 
I’m not sure I can adjust my diabetes self-
treatments if I get a cold or the flu. 
 
1 2 3 4 5 6 0 
26 
(22) 
I can fit my diabetes self-treatment routine into 
my usual lifestyle. 
 
1 2 3 4 5 6 0 
27 
(23) 
I think I’ll be able to follow my diabetes plan 
even when my daily routine changes. 
1 2 3 4 5 6 0 
 
Shaded areas indicate questions deleted to form the DSES
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In the following questions, we’d like to know how your arthritis pain affects you. For 
each of the following questions, please circle the number that corresponds to your 
certainty that you can now perform the following tasks. Please use the scale diagram 
to select the number. 
 
   1 2 3 4 5 6  0 
   very  moderately  very  not 
   uncertain uncertain  certain  applicable 
 
1 How certain are you that you can decrease you 
pain quite a bit? 
 
1 2 3 4 5 6 0 
2 How certain are you that you can continue most of 
your daily activities? 
 
1 2 3 4 5 6 0 
3 How certain are you that you can keep arthritis 
pain from interfering with your sleep? 
 
1 2 3 4 5 6 0 
4 How certain are you that you can make a small-to-
moderate reduction in your arthritis pain by using 
methods other than taking extra medication? 
 
1 2 3 4 5 6 0 
5 How certain are you that you can make a large 
reduction in your arthritis pain by using methods 
other than taking extra medication? 
1 2 3 4 5 6 0 
 
We would like to know how confident you are in performing certain daily activities. 
For each of the following questions, please circle the number that corresponds to your 
certainty that you can perform the tasks as of now, without assistive devices or help 
from another person. Please consider what you routinely can do, not what would 
require a single extraordinary effort. 
 
AS OF NOW, HOW CERTAIN ARE YOU THAT YOU CAN: 
1 walk 100 feet / 30 metres on flat ground in 20 
seconds? 
 
1 2 3 4 5 6 0 
2 walk ten steps downstairs in 7 seconds? 
 
1 2 3 4 5 6 0 
3 get out of an armless chair quickly, without using 
your hands for support? 
 
1 2 3 4 5 6 0 
4 button and unbutton 3 medium-size buttons in a 
row in 12 seconds? 
 
1 2 3 4 5 6 0 
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5 cut 2 bite-size pieces of meat with a knife and fork 
in 8 seconds? 
 
1 2 3 4 5 6 0 
6 turn an outdoor tap all the way on and all the way 
off? 
 
1 2 3 4 5 6 0 
7 scratch your upper back with both your right and 
left hands? 
 
1 2 3 4 5 6 0 
8 get in and out of the passenger side of a car 
without assistance from another person and 
without physical aids? 
 
1 2 3 4 5 6 0 
9 put on a long-sleeved front-opening shirt or blouse 
(without buttoning) in 8 seconds? 
1 2 3 4 5 6 0 
 
In the following questions, we’d like to know how you feel about you ability to control 
your arthritis. For each of the following questions, please circle the number that 
corresponds to your certainty that you can now perform the following activities or 
tasks 
 
1 How certain are you that you can control your 
fatigue? 
 
1 2 3 4 5 6 0 
2 How certain are you that you can regulate your 
activity so as to be active without aggravating 
your arthritis? 
 
1 2 3 4 5 6 0 
3 How certain are you that you can do something to 
help yourself feel better if you are feeling blue? 
 
1 2 3 4 5 6 0 
4 As compared with other people with arthritis like 
yours, how certain are you that that you can 
manage arthritis pain during your daily activities? 
 
1 2 3 4 5 6 0 
5 How certain are you that you can manage your 
arthritis symptoms so that you can do the things 
you enjoy doing? 
 
1 2 3 4 5 6 0 
6 How certain are you that you can deal with the 
frustration of arthritis? 
1 2 3 4 5 6 0 
 
 
 
